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Abstract
Imaging tests for the detection of osteomyelitis:
a systematic review
Alexis Llewellyno ,1 Julie Jones-Dietteo ,1 Jeannette Krafto ,2
Colin Holton,2 Melissa Harden1 and Mark Simmondso 1*
1Centre for Reviews and Dissemination, University of York, York, UK
2Leeds Teaching Hospitals NHS Trust, Leeds, UK
*Corresponding author mark.simmonds@york.ac.uk
Background: Osteomyelitis is an infection of the bone. Medical imaging tests, such as radiography,
ultrasound, magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT)
and positron emission tomography (PET), are often used to diagnose osteomyelitis.
Objectives: To systematically review the evidence on the diagnostic accuracy, inter-rater reliability and
implementation of imaging tests to diagnose osteomyelitis.
Data sources: We conducted a systematic review of imaging tests to diagnose osteomyelitis. We searched
MEDLINE and other databases from inception to July 2018.
Review methods: Risk of bias was assessed with QUADAS-2 [quality assessment of diagnostic accuracy
studies (version 2)]. Diagnostic accuracy was assessed using bivariate regression models. Imaging tests
were compared. Subgroup analyses were performed based on the location and nature of the suspected
osteomyelitis. Studies of children, inter-rater reliability and implementation outcomes were synthesised
narratively.
Results: Eighty-one studies were included (diagnostic accuracy: 77 studies; inter-rater reliability: 11 studies;
implementation: one study; some studies were included in two reviews). One-quarter of diagnostic accuracy
studies were rated as being at a high risk of bias. In adults, MRI had high diagnostic accuracy [95.6%
sensitivity, 95% confidence interval (CI) 92.4% to 97.5%; 80.7% specificity, 95% CI 70.8% to 87.8%].
PET also had high accuracy (85.1% sensitivity, 95% CI 71.5% to 92.9%; 92.8% specificity, 95% CI 83.0%
to 97.1%), as did SPECT (95.1% sensitivity, 95% CI 87.8% to 98.1%; 82.0% specificity, 95% CI 61.5% to
92.8%). There was similar diagnostic performance with MRI, PET and SPECT. Scintigraphy (83.6% sensitivity,
95% CI 71.8% to 91.1%; 70.6% specificity, 57.7% to 80.8%), computed tomography (69.7% sensitivity,
95% CI 40.1% to 88.7%; 90.2% specificity, 95% CI 57.6% to 98.4%) and radiography (70.4% sensitivity,
95% CI 61.6% to 77.8%; 81.5% specificity, 95% CI 69.6% to 89.5%) all had generally inferior diagnostic
accuracy. Technetium-99m hexamethylpropyleneamine oxime white blood cell scintigraphy (87.3%
sensitivity, 95% CI 75.1% to 94.0%; 94.7% specificity, 95% CI 84.9% to 98.3%) had higher diagnostic
accuracy, similar to that of PET or MRI. There was no evidence that diagnostic accuracy varied by scan
location or cause of osteomyelitis, although data on many scan locations were limited. Diagnostic accuracy
in diabetic foot patients was similar to the overall results. Only three studies in children were identified;
results were too limited to draw any conclusions. Eleven studies evaluated inter-rater reliability. MRI had
acceptable inter-rater reliability. We found only one study on test implementation and no evidence on
patient preferences or cost-effectiveness of imaging tests for osteomyelitis.
Limitations: Most studies included < 50 participants and were poorly reported. There was limited evidence
for children, ultrasonography and on clinical factors other than diagnostic accuracy.
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Conclusions: Osteomyelitis is reliably diagnosed by MRI, PET and SPECT. No clear reason to prefer one test
over the other in terms of diagnostic accuracy was identified. The wider availability of MRI machines, and
the fact that MRI does not expose patients to harmful ionising radiation, may mean that MRI is preferable in
most cases. Diagnostic accuracy does not appear to vary with the potential cause of osteomyelitis or with
the body part scanned. Considerable uncertainty remains over the diagnostic accuracy of imaging tests in
children. Studies of diagnostic accuracy in children, particularly using MRI and ultrasound, are needed.
Study registration: This study is registered as PROSPERO CRD42017068511.
Funding: This project was funded by the National Institute for Health Research Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 61.
See the NIHR Journals Library website for further project information.
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Glossary
Diagnostic odds ratio Ratio of odds of sensitivity to odds of specificity (summarises diagnostic accuracy).
Diphosphono-1,2-propanodicarboxylic acid A substance used in scintigraphy.
False negative Incorrect negative test result – an affected individual with a negative test result.
False positive Incorrect positive test result – an unaffected individual with a positive test result.
Fludeoxyglucose A radiopharmaceutical used in positron emission tomography.
Hexamethylpropyleneamine oxime A substance used in scintigraphy.
Histopathology The microscopic study of tissue samples to enable the diagnosis of osteomyelitis.
(Hydroxy)methylene diphosphonate A substance used in scintigraphy.
Index test The test for which diagnostic accuracy is being evaluated.
Indium-111 A radioisotope used in scintigraphy.
Meta-analysis Statistical (or quantitative) techniques used to combine the results of two or more studies
and obtain a combined estimate of effect.
Microbiology A laboratory method used to diagnose osteomyelitis; a microbiological culture involves
multiplying microbial organisms by letting them reproduce under controlled laboratory conditions.
Negative predictive value Proportion of people who test negative (for osteomyelitis) who do not have
the condition.
Positive predictive value Proportion of people who test positive who have the condition.
Positive rate Proportion of people with a positive index test result (i.e. who might be diagnosed
with osteomyelitis).
Sensitivity Proportion of people with the condition (osteomyelitis) who are correctly diagnosed.
Specificity Proportion of people without the condition who are correctly diagnosed.
Technetium-99m A radioisotope used in scintigraphy and single-photon emission computed tomography.
True negative A correct negative test result – an unaffected individual with a negative test result.
True positive A correct positive test result – an affected individual with a positive test result.
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List of abbreviations
18F-FDG fludeoxyglucose
3D three-dimensional
99mTc technetium-99m
AGA antigranulocyte antibody
AOM acute osteomyelitis
CDSR Cochrane Database of Systematic
Reviews
CENTRAL Cochrane Central Register of
Controlled Trials
CI confidence interval
CINAHL Cumulative Index to Nursing and
Allied Health
COM chronic osteomyelitis
CRD Centre for Reviews and
Dissemination
CT computed tomography
DARE Database of Abstracts of Reviews
of Effects
DOR diagnostic odds ratio
DPD diphosphono-1,
2-propanodicarboxylic acid
GP general practitioner
(H)MDP (hydroxy)methylene diphosphonate
HMPAO hexamethylpropyleneamine oxime
HSROC hierarchical summary receiver
operating characteristic
HTA Health Technology Assessment
MDP methylene diphosphonate
MeSH medical subject heading
MRI magnetic resonance imaging
NICE National Institute for Health and
Care Excellence
NPV negative predictive value
PET positron emission tomography
PPV positive predictive value
PR positive rate
PRISMA Preferred Reporting Items for
Systematic Reviews and
Meta-Analyses
QUADAS-2 quality assessment of diagnostic
accuracy studies (version 2)
ROC receiver operating characteristic
SPECT single-photon emission computed
tomography
WBC white blood cell
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Plain English summary
Osteomyelitis is an infection of the bone and is treated with antibiotics. Left untreated, it can causepermanent damage and can lead to amputation.
The best method to diagnose osteomyelitis is to take a bone sample (bone biopsy) but this is invasive and
painful. Imaging may help target the best locations for biopsies or remove the need for a biopsy entirely.
Several methods are available, including radiography, ultrasound, magnetic resonance imaging (MRI),
single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
This project systematically reviewed the relevant literature to determine which tests are the most accurate
and relevant for clinical practice. All types of patients and all types of osteomyelitis were reviewed. Studies
were pooled using statistical methods (meta-analyses) to estimate the overall accuracy of the imaging tests.
The review identified 81 studies and concluded that MRI, PET and SPECT all had similar accuracy, correctly
identifying over 85% of people who did have osteomyelitis and over 80% of people who did not have
osteomyelitis. Radiography and computed tomography were less accurate. Modern forms of scintigraphy
have accuracy similar to PET or MRI.
There was no evidence that the accuracy of the imaging tests was different depending on the cause of
osteomyelitis or which body part was affected. In particular, diagnostic accuracy in people with diabetic
foot ulcers was similar to other types of osteomyelitis in adults. There was not enough evidence about
which tests are most accurate in children, so further studies in children are needed.
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Scientific summary
Background
Osteomyelitis is an infection of the bone and bone marrow that may result in bone infarction and loss of
limb or joint function and, in extreme cases, may necessitate amputation of the affected limb. In children,
osteomyelitis may also inhibit limb growth. Osteomyelitis is common in people with vascular deficiency,
such as adults with diabetes mellitus.
Patients usually present with a range of symptoms including swelling, joint pain and fever. These symptoms
are often not specific to osteomyelitis, leading to delays in correct diagnosis. Blood tests are used initially to
assess inflammatory markers; when these tests show evidence of possible infection, patients are referred for
further diagnostic testing. The most accurate diagnostic tool is a bone biopsy or aspiration of a pus collection
from the bone or tissue surrounding the bone, with a histological and/or microbiological assessment of the
sample to identify the organism causing the infection. The primary treatment for osteomyelitis is a course of
antibiotics, but surgery may also be used.
Diagnostic imaging for osteomyelitis
A range of diagnostic imaging methods are available, including radiography, magnetic resonance imaging
(MRI) scans, computed tomography (CT) scans, scintigraphy, positron emission tomography (PET) scans,
single-photon emission computed tomography (SPECT) and ultrasound.
Little formal guidance [such as guidelines produced by the National Institute for Health and Care Excellence
(NICE)] exists for which imaging techniques to use to diagnose osteomyelitis. The only current NICE
guidance is for the treatment of diabetic foot ulcers. In those patients, radiography is recommended,
followed by MRI if osteomyelitis is suspected, but not confirmed, by radiography.
Objectives
The key objectives were to:
l perform a systematic review of all studies reporting the diagnostic accuracy of any relevant imaging
test, or combination of tests used to detect osteomyelitis
l perform diagnostic meta-analyses of identified studies to formally assess their diagnostic accuracy
l investigate diagnostic accuracy across the range of different types of osteomyelitis and types of patient
l compare the diagnostic accuracy of diagnostic tests both statistically and pragmatically by systematically
reviewing inter-rater reliability and also the broader issues around implementation of imaging tests,
such as availability of machinery, radiation exposure and acceptability to patients
l provide useful guidance as to which imaging tests should be preferred, according to type of disease
and patient, in the UK.
Methods
A systematic review of the clinical effectiveness was performed following the general principles
recommended in the University of York Centre for Reviews and Dissemination’s (CRD’s) guidance and the
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The protocol
details have been registered on PROSPERO (number CRD42017068511).
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Literature searches
Comprehensive searches for published and unpublished literature were carried out during August 2017
and updated in July 2018. Databases searched included MEDLINE and EMBASE.
Study selection
Titles and abstracts and the full texts of studies were independently assessed for inclusion by two reviewers
using the inclusion criteria outlined in the following sections.
Participants
Participants included any patients with suspected osteomyelitis (based on symptoms, surgical samples or
blood tests). No restrictions were made for age or disease aetiology.
Index tests
Index texts included any diagnostic imaging technique that could potentially identify osteomyelitis,
including radiography, MRI, CT, PET, scintigraphy, SPECT and ultrasound.
Reference standards
Histopathology or microbiology based on bone biopsy or pus aspiration, and surgery, were the reference
standards. As biopsies are invasive, clinical follow-up of at least 6 months with no signs or symptoms of
osteomyelitis was also accepted as confirmation of the absence of osteomyelitis.
Outcomes
Studies reporting diagnostic accuracy of imaging tests compared with a reference standard expressed in
terms of sensitivity (percentage with osteomyelitis with a positive diagnostic test result) and specificity
(percentage without osteomyelitis with a negative test result) were included.
Studies reporting inter-rater reliability data or other data on test interpretation were included. General
implementation outcomes considered were cost-effectiveness (of relevance to the UK), availability of tests,
radiation exposure and experience of patients and clinicians.
Study designs
Any study that considered an imaging test or tests for osteomyelitis and which reported data on any of the
specified outcomes was included. Only studies explicitly considering testing for osteomyelitis were included.
Data extraction
Study and patient characteristics were extracted by at least one reviewer and checked by a second
reviewer. The numbers of true-positive, true-negative, false-positive and false-negative test results were
extracted where possible.
Inter-rater reliability estimates were extracted from the papers and tabulated. For implementation studies,
relevant results (e.g. from surveys of clinicians) were extracted and summarised narratively.
Quality assessment
The quality of the included diagnostic accuracy studies was assessed using the QUADAS-2 [quality
assessment of diagnostic accuracy studies (version 2)] tool. Critical appraisal was performed by one
reviewer and independently checked by another.
Synthesis
Data were synthesised in meta-analyses across studies using logistic regression modelling. Random-effects
models were used to account for potential heterogeneity in diagnostic accuracy across studies. Results
were presented as summary sensitivity and specificity estimates, with 95% confidence intervals (CIs),
and as summary HSROC (hierarchical summary receiver operating characteristic) curves. Analyses were
performed separately for adults and children.
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When the studies were deemed too diverse for meta-analysis to be suitable, or where only one or two
studies were available, the reported diagnostic accuracy from each available study was presented in tables
and on ROC (receiver operating characteristic) plots.
Separate meta-analyses were conducted for each diagnostic imaging test and, when sufficient data were
available, in subcategories of patients including:
l patients with diabetic foot ulcers
l cause of osteomyelitis
l anatomical site.
When studies report diagnostic accuracy data for two or more imaging tests, these tests were compared
by extending the bivariate logistic regression models to include all imaging tests in one model.
Inter-rater reliability results and qualitative data on implementation were reported narratively and
tabulated. Areas where few or no data have been published were also identified.
Results
Diagnostic accuracy
The review of diagnostic accuracy included 77 studies. The sample size of the studies ranged from 7 to 339,
but most (80%) included fewer than 50 participants. Nearly one-quarter of the studies were considered as
being at a high risk of bias, although poor reporting meant that there was significant uncertainty about the
quality of most studies. Most of the evidence focused on the diagnostic accuracy of MRI, scintigraphy and
radiography for the diagnosis of diabetic foot osteomyelitis. Few studies specifically focused on the axial
skeleton, the pelvis/hip/knee and long bones.
The overall meta-analysis of diagnostic accuracy in adults found that MRI can detect osteomyelitis with high
accuracy (95.6% sensitivity, 95% CI 92.4% to 97.5%; 80.7% specificity, 95% CI 70.8% to 87.8%). PET
also had high diagnostic accuracy (85.1% sensitivity, 95% CI 71.5% to 92.9%; 92.8% specificity, 95% CI
83.0% to 97.1%), as did SPECT (95.1% sensitivity, 95% CI 87.8% to 98.1%; 82.0% specificity, 95% CI
61.5% to 92.8%). There were similar diagnostic odds ratios and summary HSROC curves for MRI, PET and
SPECT, suggesting that the three imaging tests have similar diagnostic performance.
Scintigraphy (83.6% sensitivity, 95% CI 71.8% to 91.1%; 70.6% specificity, 95% CI 57.7% to 80.8%),
CT (69.7% sensitivity, 95% CI 40.1% to 88.7%; 90.2% specificity, 95% CI 57.6 to 98.4) and radiography
(70.4% sensitivity, 95% CI 61.6% to 77.8%; 81.5% specificity, 95% CI 69.6% to 89.5%) all had generally
inferior diagnostic accuracy when compared with MRI, PET or SPECT. The most up-to-date forms of
scintigraphy, such as 99mTc HMPAO WBC (technetium-99m hexamethylpropyleneamine oxime white blood
cell) scintigraphy (87.3% sensitivity, 95% CI 75.1% to 94.0%; 94.7% specificity 95% CI 84.9% to 98.3%),
had high diagnostic accuracy, similar to that of PET or MRI. There were insufficient studies of ultrasound to
assess its diagnostic accuracy.
Key participant subgroups
The main patient subgroup was patients with diabetic foot ulcers, representing nearly half of all studies.
The results of the meta-analyses for these patients were similar to those from the main meta-analysis,
although there were too few studies of SPECT or CT to reliably assess diagnostic accuracy.
Studies of patients without diabetes were divided according to scan location and by potential cause of
osteomyelitis. Data within each category were generally limited, but there was no evidence that diagnostic
accuracy varied by scan location or cause, or that results differed substantially from the main analysis.
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Diagnostic tests in children
The evidence for the accuracy of ultrasound and MRI in children was mixed and limited overall. Ultrasonography
had moderate sensitivity and specificity in children with suspected acute haematogenous osteomyelitis but had
perfect sensitivity and specificity in a small study of children with negative or equivocal initial radiographic
findings. MRI had good sensitivity and specificity in children with suspected acute haematogenous
osteomyelitis in one study, but preoperative MRI had poor sensitivity and near perfect specificity in another
study of patients with septic hip.
Inter-rater reliability and implementation
Eleven studies evaluated the inter-rater reliability of at least one imaging test, and one study provided data
on clinician opinions on imaging tests for osteomyelitis.
Magnetic resonance imaging appeared to have acceptable inter-rater reliability. There was some evidence
suggesting that PET and scintigraphy showed near perfect inter-rater reliability, although this is limited to
two small studies. We found no evidence on patient preferences and cost-effectiveness of imaging tests
for osteomyelitis.
Only one study on the implementation of diagnostic test imaging for osteomyelitis was included. A Dutch
survey of clinicians found that preferred imaging strategies for diagnosing post-traumatic osteomyelitis
depended on specialty and availability of machinery. Most responders were not aware of local hospital
protocols for diagnosing osteomyelitis.
Discussion
Strengths and limitations of the analyses
This systematic review was the largest and most comprehensive review of the diagnosis of osteomyelitis to
date, and the first to comprehensively compare all relevant imaging tests across all types of patient.
There were few studies identified that included children. This may be because studies of children do not
discuss osteomyelitis directly, but instead mostly in the context of other conditions, such as septic arthritis.
Hence, it is possible that some possibly relevant studies were missed.
Some imaging tests were reported, particularly ultrasound and CT scans. Some aspects of studies were
inconsistently reported, such as varying descriptions of the cause of osteomyelitis, non-reporting of
whether osteomyelitis was acute or chronic and lack of clarity on whether or not radiography (or other
tests) had been used prior to the main test. This made assessment in these subgroups difficult.
We identified very few data beyond those on diagnostic accuracy, with few studies discussing broader
implementation issues such as access to machinery, costs or radiation exposure.
Uncertainties
The main uncertainties remaining following this review arise largely because of limitations in the identified
studies.
The diagnostic accuracy of imaging tests in children remains highly uncertain because of the very limited
nature of the evidence. We could reach no firm conclusions on the diagnostic accuracy of any imaging test
in children.
The diagnostic accuracy of ultrasound is currently unknown as the only two studies in adults had conflicting
results.
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Although we found no evidence that diagnostic accuracy varied across subgroups of patients, limited or
inconsistent reporting of some characteristics, such as acute versus chronic osteomyelitis, or the cause of
osteomyelitis, means than differences between tests or between subgroups cannot be ruled out.
Generalisability of the findings
The apparent consistency of diagnostic accuracy across the various types of patient and causes of
osteomyelitis suggests that the diagnostic accuracy findings are likely to be generalisable to any population
being tested for osteomyelitis. The similarity in diagnostic accuracy across MRI, PET and SPECT scans
suggests that these tests should have similar accuracy in most clinical circumstances.
The review found considerable variation in the specificity of MRI across studies. This may mean that the
observed specificity of MRI in any given setting may differ from the summary estimates calculated in this
review, depending on how MRI is implemented.
The limited evidence on diagnosis of osteomyelitis in children means that results may not be generalisable
beyond the populations in the included studies.
Conclusions
Implications for service provision
Magnetic resonance imaging, PET and SPECT all have broadly similar and high accuracy when diagnosing
osteomyelitis. All are likely to be suitable imaging tests for diagnosing osteomyelitis. No clear reason to
prefer one test over the others in terms of diagnostic accuracy was identified. The wider availability of MRI
machines, and the fact that MRI does not expose patients to harmful ionising radiation, may mean that
MRI is preferable in most cases, unless it is unsuitable for a particular patient. A PET or SPECT scan may be
required if a MRI scan is inconclusive.
Positron emission tomography had poorer sensitivity but higher specificity than MRI, with more consistent
results across studies. This may make PET better suited to situations where avoiding false-positive diagnoses
is important, for example when the test would be followed by surgery or other invasive procedures.
There is no evidence to suggest that the diagnostic accuracy varies with the potential cause of osteomyelitis
or with the body part scanned, although data on patients other than those with diabetic foot ulcers were
limited. The review identified very limited data on diagnosing osteomyelitis in children, so considerable
uncertainty remains over the diagnostic accuracy of imaging tests in children. Clinicians should be aware
of this limitation in the evidence base.
Suggested research priorities
The most urgent research priority is to perform diagnostic accuracy studies of imaging tests in children.
Large diagnostic accuracy studies are needed, which must be of high quality, with proper blinding of test
assessors and consecutive recruitment of patients. The priority tests should be MRI and ultrasound, ideally
comparing the two tests in the same children.
Ultrasound has not been widely assessed in adults. Current results suggest that ultrasound on its own may
not be sufficiently accurate to diagnose osteomyelitis, but further accuracy studies are needed to resolve
the uncertainty. It may be more appropriate to investigate the diagnostic accuracy of ultrasound as a
precursor to MRI or other tests (e.g. as a replacement for radiography).
Given the similarities in diagnostic accuracy of MRI, PET and SPECT, suitable investigation of patient and
clinician experience and opinion of these tests, through surveys or focus groups, would be useful to
identify practical reasons for the choice of test. Similarly, a formal economic evaluation of these tests,
accounting for test cost, availability and risk of radiation exposure, would help to clarify the choice
between these tests.
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Chapter 1 Background
Osteomyelitis
Osteomyelitis is an infection of the bone and bone marrow.1,2 Left untreated, it may result in bone infarction
and loss of limb or joint function and, in extreme cases may require amputation of the affected limb. If the
infection spreads, it may lead to potentially fatal septicaemia.3 In children, osteomyelitis may also inhibit limb
growth, requiring extensive orthopaedic intervention in later childhood. Staphylococcus aureus is the most
common organism causing osteomyelitis, but other common organisms such as Streptococcus spp. or
Escherichia coli may also be responsible in some cases. Bone infections occur most commonly in people aged
< 20 years or > 50 years. It accounts for around 1% of all childhood hospital admissions. The incidence of
osteomyelitis has increased over recent decades, notably in children and in patients > 60 years of age.
This growing incidence has been associated with increased prevalence of meticillin-resistant S. aureus
(MRSA) in children and an increase in diabetes mellitus-related infections in adults.4
Osteomyelitis may be acute, subacute or chronic and is divided between haematogenous osteomyelitis,
in which infection transfers from a remote location in the body via the bloodstream, and contiguous
osteomyelitis, in which infected material comes into direct contact with the bone.5 The haematogenous
type is more common in children whereas the contiguous type is more common in adults, usually as a
result of trauma or surgery.6 Osteomyelitis is also common in people with vascular deficiency, such as
adults with diabetes, as a complication of diabetic foot ulcers.7 Osteomyelitis may lead to infection of the
adjacent joint (septic arthritis) or occur secondary to septic arthritis by contiguous spread.
Patients usually present with a range of symptoms including swelling, joint pain and fever. These symptoms
are often not specific to osteomyelitis, leading to delays in correct diagnosis. Blood tests are used initially to
assess inflammatory markers indicative of infection in the body, including white blood cell (WBC) count,
C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR).8 When these tests show evidence
of possible infection, patients are referred for further diagnostic testing. The most accurate diagnostic tool
is a bone biopsy or aspiration of a pus collection from the bone or tissue surrounding the bone, with a
microbiological assessment of the sample to identify the organism causing the infection. Biopsies are invasive
and generally require a local or a general anaesthetic. The analysis of the results may take several days.
Alternative diagnostic tools include blood or tissue cultures, which may be less accurate but are useful in
identifying the organism causing an infection in the body, which enables the selection of the appropriate
antibiotic for treatment. The primary treatment for osteomyelitis is a course of antibiotics, but surgery may
also be used.9
Diagnostic imaging for osteomyelitis
Diagnostic imaging of the affected area before performing a biopsy may help improve diagnosis and avoid
unnecessary biopsies in people who may have an infection but are unlikely to have osteomyelitis. It can
also be useful to identify pus collections, assess the need for drainage procedures and establish the best
way for surgical access.
A range of diagnostic imaging methods are available, including radiography, magnetic resonance imaging
(MRI), computed tomography (CT), scintigraphy, positron emission tomography (PET), single-photon
emission computed tomography (SPECT) and ultrasound.9–12 These imaging methods each have their
advantages and disadvantages.
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Radiography are easily available and cheap to perform, but are poor at detecting osteomyelitis in its
early stages. Radiography may be most useful in identifying and ruling out other causes of the patient’s
symptoms, such as bone fractures.11 MRI is probably the most widely recommended and used technique.
It is more accurate than radiography and able to detect osteomyelitis in its early stages, but is more
expensive to perform12 and when used in children necessitates the use of sedation or general anaesthesia.
PET and bone scintigraphy are more expensive and less widely available than MRI or radiography.11,13 These
methods expose patients to ionising radiation. Ultrasound avoids the radiation exposure and is readily
available, but its diagnostic accuracy is currently uncertain.12 There is also a distinction between methods
that provide two-dimensional images (radiography, scintigraphy) and those producing three-dimensional
images (PET, MRI, CT, SPECT). Some tests (e.g. MRI) may be less suited to patients with hip replacements
or other indwelling metalwork because the metalwork can alter the reliability of the imaging.
Current diagnostic and treatment practice
Once osteomyelitis is suspected on the basis of physical examination and blood tests, MRI is currently
generally recommended as the imaging test of choice because it can detect osteomyelitis early and it can
identify pus collections within bone that might require surgical drainage. Radiography is not usually
recommended in isolation, because of their failure to detect early osteomyelitis, but are generally used
as a first-line investigation to rule out or confirm bone fractures or other causes of symptoms.12 CT,
scintigraphy and PET are less widely recommended, but are an alternative for patients in whom MRI is
not possible.
Ultrasonography is suggested as an alternative to radiological tests7,9,11,12,14 and is widely used in paediatric
practice to exclude joint effusions and pus collection next to bone.14 This is especially helpful in young
children (aged < 6 years), who would require a general anaesthetic for MRI. Ultrasound is also used to
guide aspiration and biopsy.
Little formal guidance [such as guidelines produced by the National Institute for Health and Care Excellence
(NICE)] exists about which imaging techniques to use to diagnose osteomyelitis. The only current NICE
guidance is for the treatment of diabetic foot ulcers.1 In those patients, radiography is recommended to either
confirm advanced osteomyelitis or confirm that the symptoms are due to other causes (e.g. broken bones).
Radiography is followed by MRI if osteomyelitis is suspected but not confirmed by radiography. In children,
ultrasonography is sometimes used in place of MRI. Antigranulocyte Fab fragment antibody scintigraphy
should not be used in patients with diabetic foot ulcers.15 Recommendations about its use have also been
published in the USA.16,17
Osteomyelitis is treated with a 4- to 6-week course of antibiotics.18,19 Treatment is initially intravenous,
switching to oral antibiotics after around 2 weeks. The choice of antibiotics will depend on the infecting
organism, as determined by tests such as microbiological culture and the patient’s medical history. Surgery
may also be used for debridement of necrotic tissue and affected bone, to drain pus and to reduce
bacterial load.
Pathway to diagnosis in the NHS
There are a number of ways in which a patient might be referred for imaging to diagnose osteomyelitis.
Patients may present with fever and be admitted as inpatients, or may be referred directly by their general
practitioner (GP) to an orthopaedic clinic. This pathway to clinic is slower than presenting directly to
accident and emergency and such patients often have less virulent infection or subacute osteomyelitis.
Patients may be referred from other hospitals, particularly those that lack the facilities to treat children
(e.g. if the hospital does not offer MRI under general anaesthesia). Patients presenting with acute
symptoms may have a musculoskeletal issue (often limping or joint pains) or non-specific systemic
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symptoms and sepsis (e.g. immunodeficient patients as a result of underlying chronic condition). Generally
unwell patients with sepsis are more difficult to diagnose because they might be in intensive care and joint
symptoms could initially be missed while the focus is on treating severe symptoms.
The range of symptoms and possible causes of these symptoms mean that osteomyelitis may not be
suspected at first. Patients may undergo one or more radiographic assessments (and ultrasound scans in
children) and repeated blood tests prior to final diagnosis. Patients may also have received a course of
antibiotics before diagnosis, with osteomyelitis suspected only because that treatment course was not
successful. This complicates the diagnostic process, and the practical pathway to most diagnoses of
osteomyelitis in many patients will differ from that used in formal diagnostic accuracy studies.
Existing review evidence
Several systematic reviews or meta-analyses have been performed to assess diagnostic imaging techniques
for osteomyelitis.20–30
Four of these reviews considered primarily, or only, people with diabetic foot ulcers.20,22,23,26 Their conclusions
varied, depending on the tests included, but MRI, PET and WBC scintigraphy were all suggested as suitable
imaging tests. Three reviews of osteomyelitis in the general population mostly recommended PET and SPECT
as having the best diagnostic accuracy.25,27,28 One review focused on patients with peripheral post-traumatic
osteomyelitis and concluded that WBC scintigraphy with SPECT/CT or 18F-FDG (fludeoxyglucose)-PET/CT had
the best diagnostic accuracy in this population.21 Another review of MRI in patients with pressure ulcers was
inconclusive as a result of insufficient evidence.29 Two reviews were conducted in children. One focused on
calcaneal osteomyelitis and was inconclusive because of the limited evidence.24 The other children’s review
focused on haematogenous acute and subacute paediatric osteomyelitis, and found that MRI had the
highest sensitivity and specificity compared with radiography, scintigraphy, CT and ultrasound.30
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Chapter 2 Aims and objectives
The overall aim of this project was to systematically review the literature on diagnostic imaging forosteomyelitis in order to identify the techniques with the best diagnostic accuracy and the greatest
clinical utility, across the range of types of disease and patients. The key objectives were to:
l perform a systematic review of all studies reporting the diagnostic accuracy of any relevant imaging
test, or combination of tests, used to detect osteomyelitis
l perform diagnostic meta-analyses of identified studies to formally assess their diagnostic accuracy
l investigate diagnostic accuracy across the range of different types of osteomyelitis and types of patient
l compare the diagnostic accuracy of diagnostic tests both statistically and pragmatically, by
systematically reviewing inter-rater reliability, and the broader implementation of imaging tests,
accounting for key factors such as availability of machinery, radiation exposure and acceptability
to patients
l provide useful guidance as to which imaging tests should be preferred, according to type of disease
and patient, in the UK.
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Chapter 3 Methods
A systematic review of the clinical effectiveness was performed following the general principlesrecommended in the Centre for Reviews and Dissemination’s (CRD’s) guidance and the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The protocol details have
been registered on PROSPERO (number CRD42017068511).
Literature searches
The search strategy was developed by an information specialist with input from the review team and
clinical advisors. The strategy was developed in MEDLINE (via Ovid) and included search terms for
osteomyelitis and relevant diagnostic imaging techniques. No language, date, geographical or study
design limits were applied. The MEDLINE strategy was adapted for use in the other resources searched.
The searches were carried out during August 2017 and updated in July 2018 to capture more recent
studies. The following databases were searched: MEDLINE (including Epub Ahead of Print, In-Process &
Other Non-Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE), Cochrane Central Register of
Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), Cumulative Index to
Nursing and Allied Health (CINAHL) Plus, Database of Abstracts of Reviews of Effects (DARE), EMBASE,
Health Technology Assessment (HTA) database and PubMed.
In addition, ClinicalTrials.gov and PROSPERO were searched for ongoing and unpublished studies. Relevant
guidelines were identified through searches of the National Guidelines Clearing House, NHS Evidence, the
NICE website and the Trip database. The reference lists of relevant systematic reviews were manually
checked to ensure that all relevant studies from previous reviews were identified.
The search results were imported into EndNote X8 [Clarivate Analytics (formerly Thomson Reuters),
Philadelphia, PA, USA] and de-duplicated. The complete search strategies can be found in Appendix 1.
Study selection
Titles and abstracts and the full texts of studies were independently assessed for inclusion by two reviewers
using the inclusion criteria outlined in this section. Disagreements were resolved through discussion and,
where necessary, consultation with a third reviewer. Study selection was performed using EPPI-Reviewer
4 software (Evidence for Policy and Practice Information and Co-ordinating Centre, University of London,
London, UK).
Participants
Participants were any patients with suspected osteomyelitis (based on symptoms, surgical samples or blood
tests). No restrictions were made for age or disease aetiology.
Index tests
Index tests considered included any diagnostic imaging technique that could potentially identify
osteomyelitis, either alone or in combination with other relevant tests, such as radiography, MRI, CT, PET,
SPECT and ultrasound. Variations on these tests were included, such as variations in the radioisotopes used
and differences in protocols or contrast agent use.
Scintigraphy was not a protocol-specified imaging test for this review as it was not expected to be widely
used in the UK, particularly because three-dimensional (3D) SPECT imaging may be preferred to planar
scintigraphy. However, as the protocol specified that any relevant imaging test would be considered,
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and many studies of scintigraphy were identified, scintigraphy was included in this review. To focus on
the more UK-relevant tests in the main analysis, data on scintigraphy were included only where they
were included in a study of another relevant imaging test. Studies evaluating the diagnostic accuracy
of scintigraphy alone were considered in a separate analysis.
Reference standards
The preferred reference standard was histopathology or microbiology based on bone biopsy. Surgery was also
accepted as a reference standard; other accepted methods of sample collection included pus aspiration.
As biopsies are invasive, clinical follow-up of at least 6 months with no signs or symptoms of osteomyelitis
was also accepted as confirmation of the absence of osteomyelitis. Similarly, clinical evidence that the
symptoms had another cause was accepted as confirmation of the absence of osteomyelitis.
To avoid potential bias through overestimation of diagnostic accuracy, studies were excluded if a positive
osteomyelitis diagnosis was made by using a second imaging test, or by clinical follow-up alone, without
biopsy or other microbiological testing.
Outcomes
Diagnostic accuracy review
The primary outcome was the diagnostic accuracy of the imaging test compared with the reference
standard expressed in terms of sensitivity (percentage of people/scans with osteomyelitis with a positive
diagnostic test result) and specificity (percentage of people/scans without osteomyelitis with a negative
test result). Studies reporting sensitivity and specificity, or sufficient data to calculate both measures,
were included. Studies evaluating other related conditions, such as spondylodiscitis or septic arthritis,
were included if they provided separate diagnostic accuracy data for osteomyelitis.
Inter-rater reliability and implementation of imaging tests
Studies reporting inter-rater reliability for any test, or any other measure of accuracy of test interpretation,
were included. Studies reporting information on the broader implementation and acceptability of imaging
tests for osteomyelitis were included. The following implementation outcomes were eligible for inclusion:
cost-effectiveness of imaging tests (of relevance to the UK), availability of tests (e.g. access to machinery),
radiation exposure and substantive data on the experience of patients or clinicians.
Study designs
Any study that considered an imaging test or tests for osteomyelitis that reported data on any of the
specified outcomes was included. Therefore, studies reporting any diagnostic accuracy data, other
quantitative data (e.g. inter-rater reliability) or substantive qualitative or semiqualitative data (e.g. surveys
of patients and clinicians) were included. Only studies explicitly considering testing for osteomyelitis were
included. Studies reporting on characteristics of the imaging tests more broadly were excluded.
The following types of reports were excluded: editorials and opinions, case reports, reports focusing only
on technical aspects of imaging tests (e.g. technical descriptions or specifications of machinery). We
selected the most complete or most recent report in cases of multiple reports for a given study or when
we could not exclude the possibility of overlapping populations.
Data extraction
A mapping exercise informed the development of the data extraction form, which was then piloted on
a small selection of studies by two reviewers. Data extracted included details of patient characteristics,
diagnostic tests and reference standard tests. Data were extracted by one reviewer and independently
checked for accuracy by at least one other reviewer. Discrepancies were resolved by discussion, with
METHODS
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involvement of a third reviewer when necessary. Given the high number of studies, authors were not
contacted if relevant data appeared to be unreported. In cases of multiple reports for a given study, the
most recent or most complete report was used as the main source of data.
Study characteristics were extracted, including design, year, country and patient eligibility criteria. Patient
characteristics that were extracted included age, comorbidities, diabetic status, location of osteomyelitis
and reason for referral. Data on study intervention (e.g. characteristics of imaging test used, radioisotope,
contrast agent, diagnostic cut-off point and thresholds), unit of analysis (e.g. patient, body part) and data
on exclusions from study/analysis with reasons were recorded. Types of reference standards used for
confirming positive and negative cases were recorded. The numbers of patients confirmed to be positive
or negative in accordance with the reference standard, and the numbers of true-positive, true-negative,
false-positive and false-negative test results, were extracted, if reported. If not reported, sensitivity and
specificity estimates [with their 95% confidence intervals (CIs)] or other reported diagnostic accuracy data
were extracted. Where possible, sensitivity, specificity, positive predictive values (PPVs) and negative
predictive values (NPVs) were calculated and checked against reported values in the publications to check
for any discrepancies. When more than one test was performed for the same participant in the same body
part (i.e. repeat test, or follow-up test), only the result of the first test was used.
Inter-rater reliability estimates were extracted from the papers and tabulated. For the implementation
review, relevant results on cost-effectiveness or use of machinery or data from surveys of clinicians were
extracted and summarised narratively.
Quality assessment
The quality of the included diagnostic accuracy studies was assessed using the QUADAS-2 [quality
assessment of diagnostic accuracy studies (version 2)] tool designed for diagnostic accuracy studies.31
Critical appraisal was performed by one reviewer alongside data extraction and independently checked
by at least one other reviewer. The QUADAS-2 tool was adapted to ensure that it is applicable to assessing
the quality of studies of imaging tests for detecting osteomyelitis. The tool consists of four key domains:
(1) patient selection, (2) index test, (3) reference standard and (4) flow of patients through the study and
timing of the index test(s) and reference standard. Each domain was assessed in terms of the risk of bias.
The first three domains were also assessed for concerns regarding their applicability, that is, whether or not
the participants and setting, the index test, its conduct or interpretation and the target condition (as defined
by the reference standard) were applicable to the review question. Further details on the critical appraisal
tool, including signalling questions to inform the assessment of the key domains, are reported in Appendix 2.
No validated instrument is available for appraising the quality of studies on inter-rater reliability. We used a
modified version of the tool reported by van de Pol et al.32
Synthesis
Diagnostic meta-analysis
For each diagnostic imaging test, data were synthesised in meta-analyses across studies using logistic
regression modelling. This approach fits a statistical model that regresses index test outcome (positive or
negative for osteomyelitis) against whether each person does or does not have confirmed osteomyelitis,
based on the reference standard. This has been shown33 to be equivalent to both bivariate meta-analysis
and hierarchical summary receiver operating characteristic (HSROC) analysis, which are the methods most
commonly used in diagnostic meta-analyses.34,35 It also accounts for correlation between sensitivity and
specificity, and for the fact that these may vary if different test thresholds are used across studies. This
proposed model is known as a ‘one-stage’ approach because it analyses summary diagnostic accuracy
across all studies simultaneously. It provides a more flexible approach than conventional bivariate or
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HSROC analysis; in particular, it permits the inclusion of extra terms in the model to identify subgroups of
studies or participants, and to compare different imaging tests.
Studies were pooled if three or more studies were eligible for the analysis. Random-effects models were
used to account for potential heterogeneity in diagnostic accuracy across studies. Results were presented
as summary sensitivity and specificity estimates, with 95% CIs, plotted in receiver operating characteristic
(ROC) space, and as summary HSROC curves.
When studies reported diagnostic accuracy for multiple tests, data for each test were included in the
analysis. When studies reported multiple results for the same imaging test (e.g. at different test thresholds,
or diagnosis by different clinicians) then only the data corresponding to the greatest diagnostic accuracy
[i.e. having the highest diagnostic odds ratio (DOR)] were included.
The PPVs and NPVs were also analysed using the same bivariate logistic regression approach. It should be
noted that PPV and NPV depend on the incidence of osteomyelitis in each study, and so may be more
heterogeneous than sensitivity and specificity.
In addition to the bivariate analyses, meta-analyses of estimated DOR and positive rates (PRs) (the
proportion of people whose imaging test result suggests osteomyelitis, and so who would be diagnosed
with osteomyelitis on the basis of the imaging test) were also performed. Univariate meta-analyses
(ignoring correlation between outcomes) of sensitivity, specificity, PPV and NPV were also performed, for
comparison with the bivariate analyses. In all these meta-analyses, heterogeneity was assessed using I2.36
When the studies were deemed too diverse for meta-analysis to be suitable, or when only one or two
studies were available, the reported diagnostic accuracy from each available study was presented in tables
and on ROC plots, and compared across studies, tests and subgroups. Studies that did not report full
diagnostic accuracy data, but only summary sensitivity and specificity, were summarised in narrative form
by tabulating the results.
Subgroup analyses
Separate meta-analyses were conducted for each diagnostic imaging test and, where sufficient data were
available, according to the following subcategories of patients:
l children and adults (as defined by the studies)
l cause of osteomyelitis (haematogenous, contiguous, trauma, surgical, diabetes related, other)
l acute, subacute or chronic osteomyelitis (COM)
l anatomical site (long bone, spinal, foot and ankle, pelvis, other)
l patients with hip replacements or other indwelling metalwork.
Subgroup analyses were also performed to assess the impact of different study characteristics:
l subtypes of imaging test (e.g. owing to the use of different radioisotopes, inclusion or exclusion of CT
scanning, different thresholds, or methods of image interpretation)
l choice of reference standard (biopsy, or clinical and surgical follow-up)
l study quality (based on QUADAS-2 criteria).
As having diabetic foot ulcers is one of the most common causes of osteomyelitis, we performed
meta-analyses specifically of studies of people with diabetic foot ulcers.
Analyses were performed separately for adults and children.
Analyses within subgroups were performed using the logistic regression analysis approach discussed in
Diagnostic meta-analysis. Separate analyses were performed for each subgroup.
METHODS
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Comparison of imaging tests
Diagnostic tests were compared by examining summary DORs derived from the logistic regression models
and by comparing summary ROC curves. In general, a larger DOR indicates a better performance, but this
may not be the case if ROC curves cross, in which case the trade-off between sensitivity and specificity was
considered. When there were sufficient data, these comparisons were made in each of the subgroups
listed in Subgroup analyses.
When studies reported diagnostic accuracy data for two or more imaging tests on the same patient
population, these tests were compared within the study by comparing sensitivity, specificity and DOR
estimates. The main bivariate logistic regression models were extended to include all imaging tests in one
model, to allow tests to be formally compared for differences in DOR and specificity.
Inter-rater reliability and implementation review
Owing to heterogeneity, studies evaluating inter-rater reliability results were reported narratively and
tabulated. For studies reporting qualitative data on the implementation of diagnostic tests (e.g. clinical or
patient opinions), data were synthesised using a narrative synthesis approach. Areas where few or no data
have been published were also identified.
Deviations from the protocol
Some changes in the review and analysis process were made as a consequence of the nature of the
identified studies.
Scintigraphy was not a protocol-specified imaging test, but many of the included studies compared
scintigraphy with another test. Scintigraphy was therefore included in the main review and meta-analyses
where studies compared it with another eligible test. To ensure a fair analysis of scintigraphy, a separate
meta-analysis of scintigraphy alone was performed. In that analysis, we also included studies reporting the
diagnostic accuracy of scintigraphy alone that included > 20 participants and that had been published
since 1990. These additional studies were not assessed for quality using QUADAS-2 and only basic
diagnostic accuracy data were extracted from publications.
For several proposed subgroup analyses, either we identified no relevant studies or studies did not report
sufficient data for synthesis, so no analyses were performed. The subgroups were patients with:
l acute symptoms (such as would be admitted as inpatients)
l sepsis
l milder or chronic symptoms (such as would be referred by a GP)
l concomitant diseases (e.g. cancer).
The number of studies of children and of ultrasound were too few to permit a meta-analysis, so these
studies were combined in a narrative synthesis only.
Role of patient and clinical advisors
Clinical advisors for this project attended meetings (in person or remotely) over the course of the project to
ensure that it met clinical needs. This included approving the protocol, discussing and commenting on the
provisional results and meta-analyses, and commenting on this report.
Two patient representatives, both parents of children who had been treated for osteomyelitis, were
contacted through telephone meetings over the course of the project to discuss their experience of
imaging tests and to discuss the findings of the project.
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Chapter 4 Results
Quantity and quality of research available
Included studies
Figure 1 is a flow diagram outlining the screening process with reasons for exclusion of full-text papers. The
literature searches of bibliographic databases identified 18,386 unique references. After initial screening of
titles and abstracts, 597 were considered to be potentially relevant and were ordered for full-paper screening.
In total, 77 studies37–113 (from 79 reports) were included in the diagnostic review, of which 69 were also
included in a meta-analysis.38–42,44–51,53–71,73–77,79–95,97,99–113 Eleven studies were included in the review of inter-rater
agreement,37,58,59,65,68,86,92,114–117 and one was included in the review of implementation.118 Seven studies
were included in both the diagnostic and inter-rater reliability reviews.37,58,59,65,68,86,92
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Full-text articles assessed
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(n = 513)
• Participants, n = 14
• Intervention, n = 77
• Outcome, n = 287
• Design, n = 33
• Reference standard, n = 102
Studies included
(n = 81)
(84 references)
• Diagnostic accuracy, n = 77 (79 references)
• Inter-rater agreement, n = 11
• Implementation, n = 1 (2 references)
Studies included in
meta-analysis
(diagnostic accuracy)
(n = 69)
FIGURE 1 A PRISMA flow diagram showing study selection.
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Excluded studies
Of the 597 potentially relevant studies, the most common reason for exclusion was lack of relevant outcome
data (287 references, of which 49 did not have a full text available) and 102 references did not report an
eligible reference standard. Fifty-four studies69,119–171 evaluated the diagnostic accuracy of scintigraphy
but were excluded from the main review because they did not evaluate the diagnostic accuracy of other
eligible index tests. The list of references that were excluded along with the reasons for their exclusions
is not reported because of the large number of exclusions, but is available from the authors on request.
Assessment of diagnostic accuracy
Characteristics of included studies
Table 1 presents a summary of design and patient characteristics of all included studies. Most studies
(46 out of 77) were published in or after 2000.37,38,40,41,43–46,48,51–57,60–65,67–70,72,73,77,78,80–82,84,88,93,95–99,103,105,108,109,111,113
Just under half of the studies were conducted in the USA (34 studies).39,42,46,56,63,66,67,70–72,74–76,79,80,82,83,85,86,88–92,98,
100–102,104,106,107,110–112 Eight studies were conducted in Germany,49,58–60,64,65,81,108 six in Switzerland,41,44,61,68,73,99
five in Italy50,53–55,95 and three in Egypt,37,52,113 the Netherlands48,62,105 and Turkey.51,96,97 Two studies were
conducted in France,41,45 India,77,93 the Republic of Korea,69,109 Spain40,84 and the UK.41,94 A single study was
conducted in the following countries: Austria,108 Belgium,57 Bulgaria,43 Canada,43 Israel,103 Japan,82 the
Republic of Korea,109 Kuwait,38 Lithuania78 and Oman.87 Three studies were conducted in more than one
country.41,82,108
None of the included studies was randomised, and 41 studies used a prospective design.37,41–43,45,47,49,51,52,54,
55,57–60,62,64–66,75–78,81,83–85,88–91,93,94,96,99,104,107,110–113
The sample size of the studies ranged from 7 to 339, but most studies were small: only 15 (20%) included
≥ 50 participants.40,41,46,50,67,70,71,75,78,84,86,88,98,108,113 Nearly all studies were conducted in adults. Three studies
were conducted in children exclusively,52,78,98 and 10 were conducted in a mixed population of adults
and children.44,50,57,85,87,96,101,104,106,109 Nine studies included at least some participants with indwelling
work, 39,57,61,69,73,79,81,103,108,109 but only one focused exclusively on this population.103
Nearly half of the included studies included only or mostly patients with diabetes (36 studies).37,38,40–43,47,49,51,
53,55,56,62,67,70,71,74,76,77,82,84,86,88–90,92–95,97,99,102,107,111–113 A total of 10 studies focused on patients with trauma
and/or previous surgery.57,59,61,64,68,69,72,73,79,103,105,108 Osteomyelitis was caused by non-foot-related pressure
ulcers and skin ulcerations in six studies45,63,66,72,75,80 and one study attributed osteomyelitis to each of the
following conditions specifically: soft tissue infection,96 septic arthritis98 and neuropathic osteoarthropathy.100
Eighteen studies included patients with multiple aetiologies,44,46,48,50,52,54,58,60,65,78,81,83,85,91,101,106,109,110 and three
studies did not report any specific causes.39,87,104 Only one study included patients with haematogenous
osteomyelitis.78 Appendix 3 presents further details on the study participant inclusion and exclusion criteria.
Forty-seven studies stated which type of osteomyelitis they targeted. Twelve studies aimed to detect acute
osteomyelitis (AOM) specifically,37,51,52,66,74,78,87,90,91,98,99,104 17 focused on COM46,49,58,60,61,64,68,73,79,81,93,94,96,108,111–113
and 15 focused on a mixed population of AOM and COM.38,42,44,48,50,54,57,63,65,69,71,80,85,92,106,107 Two studies targeted
patients with either subacute osteomyelitis or COM.39,59 The condition targeted was not specified in 30
studies.40,41,43,45,47,53,55,56,62,67,70,72,75–77,82–84,86,88,89,95,97,100–103,105,109,110 Most studies used the dual reference standard
for osteomyelitis of clinical follow-up for patients who tested negative and bone biopsy with histopathology or
microbiology for test-positive patients, although 34 studies used histopathology/microbiology in all participants
regardless of their imaging test results.37,38,42,43,45,49,51,53,54,56–59,61,62,70,72,75,77,79–82,84,89,90,92,93,98,100,102,107,108,113
Table 2 presents the distribution of included diagnostic accuracy studies according to tests and body part
targeted. This shows that most of the evidence focused on the diagnostic accuracy of MRI, scintigraphy
and radiography for the diagnosis of diabetic foot osteomyelitis. Few studies specifically focused on the
axial skeleton, the pelvis/hip/knee and long bones.
RESULTS
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TABLE 1 Study design and participant characteristics
First author and year
of publication Country Design n Population
Mean (SD) age
[range] (years) % male Cause of osteomyelitis
Indwelling
work (%)
Body part
targeted
Abdel Razek (2017)37 Egypt Prospective 39 Adults 51 [48–72] 54 Diabetic foot ulcer NR Foot
Al-Khawari (2005)38 Kuwait Retrospective 19 Adults 61 [41–81] 59 Diabetic foot ulcer NR Foot/ankle
Al-Sheikh (1985)39 USA NR 22 Adults NR [32–65] NR Multiple (NR) 48 Multiple
Aragón-Sánchez
(2011)40
Spain Retrospective 338 Adults NR [NR] NR Diabetic foot ulcer NR Foot
Aslangul (2013)41 France, UK and
Switzerland
Prospective 53 Adults 63 (10) [NR] 93 Diabetic foot ulcer NR Foot
Blume (1997)42 USA Prospective 27 Adults 64.7 (1) [NR] 96 Diabetic foot ulcer (93%),
other (7%)
NR Foot
Bohchelian (2002)43 Bulgaria Prospective 32 Adults NR NR Diabetic foot ulcer NR Foot
Bolouri (2013)44 Switzerland Retrospective 42 Mixed 52 [10–84] 50 Multiple NR Jaw/head
Brunel (2016)45 France Prospective 34 Adults 51 [NR] 71 Pressure ulcer 0 Pelvis/hip
Chacko (2003)46 USA Retrospective 56 NR NR [NR] NR Multiple 0 Multiple
Croll (1996)47 Canada Prospective 27 Adults 66 [34–82] 70 Diabetic foot ulcers NR Foot
Demirev (2014)48 The Netherlands Retrospective 26 Adults 59 [16–78] 54 Multiple NR Multiple
Enderle (1999)49 Germany Prospective 19 Adults 61 (10) [NR] 90 Diabetic foot ulcers NR Foot
Erdman (1991)50 Italy Retrospective 110 Mixed 37 [0–74] 71 Multiple 0 Multiple
Ertugrul (2006)51 Turkey Prospective 26 NR 62 (9) [40–77] 74 Diabetic foot ulcer NR Foot
Ezzat (2011)52 Egypt Prospective 27 Children 10 [NR] 67 Multiple NR NR
Familiari (2011)53 Italy NR 13 Adults 62 [50–89] 92 Diabetic foot ulcers NR Foot
Filippi (2006)54 Italy Prospective 15 Adults 50 (13) [NR] 61 Multiple 0 Multiple
Filippi (2009)55 Italy Prospective 17 Adults 55 (4) [NR] 59 Diabetic foot ulcer NR Foot
Franceschi (2013)56 USA NR 17 Adults NR [21–84] 62 Diabetic foot ulcer NR Foot
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TABLE 1 Study design and participant characteristics (continued )
First author and year
of publication Country Design n Population
Mean (SD) age
[range] (years) % male Cause of osteomyelitis
Indwelling
work (%)
Body part
targeted
Gemmel (2004)57 Belgium Prospective 22 Mixed 40 [14–70] 45 Surgical 82 Spine
Guhlmann (1998)58 Germany Prospective 48 Adults 49 [22–81] 76 Trauma or surgery NR Multiple
Guhlmann (1998)59 Germany Prospective 31 Adults 48 [20–78] 74 Trauma or surgery NR Multiple
Hakim (2006)60 Germany Prospective 34 Adults 54 (19) [19–93] NR Dental infection, trauma, others NR Jaw
Hartmann (2007)61 Switzerland Retrospective 33 Adults 50 [17–80] 79 Trauma 55 Multiple
Hazenberg (2011)62 The Netherlands Prospective 21 NR NR [NR] NR Diabetic foot ulcer NR Foot
Heiba (2017)63 USA Retrospective 33 Adults NR 58 Pelvic pressure ulcer NR Pelvis/hip
Horger (2003)64 Germany Prospective 27 Adults 48 [20–90] 82 Trauma NR Multiple
Horger (2007)65 Germany Prospective 31 Adults 51 [20–89] 52 Multiple (musculoskeletal infection) NR Multiple
Huang (1998)66 USA Prospective 42 Adults 41 [22–83] 82 Paralysis and skin ulceration NR Pelvis/hip
Johnson (2009)67 USA Retrospective 73 Adults 65 [26–92] 66 Diabetes, neuropathic arthropathy,
other
NR Foot
Kaim (2000)68 Switzerland Retrospective 18 Adults 45 [27–65] 72 Trauma 0 Long bone
Kim (2017)69 Republic of
Korea
Retrospective 21 Adults 51.9 (18.1) [23–77] 67 Trauma 48 Lower
extremities
La Fontaine (2016)70 USA Retrospective 52 Adults 50 (10) [26–74] 73 Diabetes and peripheral neuropathy NR Foot
Larcos (1991)71 USA Retrospective 51 Adults 62 [30–88] 61 Diabetic foot ulcers NR Foot
Larson (2011)72 USA Retrospective 44 Adults NR [NR] NR Pelvic pressure ulcer NR Pelvis/hip
Ledermann (2000)73 Switzerland Retrospective 15 Adults 41 [26–66] 67 Trauma 73 Lower
extremities
Levine (1994)74 USA Retrospective 27 Adults 52 [33–72] 44 Diabetic foot ulcer NR Foot
Lewis (1988)75 USA Prospective 52 Adults NR [NR] NR Spinal cord injury and skin
ulceration
NR Pelvis/hip
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First author and year
of publication Country Design n Population
Mean (SD) age
[range] (years) % male Cause of osteomyelitis
Indwelling
work (%)
Body part
targeted
Lipman (1998)76 USA Prospective 20 Adults 46 [28–72] 65 Diabetes (85%), peripheral
neuropathy (100%)
NR Foot
Mahendra (2017)77 India Prospective 34 Adults 52 (9) [NR] 65 Diabetic foot ulcer 0 Foot
Malcius (2009)78 Lithuania Prospective 169 Children 10 (4) [1–18] 69 Multiple (haematogenous) NR NR
Mason (1989)79 USA Retrospective 14 NR NR [NR] NR Trauma (93%), other (7%) 14 Long bone
McCarthy (2017)80 USA Retrospective 41 Adults 45 [NR] 82 Skin ulceration NR Multiple
Meller (2002)81 Germany Prospective 30 Adults NR [24–72] 47 Multiple 13 Multiple
Miki (2015)82 Japan and
the USA
Retrospective 26 Adults 67 [42–85] 77 Diabetic foot ulcers NR Foot
Modic (1985)83 USA Prospective 37 Adults 53 [22–85] 51 Multiple NR Spine
Morales Lozano (2010)84 Spain Prospective 132 NR NR [NR] NR Diabetic foot ulcer NR Foot
Morrison (1993)85 USA Prospective 49 Mixed 49 [10–80] NR Multiple NR Multiple
Morrison (1998)86 USA Retrospective 68 Adults 56 [24–85] NR Diabetes (85%), others (15%) NR Foot
Nath (1992)87 Oman NR 25 Mixed NR [2–45] NR NR NR Long bone
Nawaz (2010)88 USA Prospective 106 Adults 59 [29–85] 69 Diabetic foot ulcer NR Foot
Newman (1991)89 USA Prospective 35 NR NR [NR] NR Diabetic foot ulcer NR Foot
Newman (1992)90 USA Prospective 12 NR NR [NR] NR Diabetic foot ulcer NR Foot
Nigro (1992)91 USA Prospective 44 Adults 55 [23–84] 57 Multiple (diabetic foot ulcer, foot
ulcer or inflammation)
0 Foot
Park (1982)92 USA Retrospective 36 NR NR [NR] NR Diabetic foot ulcer NR Foot
Rastogi (2016)93 India Prospective 23 Adults 58 (8) [NR] 96 Diabetes, retinopathy, neuropathy
and/or vascular disease
0 Foot
Remedios (1998)94 UK Prospective 9 Adults 57 [25–70] 45 Diabetic foot ulcer NR Foot
Rozzanigo (2009)95 Italy Retrospective 16 Adults 58 [42–78] 69 Diabetic foot ulcers NR Foot
S¸anlı (2011)96 Turkey Prospective 30 Mixed 52 [10–93] 71 Soft tissue infection 0 Multiple
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TABLE 1 Study design and participant characteristics (continued )
First author and year
of publication Country Design n Population
Mean (SD) age
[range] (years) % male Cause of osteomyelitis
Indwelling
work (%)
Body part
targeted
Sarikaya (2003)97 Turkey NR 26 Adults 59 [18–80] 77 Diabetic foot ulcer NR Foot
Schlung (2016)98 USA Retrospective 54 Children 6 (4) [NR] 59 Septic arthritis NR Pelvis/hip
Schwegler (2008)99 Switzerland Prospective 20 Adults 66 [53–89] 60 Diabetic foot ulcer NR Foot
Seabold (1990)100 USA Retrospective 14 Adults NR [24–68] 64 Neuropathic osteoarthropathy.
Diabetes (78%), others (22%)
NR Foot (71%),
others
Seabold (1995)101 USA Retrospective 26 Mixed 55 [3–78] 52 Multiple NR Jaw/head
Segall (1989)102 USA Retrospective 23 Adults 58 (13) [25–79] 95 Diabetic foot ulcer NR Foot
Shemesh (2015)103 Israel Retrospective 10 Adults 35 [18–53] 80 Trauma or surgery 100 Long bone
Unger (1988)104 USA Prospective 35 Mixed 52 [1–84] 57 Diabetes (47%), others (NR) (53%) NR Multiple
van Vliet (2018)105 The Netherlands Retrospective 30 Adults 46 [18–74] 70.0 Trauma and septic delayed union NR Long bone
(leg), heel
Weber (1995)106 USA Retrospective 20 Mixed 46 [3–74] 50 Multiple NR Jaw/head
Weinstein (1993)107 USA Prospective 32 Adults 49 [23–81] 68 Diabetic foot infections NR Foot
Wenter (2016)108 Germany and
Austria
Retrospective 131 Adults 47 [NR] 82 Trauma 28 Multiple
Weon (2000)109 Republic of
Korea
Retrospective 37 Mixed 44 [6–77] 68 Multiple 68 Hip and/or
knee
Williamson (1989)110 USA Prospective 7 Adults 57 [40–71] 43 Diabetes (57%), others (43%) 0 Foot
Yang (2016)111 USA Prospective 48 Adults 60 (15) [36–83] 67 Diabetic foot ulcer NR Foot
Yuh (1989)112 USA Prospective 24 Adults 58 [32–74] NR Diabetic foot ulcer NR Foot
Zaiton (2014)113 Egypt Prospective 102 Adults 52 (6) [NR] 41 Diabetic foot ulcer NR Foot
NR, not reported; SD, standard deviation.
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Nearly all studies interpreted images by visual assessment without any quantitative analysis (e.g. measuring
the standardised uptake value). Some studies compared the results of qualitative and quantitative analysis
in parallel, including PET (two studies)53,108 and WBC scintigraphy.53 Other studies used a semiquantitative
approach (combined qualitative and quantitative interpretation) for PET/CT (two studies),105,108 PET108
scintigraphy + SPECT64 and SPECT/CT.64
Critical appraisal
Table 3 presents a summary of the results of the critical appraisal. Further details including justifications for
decisions are presented in Appendix 2. Overall, 23% of studies were rated as being at a high risk of bias
for at least one domain,39,47,48,52,56,57,64,65,78,80,83,91,92,95,101,102,107,111 although poor reporting of study methods,
particularly regarding the selection of patients and the conduct of the index test, means that there is
significant uncertainty about the quality of most of the studies.
TABLE 2 Diagnostic accuracy studies according to test and body part targeted
Body part
targeted
Test (number of studies)
CT MRI
PET and
PET/CT Scintigraphy
SPECT and
SPECT/CT Ultrasound Radiography
Axial (jaw/
head/spine)
344,101,106 283,101 160 344,57,83 544,57,60,101,106 0 244,83
Foot 1110 2437,38,47,49,51,62,
67,70,74,76,77,82,86,88,
90,91,93–95,99,100,107,
112,113
653,56,88,93,99,111 1942,47,49,51,53,71,
89–92,94,97,99,100,
102,107,110,112,136
341,55,70 149 1740,42,47,49,71,74,
76,84,88,89,91,92,95,
97,102,107,112
Pelvis/hip/
knee
272,75 345,66,98 0 363,75,109 263,109 0 272,75
Long bone 0 268,79 1103 268,79 0 187 187
Multiple/NR 178 748,50,73,78,80,85,104 846,48,58,59,61,81,
105,108
739,58,74,78,81,85,104 454,64,65,69 252,78 239,78
NR, not reported.
TABLE 3 Summary of critical appraisal of diagnostic accuracy studies
First author and year
of publication
Risk of bias Applicability
Patient
selection
Index
test
Reference
standard
Patient
flow
Patient
selection
Index
test
Reference
standard
Abdel Razek (2017)37 ? + + + + + +
Al-Khawari (2005)38 ? + + + + + +
Al-Sheikh (1985)39 + – + + + + +
Aragón-Sánchez (2011)40 + + + + + + +
Aslangul (2013)41 + + + + + + +
Blume (1997)42 ? + + + + + +
Bohchelian (2002)43 ? + + + + + +
Bolouri (2013)44 ? ? + + + + +
Brunel (2016)45 ? + + + + + +
Chacko (2003)46 ? + + + + + +
Croll (1996)47 ? – + + + + +
Demirev (2014)48 + – + + + + +
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TABLE 3 Summary of critical appraisal of diagnostic accuracy studies (continued )
First author and year
of publication
Risk of bias Applicability
Patient
selection
Index
test
Reference
standard
Patient
flow
Patient
selection
Index
test
Reference
standard
Enderle (1999)49 + + + + + + +
Erdman (1991)50 + + + + + + +
Ertugrul (2006)51 ? ? + + + + +
Ezzat (2011)52 – + ? + + + +
Familiari (2011)53 ? + + + + + +
Filippi (2006)54 + + + + + + +
Filippi (2009)55 + + + + + + +
Franceschi (2013)56 ? + + – ? + +
Gemmel (2004)57 – + + + ? + +
Guhlmann (1998)58 ? + + + + + +
Guhlmann (1998)59 ? + + + + + +
Hakim (2006)60 ? ? + + + + +
Hartmann (2007)61 ? + + + + + +
Hazenberg (2011)62 ? ? + + + + +
Heiba (2017)63 ? + + + + + +
Horger (2003)64 ? – + + + + +
Horger (2007)65 + – + + + + +
Huang (1998)66 + + + + + + +
Johnson (2009)67 ? + + + + + +
Kaim (2000)68 ? + + + + + +
Kim (2017)69 + + + + + + +
La Fontaine (2016)70 ? + + + + + +
Larcos (1991)71 ? ? + + + + +
Larson (2011)72 ? ? + + ? + +
Ledermann (2000)73 + ? + + + ? +
Levine (1994)74 ? ? + + + + +
Lewis (1988)75 ? ? + + ? + +
Lipman (1998)76 + + + ? + + +
Mahendra (2017)77 + + + + + ? +
Malcius (2009)78 ? – ? ? + + +
Mason (1989)79 + ? + + + + +
McCarthy (2017)80 – + + + + + +
Meller (2002)81 + + + + + + +
Miki (2015)82 ? ? + + + + +
Modic (1985)83 ? – + + ? + +
Morales Lozano (2010)84 ? ? + + + + +
Morrison (1993)85 ? ? + + + + +
Morrison (1998)86 ? + + + + + +
Nath (1992)87 ? ? + + + + +
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Over half of the studies (56%) did not provide sufficient information to assess the risk of bias associated
with the selection and enrolment of patients into the study.37,38,42–47,51,53,56,58–64,67,68,70–72,74,75,78,82–87,89,94,95,97,98,100,
101,103,106,108,110 In particular, most studies did not explicitly state whether or not all eligible patients were
included during a defined period of time. Therefore, the risk of selection bias, for instance because of the
exclusion of patients who are harder to diagnose, cannot be excluded. Nine studies did not blind the
interpretation of the index test to the results of other index tests or to the reference standard, and were
therefore considered as being at a high risk of bias.39,47,48,64,65,78,83,91,95 Another 18 studies did not provide
sufficient information on blinding and were therefore considered as being at an unclear risk of bias.44,51,60,
62,71–75,79,82,84,85,87,88,90,93,110 Nearly all studies were rated as being at a low risk of bias associated with the
reference standard (91%) and patient flow (87%) and none of the included studies raised significant
concerns about their applicability to the diagnostic accuracy review questions.
TABLE 3 Summary of critical appraisal of diagnostic accuracy studies (continued )
First author and year
of publication
Risk of bias Applicability
Patient
selection
Index
test
Reference
standard
Patient
flow
Patient
selection
Index
test
Reference
standard
Nawaz (2010)88 + ? + + + + +
Newman (1991)89 + ? + + + + +
Newman (1992)90 ? + + + + + +
Nigro (1992)91 + – ? + + + +
Park (1982)92 – + + + + + +
Rastogi (2016)93 + ? + + + + +
Remedios (1998)94 ? + + + + + +
Rozzanigo (2009)95 ? – ? ? + + +
S¸anlı (2011)96 + + ? ? + + +
Sarikaya (2003)97 ? + + + + + +
Schlung (2016)98 ? + + + + + +
Schwegler (2008)99 + + + + + + +
Seabold (1990)100 ? + + ? + + +
Seabold (1995)101 ? + + – ? + +
Segall (1989)102 – + + + + + +
Shemesh (2015)103 ? + + + + + +
Unger (1988)104 + + ? ? + + +
van Vliet (2018)105 + ? + + + + +
Weber (1995)106 ? + + + + + +
Weinstein (1993)107 + + + – + + +
Wenter (2016)108 ? + + + + + +
Weon (2000)109 + + + + + + +
Williamson (1989)110 ? ? + + + + +
Yang (2016)111 + + – – + + +
Yuh (1989)112 + + + + + + +
Zaiton (2014)113 + + + + + + +
+, low risk of bias; –, high risk of bias; ?, unclear risk of bias.
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Synthesis of diagnostic accuracy in adults
In this section we consider the synthesis of diagnostic accuracy for studies of imaging tests in adults.
Studies exclusively in children are considered in Synthesis of studies in children. Studies in mixed adult/
children groups or where the population was unclear are included in the analysis of adults.
Excluded from this analysis are studies where the combined diagnostic accuracy of two or more imaging
tests was reported (e.g. the accuracy of scintigraphy in combination with SPECT); these are discussed in
Studies reporting on combinations of imaging tests. Also excluded are studies that did not report sufficient
data to calculate 2 × 2 tables of diagnostic accuracy; these are discussed in Studies not included in the
quantitative synthesis.
This analysis included 69 diagnostic accuracy studies.38–42,44–51,53–71,73–77,79–95,97,99–113 Appendix 4, Table 19,
summarises these studies. Many of these studies compare two or more imaging tests. Comparisons
between tests are discussed in Comparisons between tests. Many studies compare imaging tests with
scintigraphy. Scintigraphy was not specified as a test of interest in the protocol, but it is included here
because of the number of studies considering it. The main analysis only considers scintigraphy in studies
where it was compared with other tests; for studies of scintigraphy alone, see Studies of scintigraphy.
Some studies reported diagnostic accuracy at multiple thresholds of a single test, or for a single test under
different conditions. Where that was the case, the main analysis uses only the result with the highest DOR,
as an indicator of the ‘best’ diagnostic accuracy for that test in that study. Where appropriate, data at
multiple thresholds are considered in the sections on individual tests (see Synthesis of specific imaging tests).
Figure 2 summarises the sensitivity (proportion of people/scans with osteomyelitis correctly diagnosed) and
specificity (proportion of people/scans without osteomyelitis correctly diagnosed) for each test in each
study in a ROC plot. This figure shows considerable variation in the diagnostic accuracy both within and
between tests. MRI and SPECT both generally have high sensitivity (> 80%), but with a wide range of
specificities. PET is generally more consistent with high sensitivity and specificity, but with some studies
having lower sensitivity. Scintigraphy results vary widely in both sensitivity and specificity. Radiographic
results generally have poor sensitivity.
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FIGURE 2 Summary ROC plot of diagnostic accuracy in adults.
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In Appendix 4, Figure 21 shows a similar plot for PPVs and NPVs. These results are also variable and
difficult to interpret. MRI, SPECT and PET generally have high PPV and NPV, but with many outliers.
Radiography generally has a poorer NPV.
We now consider the bivariate meta-analysis of sensitivity and specificity. Figure 3 shows the summary
bivariate meta-analysis results for each test (with 95% CIs for sensitivity and specificity). Figure 4 shows the
summary HSROC curves for each test.
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FIGURE 3 Bivariate meta-analysis of sensitivity and specificity: all adult studies.
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FIGURE 4 Summary HSROC curves: all adult studies.
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These results show that sensitivity and specificity are highest for SPECT, but with a wide CI for specificity.
MRI and PET also have high sensitivity and specificity. CT, radiography and scintigraphy all have poorer
sensitivity and/or specificity. The summary HSROC curves for MRI, SPECT and PET are very similar and
overlapping, suggesting that they have similar diagnostic accuracy. The curves for CT, radiography and
scintigraphy are lower, showing poorer diagnostic accuracy.
Appendix 4, Figure 22, gives the results of the bivariate meta-analysis of PPV and NPV, which shows that
MRI, PET and SPECT have higher PPV (88–93%) and NPV (> 85%) than MRI and PET, with SPECT having
the highest NPV (97%). Scintigraphy and radiography have lower PPV and NPV.
Figure 5 shows forest plots of sensitivity and specificity for MRI. These highlight the generally high
sensitivity and specificity of MRI, and the overall consistency of sensitivity across studies. As noted earlier,
the specificity of MRI varies substantially across studies, although many studies are small with correspondingly
wide CIs. This raises concerns as to the consistency of MRI performance across studies. Given the large
number of tests, and hence forest plots, no further forest plots are presented in this report, but they are
available on request from the authors.
Table 4 shows the results of univariate meta-analyses of sensitivity and specificity (i.e. meta-analysed
separately rather than jointly) and also meta-analyses of DOR (to summarise overall diagnostic accuracy)
and the PR (proportion of people testing positive for osteomyelitis based on the imaging test result alone).
The results for sensitivity and specificity match those of the bivariate analysis in Figure 3, as would be expected.
The I2 values for sensitivity and specificity are low or zero, which conflicts with the apparent heterogeneity
observed in Figure 2. This may be because most studies are small, and so there is considerable within-study
variability in estimates, which reduces I2, rather than an absence of heterogeneity.
Diagnostic odds ratios are similar for MRI, SPECT and PET, suggesting similar diagnostic accuracy for these
tests, as seen in Figure 4. The odds ratios are considerably lower for scintigraphy, radiography and CT,
suggesting that these tests have poorer diagnostic accuracy. MRI and SPECT have high PRs of > 70%, so
most people have an imaging test result that would lead to being diagnosed with osteomyelitis. This, in
part, reflects high incidence in the studies. PET, however, has a lower PR of 52.7%. This may be because
the higher specificity and lower sensitivity of PET reduce the number of positive PET scans overall, and in
particular the number of false-positive diagnoses.
Comparisons between tests
Forty of the included studies of adults reported diagnostic accuracy data for two or more imaging tests. To
determine whether or not these studies show evidence that one test is superior to another, we compared
the DORs for each test within each study. Appendix 4, Figure 23, shows these DORs for each imaging test
in each study. These results show that, when radiography was included, it was generally inferior to other
tests (particularly MRI and scintigraphy); scintigraphy was generally inferior to MRI.
In Figure 6, each dot is the difference in log-DOR between the test in the title of each subplot and the
comparator test, indicated by the colour of the dot. Points to the right of the central black line are where
the ‘title’ test has greater DOR than the ‘comparator’ test. These results suggest that SPECT and PET were
generally superior to whatever test they were compared with (but with few studies). MRI was superior to
scintigraphy and radiography, but not to PET or SPECT. Scintigraphy was superior to radiography, but not
MRI, and radiography was generally inferior to all other tests.
To formally assess whether or not these apparent differences are genuine, regression modelling was used
to compare studies. This regressed the diagnostic accuracy data to estimate differences in DORs and
specificity between tests across studies (see Chapter 3, Comparison of imaging tests). Two models were
fitted: one using radiography as the baseline test and one using MRI as the baseline test. The formal
results of these models are given in Appendix 4, Table 20, and a summary is presented in Table 5.
RESULTS
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FIGURE 5 Forest plots of sensitivity and specificity for MRI.
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These results largely confirm what was observed from the main diagnostic analysis in Diagnostic meta-analysis.
Radiography has the lowest diagnostic accuracy (in terms of DOR) of all the tests. Its specificity is similar to that
of CT, MRI and SPECT, but it has lower sensitivity than any of these. It has lower sensitivity and specificity than
PET, but has higher specificity than scintigraphy.
Magnetic resonance imaging has similar diagnostic performance to SPECT and PET, but has lower specificity
(and consequently higher sensitivity) than PET. MRI has higher DORs than CT, radiography or scintigraphy.
Synthesis of specific imaging tests
This section considers in more detail the diagnostic accuracy of each of the included imaging tests.
TABLE 4 Results of univariate meta-analyses
Test Outcome Estimate (%) 95% CI I2
CT Sensitivity 69.68 40.12 to 88.74 0
Specificity 90.24 57.64 to 98.43 0
DOR 10.28 3.86 to 27.39 0
PR 55.8 39.49 to 78.83 0
MRI Sensitivity 95.56 92.36 to 97.46 0
Specificity 80.7 70.78 to 87.84 0
DOR 44.05 22.76 to 85.23 54
PR 72.79 66.89 to 79.22 25
PET Sensitivity 85.11 71.52 to 92.86 0
Specificity 92.77 83 to 97.12 0
DOR 38.51 17.79 to 83.38 34
PR 53.00 44.2 to 63.55 0
Scintigraphy Sensitivity 83.6 71.83 to 91.07 0
Specificity 70.58 57.72 to 80.82 0
DOR 8.3 5.36 to 12.85 17
PR 72.7 66.1 to 79.96 0
SPECT Sensitivity 95.06 87.82 to 98.09 0
Specificity 81.99 61.54 to 92.83 30
DOR 65.3 18.38 to 232 57
PR 74.1 65.15 to 84.29 0
Ultrasound Sensitivity 94.07 50.17 to 99.6 0
Specificity 50.99 3.16 to 97.08 0
DOR 13.92 1.94 to 99.74 0
PR 82.08 61.66 to 100 0
Radiography Sensitivity 70.35 61.64 to 77.8 0
Specificity 81.5 69.61 to 89.45 7
DOR 6.39 3.7 to 11.01 52
PR 53.13 43.64 to 64.69 52
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
26
Studies of scintigraphy
Scintigraphy was not specified as an imaging test of interest in our protocol, but was included in many of the
eligible studies as a comparator with other tests. Hence, we included it in our main analysis in Synthesis of
diagnostic accuracy in adults. To facilitate a more complete examination of the diagnostic value of scintigraphy,
we identified larger, recent studies (> 20 participants and published since 1990) of scintigraphy for analysis,
where scintigraphy was the only imaging test reported in the publication. Nine studies132,136,142,148–152,165 from
our database searches met these criteria and reported sufficient data for meta-analysis. Because they were
off-protocol, we note that the additional nine studies have not been formally assessed for risk of bias. These
nine studies were combined with the studies of scintigraphy included in the main meta-analysis, in order to
explore the impact of this additional evidence on scintigraphy, and as a sensitivity analysis compared with using
only the primary included studies.
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FIGURE 6 Comparing DORs within studies.
TABLE 5 Summary of regression model to compare imaging tests
Parameter Radiography worse than Radiography similar to Radiography better than
DOR CT, MRI, PET, scintigraphy
and SPECT
None None
Specificity PET CT, MRI and SPECT Scintigraphy
MRI worse than MRI similar to MRI better than
DOR None PET, SPECT CT, scintigraphy and radiography
Specificity PET CT, SPECT and radiography Scintigraphy
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A summary of all scintigraphy studies is given in Appendix 4, Table 21. As with other imaging tests, most
of the studies are in people with diabetic foot ulcers. A range of types of scintigraphy have been reported,
including (hydroxy)methylene diphosphonate [(H)MDP], WBC, hexamethylpropyleneamine oxime (HMPAO)
and gallium scans. Some studies reported combinations of these tests. Three radioisotopes were used:
technetium-99m (99mTc), indium-111 (111In) and gallium-67 (67Ga).
Figure 7 presents a summary ROC plot for the sensitivity and specificity results from these studies, classified
by scintigraphy type used. This suggests that there is considerable variation both within and between types
of scintigraphy.
A bivariate meta-analysis of all scintigraphy studies gave an overall sensitivity of 85.6% (95% CI 80.9% to
89.2%) and an overall specificity of 71.7% (95% CI 62.1% to 79.6%). This is similar to the result seen in
the main analysis (see Figure 3), but with a slightly higher sensitivity, suggesting that the additional studies
(of scintigraphy only) have higher sensitivity than those where scintigraphy was compared with other tests.
This could be as a result of either bias against scintigraphy in comparative studies, or poorer quality of the
scintigraphy-only studies.
Figure 8 shows the results of bivariate meta-analyses categorised according to the type of scintigraphy
performed. This suggests that 99mTc HMPAO WBC scintigraphy and mixed 111In WBC with 99mTc MDP
(methylene diphosphonate) scintigraphy can have very high diagnostic accuracy, with sensitivity > 85% and
specificity > 90%; this is similar to the diagnostic accuracy of PET, as seen in Figure 3. The 99mTc (H)MDP
scintigraphy, by contrast, has a much lower specificity, of < 50%.
Studies of magnetic resonance imaging scans
Most studies reported only one diagnostic accuracy result for MRI, and there was insufficient information
to distinguish between different types of MRI scan. One study86 reported results for four types of MRI, with
no evidence of any difference in diagnostic accuracy among them.
The MRI results in the main analysis had a very wide range of specificities, despite fairly consistent sensitivity.
We sought to identify any characteristics of the included studies that might explain this variation in specificity.
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FIGURE 7 Summary ROC plot for scintigraphy studies.
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Appendix 4, Figure 24, shows the association between specificity and incidence of osteomyelitis for each
study. This shows that specificity declines as incidence increases. This association was statistically significant
(a decline in log-odds of specificity of 0.31 per 10% increase in incidence, p = 0.008). This suggests that
osteomyelitis may be over-diagnosed using MRI in populations in which osteomyelitis is common. The model
was not a good fit (adjusted R2 = 0.17), so incidence does not explain all the variation in specificity. No other
possible causes of this variation could be identified.
Studies of single-photon emission computed tomography and single-photon emission
computed tomography/computed tomography
As with scintigraphy studies, SPECT studies used a range of radioisotopes and test types to perform SPECT
imaging. Figure 9 shows the ROC plot of sensitivity and specificity according to the type of test used. There
are too few studies to distinguish between tests, or to perform a bivariate meta-analysis. The results show no
clear evidence of difference between the types of test. When comparing results with those for scintigraphy
(see Figure 8), the results suggest that SPECT produces higher sensitivity than planar scintigraphy for the
same test type.
There was no evidence that studies of SPECT/CT had differing diagnostic accuracy to those of SPECT
alone, although the number of studies was limited (results not shown).
Studies of positron emission tomography and positron emission tomography/
computed tomography
There was no evidence that studies describing the test used as PET/CT differed in diagnostic accuracy from
those describing the test only as PET (see Appendix 4, Figure 25). All but one study used 18F-FDG PET.
There was no evidence that quantitative analysis (such as measuring the standardised uptake value)
improved the accuracy of PET (results not shown).
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Studies of ultrasound
Only two studies of ultrasound for diagnosing osteomyelitis in adults were identified, so they could not be
included in any bivariate meta-analysis. The results of these studies are summarised in Table 6. The two
studies are not consistent in their estimated sensitivity and specificity. Both have DORs that suggest poorer
diagnostic performance than MRI, PET or SPECT (see Table 4).
Studies reporting on combinations of imaging tests
Twelve studies40,43,54,55,64,65,69,75,84,96,109,141 reported data on the diagnostic accuracy of combining two tests.
These were mostly combinations of scintigraphy with SPECT. Two studies combined radiography with
probe-to-bone tests. These are summarised here, although we note that probe to bone is not an imaging test
and so is not covered in this review.
Figure 10 shows the sensitivity and specificity estimates for all the combination tests. This shows considerable
variation in the diagnostic accuracy of combination tests. Most tests have too few studies to draw any
conclusions. A bivariate meta-analysis of the SPECT+ scintigraphy studies gives a summary sensitivity of 87.3%
(95% CI 87.2% to 87.5%) and specificity of 83.4% (95% CI 83.3% to 83.6%). This is a lower sensitivity and
specificity than was estimated for SPECT alone (see Table 4).
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TABLE 6 Summary of diagnostic accuracy of ultrasound studies
Study
Enderle et al. (1999)49 (n= 19) Nath and Sethu (1992)87 (n= 25)
Cause: diabetic foot ulcers Cause: long bone pain or swelling
Sensitivity (%) (95% CI) 78.6 (57.1 to 100) 96.8 (88 to 100)
Specificity (%) (95% CI) 80 (44.9 to 100) 30 (1.6 to 58.4)
DOR (95% CI) 14.7 (1.2 to 185.2) 12.9 (0.6 to 292.8)
PPV (%) (95% CI) 91.7 (76 to 100) 68.2 (48.7 to 87.6)
NPV (%) (95% CI) 57.1 (20.5 to 93.8) 85.7 (49.1 to 122.4)
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Figure 11 compares the DORs for the combination tests with those for the individual tests within each
study. This shows no evidence that combining tests improves diagnostic accuracy; in most studies the
combined test (circle) has a DOR no higher, and often lower, than the best single test (triangle).
One study (Aragón-Sánchez et al.40) of radiography combined with probe to bone obtained very high
diagnostic accuracy (sensitivity 97.7%, specificity 94.6%). However, this study also achieved much higher
diagnostic accuracy for radiography alone than was observed in most other studies. It is unclear whether
this result is meaningful or a chance result in one study.
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Other factors and subgroups
This section considers other factors that may affect diagnostic accuracy: the choice of reference standard,
risk of bias, the presence of indwelling metalwork, the use of imaging tests prior to the main test and
whether osteomyelitis is acute or chronic.
Choice of reference standard
The eligible reference standards for confirming the absence of osteomyelitis were histopathology,
microbiology or clinical follow-up of at least 6 months. It is possible that the choice of reference standard
could affect the diagnostic accuracy.
In Appendix 4, Figure 26 shows the ROC plots of diagnostic accuracy in accordance with the reference
standard, for each imaging test. These results suggest that, when only clinical follow-up was used,
specificity might be higher than average, particularly for MRI. A formal regression model to assess this,
however, found no statistically significant evidence of a difference between reference standards in either
specificity or DOR. We conclude that choice of reference standard is unlikely to lead to bias in the main
meta-analyses.
Study quality and risk of bias
The impact of the QUADAS-2 assessment of each study on diagnostic accuracy was investigated. In Appendix 4,
Figure 27 shows the ROC plots of sensitivity and specificity for each study according to whether the study was
rated as being at a high, unclear or low risk of bias for patient selection. In Appendix 4, Figure 28 repeats
this for quality of the index test.
Neither figure suggests that there is any evidence that diagnostic accuracy results were biased by quality
factors. Reference standard and patient flow issues were rated as being at a low risk of bias for most
studies, and there was no evidence that these had any impact on diagnostic accuracy (results not shown).
Indwelling metalwork
Few studies reported on the number of patients (if any) who had indwelling metalwork at the time of their
scan. In Appendix 4, Figure 29 shows the diagnostic accuracy data for each imaging test according to
whether indwelling metalwork was present in some patients, not present in any, or unreported. This figure
shows no evidence that indwelling metalwork alters diagnostic accuracy.
Prior use of other imaging tests
In some studies, patients were included only after performing a prior imaging test, usually radiography.
Patients would go on to the main imaging test only if osteomyelitis had not been ruled out by the initial
test. This extra testing could affect the diagnostic accuracy observed.
Figure 12 shows the sensitivity and specificity for all imaging tests, according to the prior imaging test used
(if any). This suggests that prior use of radiography might improve specificity in MRI studies, and both
sensitivity and specificity in scintigraphy studies.
Formal regression analysis to test this possibility found no statistically significant evidence that radiography
prior to MRI improved specificity (p = 0.472) or DOR (p = 0.201). There was some evidence (but not
conventionally statistically significant) that radiography prior to scintigraphy increased the DOR (p = 0.141).
Hence it is possible, but uncertain, that using radiography as a precursor test to MRI or scintigraphy may
improve diagnostic performance.
Other than radiography, few tests were used in addition to the main test. This analysis considered only
instances when prior tests were explicitly reported. In practice, it is likely that radiography will be used as
an initial test in most patients.
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Acute and chronic osteomyelitis
Studies were divided according to whether the suspected osteomyelitis was acute or chronic. Studies were
categorised as:
l acute or subacute osteomyelitis
l COM
l COM and AOM
l not reported.
Figure 13 shows the sensitivity and specificity results according to the test used and acute or chronic
status. There appears to be some pattern in the choice of test used. PET and SPECT have not been
evaluated in people with AOM; almost all studies of PET are in people with COM. This may be a
consequence of the types of people in these studies; nearly all studies of AOM were in people with
diabetic foot ulcers. From these data, there is no clear evidence that diagnostic accuracy for any of the
tests differ between COM and AOM.
Figure 14 shows the results of bivariate meta-analysis according to acute or chronic status. There is no
compelling evidence that diagnostic accuracy for any test varies with acute or chronic status. It is possible
that MRI is more specific (91%) but less sensitive (89%) in acute cases than in chronic cases (78% and
98%, respectively). The results are consistent with those in the overall analysis (see Figure 3), with MRI,
PET and SPECT generally having greater diagnostic accuracy than radiography, CT or scintigraphy.
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Synthesis of diagnostic accuracy in people with diabetic foot ulcers
This section considers the 35 studies in which diabetic foot ulcers were the primary reason for testing for
osteomyelitis.37,38,40–43,47,49,51,53,55,56,62,67,70,71,74,76,77,82,84,86,88–90,92–95,97,99,102,107,111–113 This includes studies in which at
least 60% of patients had diabetic foot ulcers; studies with smaller numbers of people with foot ulcers were
excluded. Studies primarily of patients with diabetic foot ulcers constitute around half of the total studies
in this review. One study did not report sufficient data to be included in this analysis and is presented in
Studies not included in the quantitative synthesis.37
The sensitivity and specificity estimates from these studies are presented in Figure 15. The results suggest
high sensitivity (generally > 80%) for MRI and scintigraphy, but with a wide range of specificities. PET
showed high specificity, but a range of sensitivities. Radiography generally had low sensitivity. There were
too few studies of SPECT or ultrasound to draw any conclusions, and none of CT. In Appendix 4, Figure 30
shows the results for PPV and NPV, with considerable diversity in PPV and NPV values across studies.
Figure 16 shows the results of a bivariate meta-analysis of sensitivity and specificity. The results here are
similar to those for all studies (see Figure 3). Owing to non-convergence of their respective bivariate
analyses, the univariate results are presented for PET and SPECT. Both MRI and PET have high accuracy,
with MRI having higher sensitivity but lower specificity. Scintigraphy and radiography have lower specificity,
but here scintigraphy has higher sensitivity than PET. The summary HSROC curves (see Appendix 4, Figure 31)
suggest that MRI and PET (and possibly SPECT, although data are limited) have similar overall HSROC curves,
and so similar diagnostic accuracy, whereas radiography and scintigraphy have lower accuracy.
In Appendix 4, Figure 32 gives the results of the bivariate meta-analysis of PPV and NPV, which shows
that both MRI and PET have high PPV (88%) and NPV (> 85%), with MRI having a higher NPV (95%).
Scintigraphy and radiography have lower PPV and NPV rates.
In Appendix 4, Table 23 gives the results of univariate meta-analyses. The results are consistent with
bivariate analyses. As in the overall analyses, PET has a markedly lower PR (46%) than MRI (70%).
This means that fewer people are considered to have osteomyelitis using PET; this is a consequence of
its higher specificity and lower sensitivity.
100
20
30
40
50
60
Se
n
si
ti
vi
ty
 (
%
)
70
80
90
100
90 80 70 60 50 40 30 20 10 0
Specificity (%)
Test used
MRI
PET
Scintigraphy
SPECT
Ultrasound
Radiography
FIGURE 15 Sensitivity and specificity in studies of patients with diabetic foot ulcers.
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In studies using scintigraphy in patients with diabetic foot ulcers, a range of different types of scintigraphy
were used. In Appendix 4, Figure 33 shows the results of bivariate meta-analysis of these scintigraphy
studies according to the test used. This shows substantial variation in diagnostic accuracy, with 99mTc
HMPAO WBC scintigraphy being notably most accurate (89% sensitivity for 92% specificity). This makes it
more sensitive than PET, and more specific, but less sensitive than MRI.
Comparisons of tests
We also considered studies that compared different imaging tests in people with diabetic foot ulcers. In
Appendix 4, Figure 34 shows the difference in DORs between tests within studies. This suggests that MRI was
generally superior to radiography and scintigraphy, and scintigraphy was moderately superior to radiography.
It should be noted that this includes all types of scintigraphy together and, as shown in Figure 8, 99mTc
HMPAO WBC scintigraphy may have better diagnostic accuracy. There were too few studies of other
comparisons to draw any conclusions. Results from logistic regression models to compare the tests are
summarised in Table 7 (for full results, see Appendix 4, Table 24). These results are in agreement with the
analysis using all studies (see Table 5).
TABLE 7 Comparison of tests in people with diabetic foot ulcers
Parameter Radiography worse than Radiography similar to Radiography better than
DOR MRI, PET and scintigraphy None None
Specificity PET MRI Scintigraphy
MRI worse than MRI similar to MRI better than
DOR None PET Scintigraphy and radiography
Specificity PET Radiography Scintigraphy
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FIGURE 16 Bivariate analysis of sensitivity and specificity in people with diabetic foot ulcers.
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Synthesis of diagnostic accuracy for osteomyelitis not related
to diabetes
The systematic review identified 31 studies in adults where osteomyelitis was not explicitly related to
diabetes.39,44–46,48,50,54,57–61,63–66,68,73,75,79–81,83,85,87,101,103,105,106,108,109 This excludes studies where some of the
participants had diabetes, but includes studies where diabetes was not reported, or where the studies
had a range of inclusion criteria, which may have included people with diabetes.
The studies were classified according to the location of the suspected diabetes as follows:
l axial skeleton (skull and spine)
l long bone (leg)
l pelvis, hip or knee
l multiple locations or unreported location.
Studies were also classified according to the suspected cause of osteomyelitis:
l infections and ulcers
l trauma and surgery
l contiguous disease
l multiple causes
l other or unstated cause.
Figure 17 shows the sensitivity and specificity estimates by imaging test and scan location. Similarly, Figure 18
shows results by suspected cause. There are generally few studies of any imaging test within each category,
so it is not possible to draw firm conclusions. The results are broadly similar to those obtained when
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FIGURE 17 Sensitivity and specificity according to scan location.
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considering all studies and to the results in studies of diabetic foot ulcers. There is no immediate evidence
that diagnostic accuracy varies according to location or cause. The choice of imaging test may vary according
to location, with SPECT and CT being used more commonly to image the axial skeleton, where MRI is
used less.
Plots for PPV and NPV by location are given in Appendix 4, Figure 35, and by cause in Appendix 4, Figure 36.
There is no clear evidence that PPV or NPV varies by location of imaging or cause of osteomyelitis.
Given the limited numbers of studies in each location or cause category, bivariate meta-analysis of
sensitivity and specificity could be performed for only a few tests. Results of the analyses are shown in
Appendix 4, Figure 37, by location and in Appendix 4, Figure 38, by cause. The limited number of studies
means that CIs for most meta-analysis results are wide, so it is difficult to draw any firm conclusions. There
is no clear evidence that diagnostic accuracy varies by location or cause, or that results differ from those
seen in the overall meta-analysis of all studies (see Figure 3).
Given that there was no clear evidence that diagnostic accuracy for any of the tests varied by cause or
location, a combined meta-analysis of all studies in adults without diabetes was performed. The results
of the bivariate analysis of sensitivity and specificity are shown in Figure 19. Results from univariate
meta-analyses are provided in Appendix 4, Table 23.
These results are broadly comparable to the results using all studies (see Figure 3). There is some
suggestion that scintigraphy has slightly higher specificity and MRI has slightly lower specificity than the
overall results, or to those in diabetic foot ulcer studies (see Figure 15), but 95% CIs are too wide to draw
any firm conclusions.
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FIGURE 18 Sensitivity and specificity according to likely cause of osteomyelitis.
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Comparisons of tests
We also considered studies that compared different imaging tests in people without diabetes. In Appendix 4,
Figure 39 shows the difference in DORs between tests within studies (as in Figure 6 for all studies). This
suggests that PET and SPECT are generally superior to radiography and scintigraphy. Results from logistic
regression models to compare the tests are summarised in Table 8 (for full results, see Appendix 4, Table 26).
These appear to be similar to the results for all studies overall, but there were limited data on comparisons
between tests.
Studies not included in the quantitative synthesis
Of the two adult studies that were not included in any of the above quantitative syntheses, one evaluated
the accuracy of MRI37 and one compared radiography, CT and radiography + CT72 (Table 9). The results of
both studies differed somewhat from the meta-analysis and showed worse diagnostic accuracy overall,
although these results should be interpreted with caution owing to the relatively small size of the studies.
Abdel Razek and Samir37 conducted a prospective study that evaluated MRI in adults with suspected acute
diabetic foot osteomyelitis. MRI had a sensitivity of 65% (95% CI 46% to 85%) and a specificity of 61%
(95% CI 39% to 84%). These results differ from the meta-analysis, which found higher sensitivity and
TABLE 8 Comparison of tests in people without diabetes
Parameter Radiography worse than Radiography similar to Radiography better than
DOR MRI, PET and SPECT CT and scintigraphy None
Specificity Too few data to draw conclusions Scintigraphy
MRI worse than MRI similar to MRI better than
DOR None PET, SPECT Scintigraphy and radiography
Specificity Too few data to draw conclusions
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FIGURE 19 Bivariate meta-analysis in studies of people without diabetes.
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specificity for MRI (see Table 4). Larson et al.72 undertook a retrospective study conducted in patients with
suspected osteomyelitis associated with pelvic pressure ulcers. Results for radiography (sensitivity 88%;
specificity 32%), CT (sensitivity 50%; specificity 85%) differed from the meta-analysis, which found lower
sensitivity and higher specificity for radiography, and higher sensitivity for CT overall (see Table 4). The
combination of radiography and CT increased the sensitivity of CT alone, but reduced specificity (sensitivity
61%; specificity 69%). This differs from the results of the only other study of radiography+ CT reported
earlier, which found that radiography and CT combined had a sensitivity of 38% and a specificity of 85%
(see Studies reporting on combinations of imaging tests).75
Synthesis of studies in children
The three studies of children were conducted in single centres in patients with suspected AOM.52,78,98 Two
studies evaluated ultrasonography,52,78 and two used MRI.78,98 Radiography, scintigraphy and CT were
evaluated in only one study.78
The evidence for the accuracy of ultrasound and MRI in children was mixed and limited overall. Ultrasonography
had moderate sensitivity (55%, 95% CI 43% to 67%) and specificity (47%, 95% CI 24% to 70%) in
82 children with suspected acute haematogenous osteomyelitis,78 but had perfect (100%) sensitivity and
specificity in a study of 27 children with negative or equivocal initial radiographic findings.52 MRI had a
sensitivity of 81% (95% CI 64% to 93%) and a specificity of 67% (95% CI 22% to 96%) in 38 children
with suspected acute haematogenous osteomyelitis,78 but preoperative MRI had 38% sensitivity and 95%
specificity in a study of 54 patients with septic hip. A study-by-study summary is provided in Table 10.
Malcius et al.78 conducted a prospective study of 183 hospitalised children with suspected acute
haematogenous osteomyelitis. A total of 169 early radiography (median first day of hospital), 142 late
radiographic assessments (15th day of hospital stay), 82 ultrasonographies (second day), 76 scintigraphies
(third day), 38 MRI scans (seventh day) and 17 CT scans (15th day) were conducted. Scintigraphy (99mTc-MDP)
was conducted in patients who had an unclear diagnosis based on early radiography and/or ultrasound,
and MRI and CT were performed when results from scintigraphy were inconclusive. The reference standard
included clinical follow-up, microbiology (blood or bone culture) and/or surgery. Acute haematogenous
osteomyelitis was confirmed in 156 (85.2%) patients.
Early radiography had low sensitivity (16%, 95% CI 100% to 23%) but high specificity (96%, 95% CI 78% to
100%). Late radiography had high sensitivity (82%, 95% CI 75% to 88%) and specificity (92%, 95% CI 62%
to 100%).
Ultrasonography had moderate sensitivity (55%, 95% CI 43% to 67%) and specificity (47%, 95% CI 24%
to 70%). Bone scintigraphy had high sensitivity (81%, 95% CI 68% to 90%) and specificity (84%, 95% CI
60% to 97%).
TABLE 9 Studies not included in the quantitative synthesis
First author and
year of publication n Population Tests
Sensitivity (%)
(95% CI)
Specificity (%)
(95% CI) DOR
Abdel Razek (2017)37 39 Adults with diabetic
foot ulcer with
suspected AOM
MRI 65 (46 to 85) 61 (39 to 84) NR
Larson (2011)72 44 Adults with pelvic
pressure ulcer with
suspected pelvis/hip
osteomyelitis
Radiography,
CT, CT +
radiography
Radiography: 88;
CT: 50; CT +
radiography: 61
Radiography: 32;
CT: 85; CT +
radiography: 69
NR
NR, not reported.
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TABLE 10 Diagnostic accuracy results of studies in children
First author
and year of
publication Country Design n Population Tests Reference standard
Sensitivity (%)
(95% CI)
Specificity (%)
(95% CI) DOR (95% CI)
Malcius (2009)78 Lithuania Prospective 169 Children with
suspected acute
haematogenous
osteomyelitis
Early radiography,
late radiography,
ultrasound, scintigraphy
(99mTc-MDP), MRI, CT
Physical examination
and/or microbiology
(blood or bone culture)
or surgery
Early radiography:
16 (1 to 23)
Late radiography:
82 (75 to 88)
Ultrasound:
55 (43 to 67)
Scintigraphy:
81 (68 to 90)
MRI:
81 (64 to 93)
CT: 67
(38 to 88)
Early radiography:
96 (78 to 100)
Late radiography:
92 (62 to 100)
Ultrasound:
47 (24 to 7)
Scintigraphy:
84 (60 to 97)
MRI: 67
(22 to 96)
CT: 5
(1 to 98)
Early radiography:
4.34 (0.63 to 186.3)
Late radiography:
51.17 (6.61 to
2222.0)
Ultrasound:
1.08 (0.30 to 3.84)
Scintigraphy:
22.3 (4.9 to 132.7)
MRI: 8.67
(0.91 to 108.5)
CT: 2.0
(0.02 to 172.4)
Schlung (2016)98 USA Retrospective 54 Children with
septic hip
undergoing
preoperative MRI
MRI Positive joint fluid
culture or positive
peripheral blood
culture with joint
aspirate > 50,000
WBCs
37.5 (NR) 94.7 (NR) NR
Ezzat (2011)52 Egypt Prospective 27 Children with
suspected AOM
and negative or
equivocal plain
radiography
Ultrasound (greyscale
and power Doppler)
Surgery, cytology,
or clinical follow-up
100 (NR) 100 (NR) NR
NR, not reported.
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Magnetic resonance imaging had a sensitivity of 81% (95% CI 64% to 93%) and a specificity of 67%
(95% CI 22% to 96%), and CT had a sensitivity of 67% (95% CI 38% to 88%) and a specificity of 50%
(95% CI 1% to 98%), although results should be interpreted with caution because of the small number of
patients tested.
Overall, Malcius et al.78 found that scintigraphy and MRI are most valuable for detecting acute
haematogenous osteomyelitis at the onset of the disease, and late radiography is the most valuable
radiological method. The comparability of index tests is limited by the fact that more advanced tests were
performed only in harder-to-diagnose subgroups.
Schlung et al.98 conducted a retrospective study of 83 children with suspected septic hip arthritis, of whom
54 underwent preoperative MRI. Osteomyelitis was confirmed by positive joint fluid culture or positive
peripheral blood culture with joint aspirate. The sensitivity of MRI was 38% and the specificity was 95%.
Of the 10 false-negative cases missed by MRI, six had a positive femoral aspiration that resulted in
appropriate management, but three had significant morbidity owing to missed or delayed diagnosis; results
for the remaining patient were not reported.
Ezzat et al.52 conducted a small prospective study of children with suspected AOM with negative or
equivocal conventional plain radiography. The accuracy of greyscale and power Doppler ultrasound was
evaluated in 27 children, of whom 23 underwent surgery. Osteomyelitis was confirmed as positive in 25
out of 27 patients. Ultrasonography had a sensitivity of 100% and a specificity of 100%. The results of
this study need to be interpreted with caution because of the limited number of patients.
Review of inter-rater reliability
Characteristics of included studies
Table 11 presents a summary of study and patient characteristics of the 11 studies evaluating the
inter-rater reliability of imaging tests for the diagnosis of osteomyelitis.37,58,59,65,68,86,92,114–117
Three studies were conducted in Germany,58,59,65 three in the USA86,92,116 and two in Spain.114,115 A single
study was conducted in the following countries: Egypt,37 Switzerland68 and the UK.117 Five studies were
conducted prospectively37,58,59,65,114 and six were retrospective.68,86,92,115–117 One study was conducted in
children.116 The majority of participants were male. The condition targeted was COM in four studies,58,59,68,117
AOM in one study,37 AOM and COM in one study,65,92 and chronic or subacute osteomyelitis in one study.59,65
Five studies did not report what specific osteomyelitis subtypes were targeted.86,92,114–116 All studies included
experienced raters, although two studies also involved inexperienced radiologists.114,116
Five studies included patients with diabetic foot ulcer,37,86,92,114,115 one study included patients with trauma
or surgery as the suspected cause of osteomyelitis,68 and one included patients with spinal cord injury and
pressure ulcers.117 Three studies did not report the cause of osteomyelitis.58,59,65
The inter-rater reliability of the following tests was evaluated: MRI (five studies),37,68,86,116,117 radiography
(two studies),114,115 PET (two studies),58,59 scintigraphy (two studies),58,92 scintigraphy + SPECT (one study),65
SPECT/CT (one study)65 and SPECT with CT, MRI or radiography (one study).65 Four studies evaluated the
inter-rater reliability of more than one test.58,65,86,92
Critical appraisal
Table 12 presents a summary of the results of the critical appraisal. The studies were considered to be
of fair quality overall, although most were small and none provided satisfactory measures of intra-rater
reliability (the degree of agreement among repeated administrations of a test by a single rater).
RESULTS
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Overall, there were no significant concerns about the applicability of the study participants, raters and
conduct of imaging test to the review question. Six studies blinded radiographers to relevant patient
clinical information;37,68,86,92,115,116 this may limit the applicability of these studies to clinical practice as such
information would typically be available to clinicians, but may also reduce the risk of bias in the interpretation
of imaging test results. Three studies did not state whether or not raters were blinded to each other’s ratings,
which may limit their validity.65,68,115 There were no significant concerns about loss to follow-up. Only one
study provided an estimate of intra-rater reliability, which was below our prespecified acceptability score
(κ = 0.8).114 All studies used an appropriate measure for calculating reliability (kappa), except one that used
percentage agreement only.92
TABLE 11 Characteristics of inter-rater reliability studies
First author
and year of
publication Country Design n Population
Mean (SD)
age [range]
(years)
%
male Tests
Abdel Razek
(2017)37
Egypt Prospective 41 Adults, DFU,
suspected
AOM
51 [48–72] 54 MRI
Álvaro-Afonso
(2013)114
Spain Prospective 123 Adults, DFU 65 (13) [NR] 72 Radiography
Álvaro-Afonso
(2014)115
Spain Retrospective 37 Adults, DFU 58 (14) [NR] NR Radiography
Averill (2009)116 USA Retrospective 42 Children,
suspected
non-spinal
osteomyelitis
NR NR MRIa
Guhlmann
(1998)58
Germany Prospective 51 Adults,
suspected
COM
49 [22–81] 76 PET, scintigraphyb
Guhlmann
(1998)59
Germany Prospective 31 Adults,
suspected
COM
48 [20–78] 74 PET
Hauptfleisch
(2013)117
UK Retrospective 37 Adults with
spinal cord
injury,
suspected
pelvic COM
52 [22–83] 70 MRI
Horger (2007)65 Germany Prospective 31 Adults,
suspected
AOM and
COM
51 [20–89] 52 Scintigraphy + SPECT;
SPECT/CT; SPECT
with CT, MRI or
radiography
Kaim (2000)68 Switzerland Retrospective 18 Adults,
suspected
post-
traumatic
COM in long
bone
45 [27–65] 72 MRI
Morrison (1998)86 USA Retrospective 68 Adults, DFU 56 [24–85] NR MRIc
Park (1982)92 USA Retrospective 39 Adults, DFU NR [NR] NR Scintigraphyd
AGA, antigranulocyte antibody; DFU, diabetic foot ulcer; NR, not reported; SD, standard deviation; SE, spin echo;
SOM, subacute osteomyelitis; STIR, Short-TI Inversion Recovery.
a Contrast enhanced.
b 99mTc-MDP + AGAb.
c T1-weighted SE; T2-weighted fast SE with fat suppression; fast SE STIR; gadolinium-enhanced T1-weighted fast SE with
fat suppression).
d 99Tc-MDP critical appraisal.
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Results of inter-rater reliability studies
Table 13 presents the results of the studies of inter-rater reliability. Overall, the tests that showed the best
inter-rater reliability were PET (κ = 0.93 and 0.96, two studies)58,59 and scintigraphy (κ = 0.91 and 95%
agreement, two studies).58,92 The inter-rater reliability of MRI ranged from substantial to near perfect
(κ = 0.71 to 0.93, five studies).37,68,86,116,117 The inter-rater reliability of radiography ranged from fair to
substantial (κ = 0.35 to 0.40 in one study and κ = 0.77 in one study).114,115 One study found near-perfect
agreement between raters for SPECT/CT (κ = 0.86) and SPECT with CT, MRI or radiography (κ = 0.87), and
moderate agreement for scintigraphy + SPECT (κ = 0.54).65 There was no evidence that results differed
according to radiographer experience or patient population.
Review of implementation
One study of implementation was identified by the review.118
Govaert et al.118 was a survey of orthopaedic and trauma surgeons, radiologists and nuclear medicine
physicians in the Netherlands on preferred imaging strategies for diagnosing post-traumatic osteomyelitis.
The 16-question survey included four patient-based clinical cases of fracture-related osteomyelitis. Each
case included relevant medical history of the patient combined with a clinical picture of the affected limb
and radiographic results. Participants were asked to select which imaging test(s) they considered most
appropriate to diagnose or exclude the presence of post-traumatic osteomyelitis.
TABLE 12 Critical appraisal of inter-rater reliability studies
First author and year of publication
Question
1 2 3 4 5 6 7 8 9 10
Abdel Razek (2017)37 Y Y Y N Y Y Y Y N Y
Álvaro-Afonso (2013)114 Y Y Y N Y Y Y Y Na Y
Álvaro-Afonso (2014)115 Y Y Y Y Y Y UCb Y N Y
Averill (2009)116 Y Y Y N Y Y Y Y N Y
Guhlmann (1998)58 Y Y Y Y Y Y Y Y N Y
Guhlmann (1998)59 Y Y Y Y Y Y Y Y N Y
Hauptfleisch (2013)117 Y Y Y UCb Y Y Y UCb N Y
Horger (2007)65 Y Y Y Y Y Y UCb Y N Y
Kaim (2000)68 Y Y Y N Y Y UCb Y N Y
Morrison (1998)86 Y UCb Y N Y Y Y UCc N Y
Park (1982)92 Y Y Y N Y Y Y Y N N
N, no; UC, unclear; Y, yes.
a Experienced 0.75, p < 001; moderately experienced 0.61, p < 001; inexperienced clinicians 0.57, p < 001.
b Insufficient information reported.
c Differing sample sizes for each subtest.
Notes
Reproduced from van de Pol et al. (2010).32 See www.elsevier.com/about/policies/open-access-licenses/elsevier-user-license.
Questions: 1. Was a representative sample of participants used? 2. Was a representative sample of raters used? 3. Is replication of
the measurement procedure possible? 4. Was clinical information from participants available to raters and comparable to clinical
practice? 5. Were participants’ characteristics stable during the study? 6. Were raters’ characteristics stable during the study?
7. Were raters blinded to each other’s results? 8. Can non-random loss to follow-up be ruled out? 9. Was an estimate of
intra-rater reliability validly determined and was it above 0.80? 10. Were appropriate measures used for calculating reliability?
RESULTS
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TABLE 13 Results of inter-rater reliability studies
First author and year
of publication Population Test Raters (n)
Replicate
observations (n)
Raters
experience Result p-value
Abdel Razek (2017)37 Adults, DFU, suspected
AOM
MRI 2 NR Experienceda κ = 0.93 NR
Averill (2009)116 Children, multiple MRI 2 42 Inexperienced vs.
very experiencedb
κ = 0.72 (95% CI 0.52 to 0.92) NR
Hauptfleisch (2013)117 Adults with spinal cord
injury, suspected pelvic
COM
MRI 2 41 Experienced κ = 0.92 (95% CI 0.84 to 1.01);
agreement 88%
< 0.0001
Kaim (2000)68 Adults, suspected
post-traumatic COM in long
bone
MRI 2 19 Experienced κ = 0.88 NR
Morrison (1998)86 Adults, DFU (85%), others
(15%)
MRIc 2 57 to 71d Experienced κ = 0.71 to 0.92e NR
Guhlmann (1998)59 Adults, suspected
post-traumatic COM
PET 2 31 Experienced κ = 0.93 NR
Guhlmann (1998)58 Adults, suspected
post-traumatic COMf
PET; scintigraphy
g
2 51 Experienced PET, κ = 0.96; scintigraphy,
κ = 0.91
NR
Park (1982)92 Adults, DFU with suspected
AOM and COM
Scintigraphyh 3 36 Experiencedi 95% agreement NR
Horger (2007)65 Adults with suspected AOM
and COM, musculoskeletal
infection
Scintigraphy+ SPECT;
SPECT/CT; SPECT with CT,
MRI or radiography
2 31 Experienced Scintigraphy+ SPECT, κ = 0.54;
SPECT/CT, κ = 0.86; SPECT with
CT, MRI or radiography, κ = 0.87
NR
Álvaro-Afonso (2013)114 Adults, DFU Radiography 6 369 (123 × 3) Inexperienced to
very experienced
j
κ = 0.35 to 0.40k < 0.001
Álvaro-Afonso (2014)115 Adults, DFU Radiography 2 NR Experienced κ = 0.77 < 0.01
AGA, antigranulocyte antibody; DFU, diabetic foot ulcer; NR, not reported; SE, shot echo; STIR, short-TI intervension recovery.
a 10 and 20 years.
b 20 years vs. limited (paediatric fellow).
c T1-weighted SE; T2-weighted fast SE with fat suppression; fast SE STIR; gadolinium-enhanced T1-weighted fast SE with fat suppression.
d T1-weighted SE: 71; T2-weighted fast SE with fat suppression: 71; fast SE STIR: 42; gadolinium-enhanced T1-weighted fast SE with fat suppression: 57.
e T1-weighted SE: 0.91; T2-weighted fast SE with fat suppression: 0.71; fast SE STIR: 0.72; gadolinium-enhanced T1-weighted fast SE with fat suppression: 0.92.
f ≥ 23% had indwelling work.
g 99mTc-MDP+ AGAb.
h 99Tc-MDP.
i ≥ 7 years.
j Two inexperienced, two moderately experienced, two very experienced.
k 0.35 (very experienced), 0.39 (moderately experienced), 0.40 (inexperienced).
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There were 346 responders, comprising 153 trauma surgeons, 104 orthopaedic surgeons, 56 nuclear
medicine physicians and 33 musculoskeletal radiologists. There was consensus on the usefulness of
radiography in patients with a late infection, but not in patients with acute infection. There was a marked
difference between trauma surgeons, and orthopaedic surgeons’ choice of nuclear medicine imaging for late
infection: trauma surgeons preferred PET and orthopaedic surgeons favoured WBC scintigraphy. Similarly,
there was a consistent difference between radiologists and nuclear medicine physicians: musculoskeletal
radiologists favoured MRI whereas nuclear medicine clinicians preferred PET/CT. CT and three-phase bone
imaging for late fracture-related infections were favoured by orthopaedic surgeons and some musculoskeletal
radiologists, but not by trauma surgeons or nuclear medicine physicians. Ultrasound-guided biopsy was
regarded by all physicians to have some role in patients with early infection but was not popular for late
infections. Preference of imaging was influenced by access to equipment, with clinicians selecting imaging
methods they had access to in their own hospital.
Summary of previous systematic reviews
The systematic database searches identified 11 previous systematic reviews of the diagnosis of
osteomyelitis.20–30 Most of the studies included in these reviews were also included in this review, although
some did not meet our inclusion criteria. The previous reviews are summarised in Table 14.
Four of these reviews considered primarily, or only, people with diabetic foot ulcers.20,22,23,26 Their
conclusions varied, depending on the tests included, but MRI, PET and WBC scintigraphy were all
suggested as suitable imaging tests.
The Lauri et al.23 review, which is the most recent review of patients with diabetic foot osteomyelitis,
concluded that MRI, PET and WBC scintigraphy have similar sensitivity, but MRI has lower specificity.
This is similar to the findings of this review.
Three reviews of osteomyelitis in the general population mostly recommended PET and SPECT as having
the best diagnostic accuracy,25,27,28 but that leucocyte scintigraphy could be useful in some cases, such as
for COM in the peripheral skeleton,25 or when PET is unavailable.28 Only one of these three reviews
considered MRI.25 One review focused on patients with peripheral post-traumatic osteomyelitis and
concluded that WBC [or antigranulocyte antibody (AGA)] scintigraphy with SPECT/CT or 18F-FDG-PET/CT
has the best diagnostic accuracy in this population.21 Another review of MRI in patients with pressure
ulcers was inconclusive owing to insufficient evidence.29
Only two reviews considered osteomyelitis in children. One focused on calcaneal osteomyelitis. The review
included only three diagnostic accuracy studies and was inconclusive owing to the limited evidence.24 One
review focused on haematogenous acute and subacute paediatric osteomyelitis.30 The review included three
studies of radiography that showed low sensitivity (16–20%) but high specificity (80–100%). 99Tc bone
imaging had variable sensitivity (53–100%) and specificity (50–100%) (three studies). MRI had the highest
sensitivity (80–100%) and specificity (70–100%) (five studies), compared with CT (sensitivity 67%, specificity
50%, two studies) and ultrasound (sensitivity 55%, specificity 47%, one study). Only one of the studies
included in this review met our inclusion criteria, which was the largest and most comprehensive study in
children.78 Overall, the diagnostic accuracy findings of this review broadly agree with the evidence in adults.
Clinical effectiveness summary and conclusions
Summary of included studies
The review of diagnostic accuracy included 77 studies. Nearly one-quarter of the studies were considered
to be at a high risk of bias.
RESULTS
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TABLE 14 Summary of previous systematic reviews
First author and
year of publication Studies (n) Osteomyelitis Index test(s) Meta-analysis Main findings Conclusions
Dartnell (2012)30 7 Haematogenous acute
and subacute paediatric
osteomyelitis
Any No Radiography: sensitivity 16–20%,
specificity 80–100%
99Tc scintigraphy: sensitivity
53–100%, specificity 50–100%
MRI: sensitivity 80–100%,
specificity 70–100%
CT: sensitivity 67%, specificity
50%
Ultrasound: sensitivity 55%,
specificity 47%
Radiographs are essential for
exclusion of other diagnoses.
MRI is the gold-standard imaging
technique. If unavailable or a
delay is likely, bone and
ultrasound scans usually give
adequate diagnostic information
Dinh (2008)20 9 Diabetic foot osteomyelitis Any Yes Radiography: sensitivity 54%,
specificity 68%, DOR 2.84
MRI: sensitivity 90%, specificity
79%, DOR 24.36
Scintigraphy: sensitivity 81%,
specificity 28%, DOR 2.10
WBC scintigraphy: sensitivity
74%, specificity 68%, DOR 10.07
MRI is the most accurate imaging
test for DFO
Govaert (2017)21 10 Peripheral post-traumatic Any No WBC scintigraphy: sensitivity
50–100%, specificity 0–97%
PET: sensitivity 83–100%,
specificity 51–100%
PET/CT: sensitivity 86–94%,
specificity 76–100%
WBC scintigraphy + SPECT/CT:
sensitivity 100%, specificity
89–97%
WBC (or AGA) scintigraphy with
SPECT/CT or 18F-FDG/CT have
the best diagnostic accuracy for
peripheral PTO
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TABLE 14 Summary of previous systematic reviews (continued )
First author and
year of publication Studies (n) Osteomyelitis Index test(s) Meta-analysis Main findings Conclusions
Kapoor (2007)22 17 Foot osteomyelitis (mainly
diabetic)
MRI, scintigraphy
and radiography
Yes MRI: DOR 42.1 (95% CI 14.8 to
119.9)
MRI vs. scintigraphy (n = 7): DOR
149.9 vs. 3.6
MRI vs. radiography (n = 9): DOR
81.5 vs. 3.3
MRI vs. WBC (n = 3): DOR 120.3
vs. 3.4
Accuracy of MRI was markedly
superior to that of 99mTc bone
scanning, plain radiography and
WBC
Lauri (2017)23 29 Diabetic foot osteomyelitis MRI, PET, WBC
scintigraphy
Yes PET: sensitivity 89%, specificity
92%, DOR 95
WBC 111In scintigraphy: sensitivity
92%, specificity 75%,
DOR 34
WBC 99mTc-HMPAO: sensitivity
91%, specificity 92%, DOR 118
MRI: sensitivity 93%, specificity
75%, DOR 37
MRI, PET and WBC have similar
sensitivities, PET and WBC have
highest specificities
Mooney (2017)24 3 Children (calcaneal
osteomyelitis)
MRI and
radiography
No MRI: accuracy 100%
Radiography: accuracy 14–71.4%
No clear approach to diagnosis of
calcaneal osteomyelitis in children
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First author and
year of publication Studies (n) Osteomyelitis Index test(s) Meta-analysis Main findings Conclusions
Termaat (2005)25 23 General (chronic) Any Yes PET: sensitivity 96% (95% CI
88% to 99%), specificity 91%
(95% CI 81% to 95%)
Bone scintigraphy: sensitivity 82%
(95% CI 70% to 89%), specificity
25% (95% CI 16% to 36%)
Leucocyte scintigraphy: sensitivity
61% (95% CI 43% to 76%),
specificity 77% (95% CI 63% to
87%)
Bone +WBC scintigraphy:
sensitivity 78% (95% CI 72% to
83%), specificity 84% (95% CI
75% to 90%)
MRI: sensitivity 84% (95% CI
69% to 92%), specificity 60%
(95% CI 38% to 78%)
PET has highest accuracy.
Leucocyte scintigraphy has an
appropriate accuracy in the
peripheral skeleton, but 18F-FDG-PET
is superior in the axial skeleton
Treglia (2013)26 9 Diabetic foot osteomyelitis PET Yes PET: sensitivity 74% (95% CI
60% to 85%), specificity 91%
(95% CI 85% to 96%), DOR
16.96 (95% CI 2.1 to 139.7),
AUC 0.874
18F-FDG-PET and PET/CT showed
high specificity and are potentially
useful if combined with other
imaging methods such as MRI,
although data are limited
van der Bruggen
(2010)27
11 General PET No PET: sensitivity 94–100%,
specificity 87–100%
18F-FDG-PET is also useful for
diagnosis of osteomyelitis with
improved spatial resolution over
SPECT imaging, allowing more
accurate localisation. Localisation
can be further improved by
adding CT
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TABLE 14 Summary of previous systematic reviews (continued )
First author and
year of publication Studies (n) Osteomyelitis Index test(s) Meta-analysis Main findings Conclusions
Wang (2011)28 23 General PET, scintigraphy Yes PET: sensitivity 92%, specificity
92%, AUC 0.97
Scintigraphy: sensitivity 83%,
specificity 45%, AUC 0.65
Leucocyte scintigraphy: sensitivity
74%, specificity 88%, AUC 0.91
MOAB scintigraphy: sensitivity
88%, specificity 71%, AUC 0.89
PET is superior to scintigraphy,
but leucocyte scintigraphy is
reasonable if PET is unavailable
Xu (2017)29 3 Pressure ulcer MRI No Sensitivity 98% and 94.3%,
specificity 89% and 22.2%.
NR for 3rd study
Insufficient evidence
AGA, antigranulocyte antibody; AUC, area under the curve; DFO, diabetic foot ulcer; MOAB, monoclonal antigranulocyte antibody; NR, not reported; PTO, post-traumatic osteomyelitis.
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The review of inter-rater reliability identified 11 studies. The studies were considered of fair quality overall,
although most were small and none provided satisfactory measures of intra-rater reliability.
Only one study on the implementation of diagnostic test imaging for osteomyelitis from the Netherlands
was included. The applicability of its findings to other health-care systems is uncertain.
General conclusions from synthesis
In adults, MRI, PET and SPECT scans all had summary sensitivity and specificity of between 80% and 95%.
Similarly, they had PPVs between 85% and 93%, and NPVs between 85% and 97%. All had similar DORs
and summary HSROC curves, suggesting that overall diagnostic accuracy was similar across the three tests.
Despite this good performance, MRI and SPECT showed a very high variability in specificity across studies;
for MRI, specificity ranged from 0% to 98%. Results for PET were generally more consistent.
Radiography and CT generally had lower sensitivity, and scintigraphy had lower specificity than MRI, PET
and SPECT. Radiography, CT and scintigraphy all had substantially lower DORs than MRI, PET or SPECT,
suggesting poorer diagnostic performance in general. Formal comparisons of the tests in studies that
analysed multiple imaging tests confirmed the above conclusions. These analyses also confirmed that MRI
generally has higher sensitivity, but lower specificity, than PET.
There were only two studies of ultrasound, which were not consistent in their findings, so no conclusions
on the diagnostic value of ultrasound can be drawn.
The diagnostic accuracy of scintigraphy depended on the type of scintigraphy performed. Although
sensitivity was similar across types of scintigraphy (75% to 92%), specificity was poor for 99mTc-(H)MDP
(at 36% to 46%), but high for 99mTc-HMPAO WBC (94%) and mixed for 111In WBC and 99mTc-MDP
scintigraphy (88%). This suggests that newer forms of scintigraphy have diagnostic accuracy similar to MRI,
PET and SPECT. This is perhaps unsurprising as most SPECT studies used 99mTc-HMPAO WBC imaging.
No other differences in performance within tests were identified. In particular, there was no evidence that
SPECT/CT differed from SPECT alone, or that PET/CT and PET alone differed in diagnostic accuracy. In
general, there were too few data reported to distinguish between subtypes of test and few studies compared
subtypes of test. In particular, we found no evidence on the impact of contrast agents for MRI.
There was some evidence that the specificity of MRI declined as the incidence of osteomyelitis in the study
population increased. This might suggest that there is overdiagnosis of osteomyelitis when using MRI,
particularly when most people tested will have osteomyelitis, perhaps because of a desire not to miss
actual cases.
Few studies described the diagnostic accuracy when combining different tests, such as combining
scintigraphy and SPECT. There was no evidence that test combinations improved diagnostic accuracy
compared with using a single test (MRI, PET or SPECT). Some studies were of patients who had already
received radiography prior to their main imaging test. There was some suggestion that performing
radiography before MRI could improve diagnostic accuracy, but this was not conclusive.
Diagnostic accuracy by cause or nature of osteomyelitis
The largest group of people receiving imaging tests for osteomyelitis were people with diabetic foot ulcers,
representing nearly half of the included studies. Results were broadly consistent with the overall analysis.
MRI (96% sensitivity, 84% specificity) and PET (79% sensitivity, 92% specificity) both had high diagnostic
accuracy, with MRI having higher sensitivity but lower specificity. 99mTc-HMPAO scintigraphy had high
accuracy (92% sensitivity, 89% specificity), comparable to that of PET and MRI.
In studies of people without diabetes, a range of locations (including long bones, pelvis, knee, hip, spine and
skull) and a range of possible causes of osteomyelitis (including infections, trauma and surgery) were tested.
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The numbers of studies in any category were small so the ability to compare studies was limited. There was,
however, no clear evidence that location or cause of osteomyelitis had any impact on the diagnostic
accuracy of any imaging test.
When combining all studies of people without diabetes, the results were similar to the overall results and
to those in people with diabetic foot ulcers. MRI (94% sensitivity, 72% specificity), PET (88% sensitivity,
90% specificity) and SPECT (96% sensitivity, 95% specificity) all had high diagnostic accuracy, although
diagnostic accuracy was poorer for radiography, scintigraphy and CT.
Overall, there was no statistically significant evidence that diagnostic accuracy of any test varies according
to the location or possible cause of osteomyelitis. The choice of tests did vary, with MRI most studied in
people with diabetic foot ulcers. SPECT, by contrast, has been little studied in people with diabetes.
Studies of children, inter-rater reliability and implementation
Only three studies of children were identified. The evidence for the accuracy of ultrasound and MRI in children
was mixed and limited overall. Only one study evaluated radiography, scintigraphy and CT in children.
There was some evidence to suggest that MRI has an acceptable degree of agreement among radiologists.
The evidence for the inter-rater reliability of other imaging tests was very limited.
There is also very limited evidence on the implementation of imaging tests for the diagnosis of
osteomyelitis. Notably, there is a lack of evidence on patient preferences and on the cost-effectiveness of
diagnostic imaging tests and pathways for osteomyelitis.
RESULTS
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Chapter 5 Discussion
Statement of principal findings
This systematic review identified 81 studies relating to imaging tests for the diagnosis of osteomyelitis.
Seventy-seven of these were studies of diagnostic accuracy, of which 69 reported diagnostic accuracy data
sufficient to be included in a quantitative synthesis. Thirty-six diagnostic accuracy studies were in patients
with diabetic foot ulcers, and 40 were in patients without diabetes.
Eleven studies evaluated the inter-rater reliability of at least one imaging test and one study provided data
on clinician opinions on imaging tests for osteomyelitis.
Overall, most diagnostic accuracy studies were small (80% had < 50 participants) and nearly one-quarter
were considered as being at a high risk of bias, although poor reporting means that there is significant
uncertainty about the quality of most of the studies. The studies of inter-rater reliability were considered of
fair quality overall, although most were small and none provided satisfactory measures of intra-rater reliability.
Only one study from the Netherlands on the implementation of diagnostic test imaging for osteomyelitis
was included.118 The applicability of its findings to other health-care systems is uncertain.
Diagnostic accuracy in adults
The overall meta-analysis of diagnostic accuracy in adults found that MRI (the most widely studied test) can
detect osteomyelitis with high accuracy (95.6% sensitivity, 95% CI 92.3% to 97.5%; 80.7% specificity,
95% CI 70.7% to 87.8%). There was, however, considerable variation in the specificity across tests. This
may partly be as a result of the overdiagnosis of osteomyelitis, particularly in studies with a high incidence
of osteomyelitis.
Positron emission tomography also had high diagnostic accuracy (85.1% sensitivity, 95% CI 71.5% to
92.9%; 92.7% specificity, 95% CI 83.0% to 97.1%), with lower sensitivity, but higher specificity, than
MRI. SPECT also had high accuracy (95.0% sensitivity, 95% CI 87.8% to 98.1%; 82.0% specificity,
95% CI 61.5% to 92.8%). There was no evidence that PET alone differed in accuracy from PET/CT, nor
that SPECT differed from SPECT/CT. MRI, PET and SPECT all had similar DORs and summary HSROC curves,
suggesting that the three imaging tests have broadly similar diagnostic performance.
Scintigraphy (83.6% sensitivity, 95% CI 71.8% to 91.1%; 70.1% specificity, 95% CI 57.7% to 80.8%),
CT (69.7% sensitivity, 95% CI 40.1% to 88.7%; 90.2% specificity, 95% CI 57.6% to 98.4%) and
radiography (70.3% sensitivity, 95% CI 61.6% to 77.8%; 81.5% specificity, 95% CI 69.6% to 89.4%) all
had generally inferior diagnostic accuracy to MRI, PET or SPECT. This was confirmed by their lower DORs
and poorer HSROC curves. There was evidence that the diagnostic accuracy of scintigraphy depended on
the type of scintigraphy used. The most up-to-date forms of scintigraphy, such as 99mTc HMPAO WBC
scintigraphy (87.3% sensitivity, 95% CI 75.1% to 94.0%; 94.7% specificity, 95% CI 84.9% to 98.3%)
had higher diagnostic accuracy, similar to that of PET or MRI. However, its estimated sensitivity was lower
than for 3D SPECT imaging.
There were insufficient studies of ultrasound to assess its diagnostic accuracy.
Comparisons and combinations of diagnostic tests
In studies that compared two or more imaging tests, informal and formal comparisons of these tests
confirmed the findings discussed above. MRI, PET and SPECT all had similar diagnostic accuracy in terms of
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DORs. MRI had higher sensitivity but poorer specificity than PET. Scintigraphy (all types combined),
radiography and CT all had lower DORs than MRI, PET or SPECT.
In studies that reported the diagnostic accuracy of combinations of imaging tests (e.g. of the combination
of scintigraphy and SPECT), there was no clear evidence that combining tests improved diagnostic accuracy
over using a single test alone, although data were limited.
Studies were generally not clear about whether or not radiography was performed prior to the main
imaging test. It was possible that prior use of radiography could improve diagnostic accuracy of
scintigraphy or MRI, but data were limited and results were not statistically significant.
Subgroups of patients
The main patient subgroup was patients in whom osteomyelitis was suspected as a complication of
diabetic foot ulcers. This group represented nearly half of all included studies. The results of meta-analyses
in these patients were similar to those from the main meta-analysis, except that there were too few studies
of SPECT or CT to reliably assess diagnostic accuracy. There was no evidence to suggest that diagnostic
accuracy in patients with diabetic foot ulcers differed from the overall analysis.
Studies of patients without diabetes were divided according to scan location (axial skeleton, long bone,
etc.) and by potential cause of osteomyelitis (trauma or surgery, infection, etc.). Data within each category
were generally limited, but there was no clear evidence that diagnostic accuracy varied by scan location or
cause, or that results differed substantially from the main analysis.
When all studies of patients without diabetes were combined, results were generally similar to the overall
analyses. There was some suggestion that the specificity of MRI and PET was lower than in the overall
analysis, but CIs were too wide for this to be conclusive.
Few studies reported whether osteomyelitis was acute or chronic, but there was no compelling evidence
that this affected diagnostic accuracy. Similarly, there was no evidence that the presence of indwelling
metalwork or the choice of reference standard test (microbiology or clinical follow-up) altered diagnostic
accuracy. There was no evidence of systematic bias in the results; diagnostic accuracy did not appear to
vary according to risk of bias as assessed using QUADAS-2.
Diagnostic tests in children
The evidence for the accuracy of ultrasound and MRI in children was mixed and limited overall.
Ultrasonography had moderate sensitivity and specificity in children with suspected acute haematogenous
osteomyelitis but had perfect sensitivity and specificity in a small study of children with negative or
equivocal initial radiographic findings. MRI had good sensitivity and specificity in children with suspected
acute haematogenous osteomyelitis in one study,78 but preoperative MRI had poor sensitivity and near-
perfect specificity in another study of patients with septic hip.98
Inter-rater reliability and implementation
Magnetic resonance imaging appeared to have acceptable inter-rater reliability. There was some evidence
suggesting that PET and scintigraphy had near-perfect inter-rater reliability, although this is limited to few
small studies.58,59,92 We found no evidence on patient preferences and cost-effectiveness of imaging tests
for osteomyelitis.
Strengths and limitations of the assessment
Strengths
This systematic review was conducted in accordance with PRISMA guidelines; searches of numerous
databases were performed, studies were assessed for quality using the QUADAS-2 framework and,
DISCUSSION
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provided they reported sufficient data, studies were synthesised using bivariate meta-analysis methods to
assess diagnostic accuracy.
Over 18,000 database records were assessed and 81 published studies were included in this review,
making it the largest and most comprehensive review of the diagnosis of osteomyelitis to date. This was
the first review in the field to consider all relevant imaging tests across all types of patient receiving
imaging tests to diagnose osteomyelitis. This was, therefore, the first review to our knowledge that was
able to comprehensively compare imaging tests and to investigate whether or not the choice of imaging
test varies with type of patient.
This review used recommended contemporary meta-analysis methods such as bivariate analysis and HSROC
analysis to synthesise studies, so the synthesis is robust and meets the highest statistical standards. This was
the first meta-analysis of osteomyelitis and, to our knowledge, the first practical diagnostic meta-analysis
in any field, to use regression models to formally compare different diagnostic tests. This made it the first
analysis to comprehensively and reliably compare the various imaging tests for osteomyelitis.
Limitations
The limitations of this review are largely a consequence of the limitations in the identified studies.
There were numerous concerns about the potential for bias in the included studies. Most studies were
small, with < 50 participants, and were conducted retrospectively. The risk-of-bias assessment suggested
potential bias because of unclear methods of patient selection and lack of blinding between index tests
and references standards. However, statistical analysis found no evidence that these concerns led to actual
biases in the results.
There were few studies identified that included children. This may be because studies of children do not
discuss osteomyelitis directly, but only in the context of other conditions such as septic arthritis. Hence, it is
possible that some possibly relevant studies were missed. However, subsequent informal searches did not
identify any further useful reviews or studies that could be included and so we were unable to draw any
firm conclusions on the accuracy of imaging in children.
Some imaging tests were reported in a few studies, particularly ultrasound and CT, so we were not able to
fully assess their diagnostic accuracy. Some aspects of studies were inconsistently reported, such as varying
descriptions of the cause of osteomyelitis, non-reporting of whether osteomyelitis was acute or chronic,
and lack of clarity on whether or not radiography (or other tests) had been used prior to the main test.
This made assessment in these subgroups difficult.
We identified very few data beyond those on diagnostic accuracy, with few studies discussing broader
implementation issues such as access to machinery, costs or radiation exposure. This meant that this review
could not consider the broader issues of how imaging tests should be used, for example whether or not
differences in diagnostic accuracy between PET/SPECT and MRI merit the additional radiation exposure,
or suggest that PET/SPECT machines should be made more widely available.
Scintigraphy was not specified in the protocol as a test of interest as it is little used in the UK. However,
many studies of scintigraphy were identified during abstract screening and many studies compare
scintigraphy with other tests. Given this, we decided to include scintigraphy in the main analysis where it
had been compared with other tests. Studies of scintigraphy alone were included in further analyses, but
these studies were not fully assessed for quality. This uncertainty in quality, and the consequence that the
scintigraphy-only studies may be of lower quality than the studies that were fully assessed, is a limitation
of this analysis.
Our analysis therefore has the potential for bias, either because the diagnostic accuracy of scintigraphy
may be underestimated when it is compared with other tests expected to be better, or because studies
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of scintigraphy alone may be of poorer quality. However, the diagnostic accuracy of the scintigraphy-only
studies was similar to that of the fully assessed studies. Any bias is likely to be modest and the overall
conclusions reasonable. The benefits of assessing all the evidence on scintigraphy (e.g. being able to
compare different test types) probably outweigh any risk of bias.
Uncertainties
The main uncertainties remaining from this review arise largely because of limitations in the identified
studies.
The diagnostic accuracy of imaging tests in children remains highly uncertain owing to the very limited
nature of the evidence. We could reach no firm conclusions on the diagnostic accuracy of any imaging
test in children.
The diagnostic accuracy of ultrasound is currently unknown as the only two studies in adults had
conflicting results. However, DORs in both studies were low, suggesting that ultrasound is unlikely to have
similar or better diagnostic accuracy than MRI, PET or SPECT. Ultrasound, however, is a test of choice in
patients with metalwork in situ as this causes artefacts in CT and MRI.
Although we found no evidence that diagnostic accuracy varied across subgroups of patients, limited
or inconsistent reporting of some characteristics, such as AOM versus COM, or the cause or location
of osteomyelitis, means than differences between tests or between subgroups cannot be ruled out.
Considerations from patient representatives
Both patient representatives were parents of children who were treated for osteomyelitis. Both discussed
the fact that diagnosis was generally a long process, with multiple imaging tests performed, with
preliminary radiography and then ultrasound tests, both of which might be repeated. MRI was used for the
‘definitive’ diagnosis, and MRI was also used to confirm that treatment had been effective. We note that
this process of multiple tests and their interactions could not be easily captured in this systematic review,
and the impact and value of multiple imaging tests remain uncertain.
Antibiotics were given early in the diagnostic process, before ultrasound or MRI was performed. This may
affect evaluations of diagnostic accuracy, because osteomyelitis is treated before being formally diagnosed.
In future studies, the impact on diagnostic accuracy of treatment, given the ethical need for prompt
treatment, will need to be considered.
Both parents noted that there was little time to discuss the tests or decide which was best for their child
and they accepted whatever their doctors recommended. Both felt that the need to correctly diagnose
osteomyelitis outweighed any concerns about the tests themselves. So, for example, they were willing to
accept MRI requiring general anaesthesia.
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
56
Chapter 6 Conclusions
Implications for health care
This review found that MRI, PET and SPECT all have broadly similar and high accuracy when diagnosing
osteomyelitis. All three tests correctly diagnose most people with, and most people without, osteomyelitis.
All three are therefore suitable imaging tests for reliably diagnosing osteomyelitis. No clear reason to
prefer one test over the other in terms of diagnostic accuracy was identified. The wider availability of MRI
machines, and the fact that MRI does not expose patients to harmful ionising radiation, may mean that
MRI is preferable in most cases, unless it is unsuitable for a particular patient. MRI also gives additional
information as to the location of fluid collections and anatomical detail for surgical planning not given by
SPECT or PET in such detail. PET or SPECT may be required if MRI is inconclusive.
Magnetic resonance imaging generally had poorer specificity than PET or SPECT, with a wide range of
specificities across studies. This means that there may be substantial numbers of ‘false-positive’ cases
when using MRI and clinicians should be aware of this potential for overdiagnosis. This may mean that
MRI may be best suited to cases where false-positive cases are of lesser concern, perhaps such as when
patients would proceed directly to antibiotic treatment. This might, however, be an artefact of the
diagnostic studies; actual diagnoses of osteomyelitis will consider the clinical background of the patient
(e.g. fever and infection markers in the blood test), so diagnosis is not based on the imaging test alone.
Position emission tomography had poorer sensitivity, but higher specificity, than MRI, with more consistent
results across studies. This may make PET better suited to situations where avoiding false-positive diagnoses is
important, for example when the test would be followed by surgery or other invasive procedures. However,
MRI may still provide greater visual detail to guide the surgical approach than PET/CT alone.
Scintigraphy, in general, is less accurate than MRI or PET, but current methods of scintigraphy, particularly
99mTc HMPAO WBC scintigraphy, may have comparable accuracy, and this should be the preferred
approach. However, planar scintigraphy may have poorer diagnostic accuracy than 3D SPECT imaging,
so should perhaps be used only when SPECT is unavailable or unsuitable.
Data on ultrasound and CT were limited, but suggested that these tests have poorer diagnostic accuracy
and perhaps should not currently be used in adults.
Radiography on its own has poor diagnostic accuracy so should probably not be used in isolation. This review
could not confirm whether or not using radiography prior to MRI or other tests improves accuracy or reduces
costs. It is, therefore, unclear whether or not the common practice of using radiography as a first test and
proceeding to a MRI or another test if the radiography is inconclusive maximises diagnostic accuracy. It is,
however, likely that radiography can be usefully used to rule out osteomyelitis in more obvious cases (e.g.
when symptoms are the result of bone fracture). Radiography is probably more useful in chronic or subacute
osteomyelitis, when bone destruction is already visible, but not in acute haematogenous osteomyelitis, when
early changes are looked for.
The review found that diagnostic accuracy in adults does not appear to vary with the potential cause of
osteomyelitis, or with the body part scanned. In particular, there was no evidence that diagnostic accuracy
was different in patients with diabetic foot ulcers. This suggests that MRI, PET and SPECT are all reasonable
tests to use in adults, regardless of the underlying conditions the patient has. The choice may depend primarily
on suitability for the patient, such as potential difficulties in interpreting MRI scans in patients with indwelling
metalwork. However, data on specific locations or causes of osteomyelitis other than diabetic foot ulcers
were limited, so the possibility that diagnostic accuracy is different for some locations or causes remains.
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The review identified very limited data on diagnosing osteomyelitis in children, so considerable uncertainty
remains over the diagnostic accuracy of imaging tests in children. Clinicians should be aware of this
limitation in the evidence base.
There was some evidence to suggest that MRI has an acceptable degree of agreement among radiologists.
The evidence for the inter-rater reliability of other imaging tests is too limited to draw conclusions. There is
also very limited evidence on the implementation of imaging tests for the diagnosis of osteomyelitis. Notably,
there is a lack of evidence on patient preferences and on the most cost-effective diagnostic imaging
pathways for osteomyelitis.
Suggested research priorities
The most urgent research priority is to perform diagnostic accuracy studies of imaging tests in children,
given the limitations of the current evidence base. Large diagnostic accuracy studies are needed to assess
imaging tests in children. These should be of high quality, with proper blinding of test assessors and
consecutive recruitment of patients, and reporting of the appropriate reference standard used to confirm
positive and negative diagnoses. The priority tests should be MRI and ultrasound, ideally comparing the
two tests in the same children.
Ultrasound has not been widely assessed in adults. Current results suggest that ultrasound on its own may
not be sufficiently accurate to diagnose osteomyelitis, but further accuracy studies are needed to resolve
the uncertainty. It may be more appropriate to investigate the diagnostic accuracy of ultrasound as a
precursor to MRI or other tests (e.g. as a replacement for radiography).
Consistency of test interpretation is an important area in diagnostic testing that is often overlooked.
Further investigation of inter- and intra-rater reliability for all tests is needed. Ideally this should be included
in diagnostic accuracy tests, but it could also be investigated in case series or clinical audits.
Given the similarities in diagnostic accuracy of MRI, PET and SPECT, suitable investigation of patient and
clinician experience and opinion of these tests, through surveys or focus groups, would be useful to
identify practical reasons for the choice of test. Similarly, a formal economic evaluation of these tests,
accounting for test cost, sequencing of tests, availability and risk of radiation exposure, would also help to
clarify the choice between these tests.
CONCLUSIONS
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Appendix 1 Literature searches
The aim of the literature search was to systematically identify relevant studies of diagnostic imaging forthe detection of osteomyelitis. The search strategy was developed by an information specialist with
input from the review team and clinical advisors. The strategy was developed in MEDLINE (via Ovid) and
included search terms for osteomyelitis and relevant diagnostic imaging techniques. No language, date,
geographical or study design limits were applied. The MEDLINE strategy was adapted for use in the other
resources searched.
The searches were carried out during August 2017 and updated in June 2018 to capture more recent
studies. The following databases were searched: MEDLINE (including Epub Ahead of Print, In-Process &
Other Non-Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE), Cochrane Central Register of
Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), Cumulative Index to
Nursing and Allied Health (CINAHL) Plus, Database of Abstracts of Reviews of Effects (DARE), EMBASE,
Health Technology Assessment (HTA) database and PubMed.
In addition, ClinicalTrials.gov and PROSPERO were searched for ongoing and unpublished studies. Relevant
guidelines were identified through searches of the National Guidelines Clearing House, NHS Evidence, the
NICE website and the Trip database.
The reference lists of relevant systematic reviews were manually checked to ensure that all relevant studies
from previous reviews were identified. Abstracts from a number of conferences were consulted, including
the Annual Meeting of the European Society of Paediatric Radiology, the Annual Meeting of the Society of
Skeletal Radiology, the Annual Congress of the European Association of Nuclear Medicine and Paediatric
Rheumatology. The search results were imported into EndNote X8 and de-duplicated. The complete search
strategies can be found below.
Database search strategies
MEDLINE [Epub Ahead of Print, In-Process & Other Non-Indexed Citations,
Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)] via Ovid (http://ovidsp.ovid.com/)
Date range searched: 1946 to present.
Date searched: 9 August 2017.
Records retrieved: 10,184.
The search was updated on 20 June 2018 and identified 10,274 records.
Search strategy
1 Osteomyelitis/ [19,486]
2 Petrositis/ [74]
3 (osteomyelitis or osteomyelitides).ti,ab. [20,136]
4 ((bone$ or osseous or osteo) adj3 infect$).ti,ab. [6234]
5 ((spine or spines or spinal or vertebra$ or skeleton$ or skeletal or musculoskeletal) adj3 infect$).ti,ab. [4066]
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6 ((tibia or tibial or femur or humerus or humeral) adj3 infect$).ti,ab. [405]
7 majeed syndrome$.ti,ab. [32]
8 (petrositis or petrositides or Gradenigo$ or petrous apiciti$).ti,ab. [251]
9 or/[1-8 34,520]
10 exp Diagnostic Imaging/ [2,430,931]
11 (imag$ adj3 (diagnos$ or test$ or tool$ or procedure$ or method$ or technique$ or technolog$ or
modalit$)).ti,ab. [168,689]
12 radiograph$.ti,ab. [191,546]
13 (x-ray$ or xray$ or roentgen$).ti,ab. [337,423]
14 (bone$ adj2 (scan$ or imag$)).ti,ab. [12,239]
15 (radionuclide adj2 (imag$ or scan$ or diagnos$)).ti,ab. [4856]
16 radioisotope$ scan$.ti,ab. [683]
17 (nuclear adj2 (medicine or imag$ or scan$)).ti,ab. [14,606]
18 ((magnetic resonance adj (imag$ or scan$ or tomograph$)) or MRI or MR imag$ or MR scan$ or MR
tomograph$ or MRT or NMR or NMRI or fMRI or chemical shift imag$).ti,ab. [510,943]
19 ((compute$ adj2 tomograph$) or tomodensitometry or cine-CT).ti,ab. [253,513]
20 ((CT or CAT) adj (scan$ or imag$)).ti,ab. [105,989]
21 ((emission or positron or proton) adj2 tomograph$).ti,ab. [64,652]
22 (PET or PET-CT$ or PET?CT$ or CT-PET$ or CT?PET$).ti,ab. [79,016]
23 (SPECT or SPECT-CT$ or SPECT?CT$ or CT-SPECT$ or CT?SPECT$).ti,ab. [25,475]
24 (SPET or SPET-CT$ or SPET?CT$ or CT-SPET$ or CT?SPET$).ti,ab. [1321]
25 (PET-MRI$ or PET?MRI$).ti,ab. [1227]
26 Fluorodeoxyglucose F18/ [25,483]
27 ((FDG or fluorodeoxyglucose) adj4 (imag$ or scan$)).ti,ab. [9778]
28 (FDG-PET$ or FDG?PET$).ti,ab. [20,415]
29 (ultrasound$ or ultrasonograph$ or echograph$ or ultrasonic or sonograph$ or echotomograph$ or
echogram$ or echoscop$ or echosound$).ti,ab. [351,485]
30 (scintigraph$ or scintiphotograph$ or scintigram$).ti,ab. [47,128]
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31 (scintiscan$ or immunoscintigra$ or leu#oscintigra$).ti,ab. [2486]
32 ((leu#ocyte$ adj2 (scan$ or imag$)) or leu#oscan$).ti,ab. [697]
33 (white blood cell$ adj2 (scan$ or imag$)).ti,ab. [195]
34 (WBC scan$ or WBCS).ti,ab. [2034]
35 or/[10-34 3,217,417]
36 9 and [35 10,908]
37 exp animals/not humans/ [4,448,945]
38 36 not [37 10,184]
Key
/ = indexing term (MeSH heading).
exp = exploded indexing term (MeSH heading).
$ = truncation.
? = optional wildcard, stands for zero or one character.
# = mandated wildcard, stands for one character within a word.
ti,ab = terms in either title or abstract fields.
adj3 = terms within three words of each other (any order).
Cochrane Central Register of Controlled Trials via Wiley (http://onlinelibrary.wiley.com/)
Date range searched: issue 7 of 12, July 2017.
Date searched: 9 August 2017.
Records retrieved: 147.
The strategy below was used to search CENTRAL and CDSR.
The search was updated on 20 June 2018 and identified 167 records from CENTRAL.
Search strategy
#1 MeSH descriptor: [Osteomyelitis] this term only [131]
#2 MeSH descriptor: [Petrositis] this term only [0]
#3 (osteomyelitis or osteomyelitides):ti,ab,kw [367]
#4 ((bone* or osseous or osteo) near/3 infect*):ti,ab,kw [307]
DOI: 10.3310/hta23610 HEALTH TECHNOLOGY ASSESSMENT 2019 VOL. 23 NO. 61
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Llewellyn et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
75
#5 ((spine or spines or spinal or vertebra* or skeleton* or skeletal or musculoskeletal) near/3
infect*):ti,ab,kw [184]
#6 ((tibia or tibial or femur or humerus or humeral) near/3 infect*):ti,ab,kw [55]
#7 (majeed next syndrome*):ti,ab,kw [0]
#8 (petrositis or petrositides or Gradenigo* or petrous next apiciti*):ti,ab,kw [3]
#9 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 [845]
#10 MeSH descriptor: [Diagnostic Imaging] explode all trees [45,280]
#11 (imag* near/3 (diagnos* or test* or tool* or procedure* or method* or technique* or technolog* or
modalit*)):ti,ab,kw [10,201]
#12 radiograph*:ti,ab,kw [14,487]
#13 (x-ray* or xray* or roentgen*):ti,ab,kw [12,891]
#14 (bone* near/2 (scan* or imag*)):ti,ab,kw [513]
#15 (radionuclide near/2 (imag* or scan* or diagnos*)):ti,ab,kw [1683]
#16 (radioisotope* next scan*):ti,ab,kw [6]
#17 (nuclear near/2 (medicine or imag* or scan*)):ti,ab,kw [1197]
#18 ((magnetic next resonance next (imag* or scan* or tomograph*)) or MRI or MR next imag* or
MR next scan* or MR next tomograph* or MRT or NMR or NMRI or fMRI or chemical next shift next
imag*):ti,ab,kw [18,678]
#19 ((compute* near/2 tomograph*) or tomodensitometry or cine-CT):ti,ab,kw [13,251]
#20 ((CT or CAT) next (scan* or imag*)):ti,ab,kw [3595]
#21 ((emission or positron or proton) near/2 tomograph*):ti,ab,kw [5445]
#22 (PET or PET-CT* or PET*CT* or CT-PET* or CT*PET*):ti,ab,kw [3930]
#23 (SPECT or SPECT-CT* or SPECT*CT* or CT-SPECT* or CT*SPECT*):ti,ab,kw [1385]
#24 (SPET or SPET-CT* or SPET*CT* or CT-SPET* or CT*SPET*):ti,ab,kw [96]
#25 (PET-MRI* or PET*MRI*):ti,ab,kw [49]
#26 MeSH descriptor: [Fluorodeoxyglucose F18] this term only [815]
#27 ((FDG or fluorodeoxyglucose) near/4 (imag* or scan*)):ti,ab,kw [602]
#28 (FDG-PET* or FDG*PET*):ti,ab,kw [1142]
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#29 (ultrasound* or ultrasonograph* or echograph* or ultrasonic or sonograph* or echotomograph* or
echogram* or echoscop* or echosound*):ti,ab,kw [24,819]
#30 (scintigraph* or scintiphotograph* or scintigram*):ti,ab,kw [2121]
#31 (scintiscan* or immunoscintigra* or leu?oscintigra*):ti,ab,kw [868]
#32 ((leu?ocyte* near/2 (scan* or imag*)) or leu?oscan$):ti,ab,kw [29]
#33 (“white blood cell” near/2 (scan* or imag*)):ti,ab,kw [5]
#34 (“white blood cells” near/2 (scan* or imag*)):ti,ab,kw [0]
#35 (WBC next scan* or WBCS):ti,ab,kw [136]
#36 {or #10 to #35} [93,342]
#37 #9 and #36 [164]
#38 #9 and #36 in Cochrane Reviews (Reviews and Protocols) 6
#39 #9 and #36 in Trials [147]
Key
MeSH descriptor = indexing term (MeSH heading).
* = truncation.
? = wildcard, matches a single character within a word.
ti,ab,kw = terms in either title or abstract or keyword fields.
near/3 = terms within three words of each other (any order).
next = terms next to each other (order specified).
“ “ = phrase search.
Cochrane Database of Systematic Reviews via Wiley (http://onlinelibrary.wiley.com/)
Date range searched: issue 8 of 12, August 2017.
Date searched: 9 August 2017.
Records retrieved: 6.
See above under CENTRAL for search strategy used.
The search was updated on 20 June 2018 and identified six records from CDSR.
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Cumulative Index to Nursing and Allied Health Plus via EBSCO (www.ebscohost.com/)
Date range searched: inception to 8 August 2017.
Date searched: 9 August 2017.
Records retrieved: 1590.
The search was updated on 20 June 2018 and identified 1781 records.
Search strategy
S1 (MH “Osteomyelitis”) [2641]
S2 (MH “Gradenigo Syndrome”) [15]
S3 TI (osteomyelitis or osteomyelitides) OR AB (osteomyelitis or osteomyelitides) [2690]
S4 TI ((bone* or osseous or osteo) N3 infect*)) OR AB ((bone* or osseous or osteo) N3 infect*)) [906]
S5 TI ((spine or spines or spinal or vertebra* or skeleton* or skeletal or musculoskeletal) N3 infect*) OR
AB ((spine or spines or spinal or vertebra* or skeleton* or skeletal or musculoskeletal) N3 infect*) [1003]
S6 TI ((tibia or tibial or femur or humerus or humeral) N3 infect*) OR AB ((tibia or tibial or femur or
humerus or humeral) N3 infect*) [153]
S7 TI majeed N1 syndrome* OR AB majeed N1 syndrome* [12]
S8 TI (petrositis or petrositides or Gradenigo* or petrous N1 apiciti*) OR AB (petrositis or petrositides or
Gradenigo* or petrous N1 apiciti*) [32]
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 [5277]
S10 (MH “Diagnostic Imaging+”) [292,403]
S11 TI (imag* N3 (diagnos* or test* or tool* or procedure* or method* or technique* or technolog* or
modalit*)) OR AB (imag* N3 (diagnos* or test* or tool* or procedure* or method* or technique* or
technolog* or modalit*)) [28,469]
S12 TI radiograph* OR AB radiograph* [38,222]
S13 TI (x-ray* or xray* or roentgen*) OR AB (x-ray* or xray* or roentgen*) [16,289]
S14 TI ((bone* N2 (scan* or imag*)) OR AB ((bone* N2 (scan* or imag*)) [1884]
S15 TI (radionuclide N2 (imag* or scan* or diagnos*)) OR AB (radionuclide N2 (imag* or scan* or
diagnos*)) [394]
S16 TI radioisotope* N1 scan* OR AB radioisotope* N1 scan* [26]
S17 TI (nuclear N2 (medicine or imag* or scan*)) OR AB (nuclear N2 (medicine or imag* or scan*)) [1840]
S18 TI ((“magnetic resonance” or MR) N1 (imag* or scan* or tomograph*)) OR AB ((“magnetic
resonance” or MR) N1 (imag* or scan* or tomograph*)) [39,205]
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S19 TI (MRI or MRT or NMR or NMRI or fMRI) OR AB (MRI or MRT or NMR or NMRI or fMRI) [39,230]
S20 TI chemical N1 shift N1 imag* OR AB chemical N1 shift N1 imag* [71]
S21 TI ((compute* N2 tomograph*) or tomodensitometry or cine-CT) OR AB ((compute* N2 tomograph*)
or tomodensitometry or cine-CT) [42,942]
S22 TI (CAT N1 (scan* or imag*)) OR AB (CAT N1 (scan* or imag*)) [100]
S23 TI ((emission or positron or proton) N2 tomograph*) OR AB ((emission or positron or proton) N2
tomograph*) [9054]
S24 TI (PET or PET-CT* or PET#CT* or CT-PET* or CT#PET*) OR AB (PET or PET-CT* or PET#CT* or
CT-PET* or CT#PET*) [59,312]
S25 TI (SPECT or SPECT-CT* or SPECT#CT* or CT-SPECT* or CT#SPECT*) OR AB (SPECT or SPECT-CT*
or SPECT#CT* or CT-SPECT* or CT#SPECT*) [54,720]
S26 TI (SPET or SPET-CT* or SPET#CT* or CT-SPET* or CT#SPET*) OR AB (SPET or SPET-CT* or
SPET#CT* or CT-SPET* or CT#SPET*) [52,699]
S27 TI (PET-MRI* or PET#MRI*) OR AB (PET-MRI* or PET#MRI*) [235]
S28 (MH “Fludeoxyglucose F 18”) [4313]
S29 TI ((FDG or fluorodeoxyglucose) N4 (imag* or scan*)) OR AB ((FDG or fluorodeoxyglucose) N4 (imag*
or scan*)) [1791]
S30 TI (FDG-PET* or FDG#PET*) OR AB (FDG-PET* or FDG#PET*) [3659]
S31 TI (ultrasound* or ultrasonograph* or echograph* or ultrasonic or sonograph* or echotomograph*
or echogram* or echoscop* or echosound*) OR AB (ultrasound* or ultrasonograph* or echograph* or
ultrasonic or sonograph* or echotomograph* or echogram* or echoscop* or echosound*) [54,423]
S32 TI (scintigraph* or scintiphotograph* or scintigram*) OR AB (scintigraph* or scintiphotograph* or
scintigram*) [2711]
S33 TI (scintiscan* or immunoscintigra* or leu?oscintigra*) OR AB (scintiscan* or immunoscintigra* or
leu?oscintigra*) [34]
S34 TI (leu?ocyte* N2 (scan* or imag*)) OR AB (leu?ocyte* N2 (scan* or imag*)) [43]
S35 TI leu?oscan* OR AB leu?oscan* [1]
S36 TI (“white blood cell” N2 (scan* or imag*)) OR AB (“white blood cell” N2 (scan* or imag*)) [16]
S37 TI (“white blood cells” N2 (scan* or imag*)) OR AB (“white blood cells” N2 (scan* or imag*)) [4]
S38 TI ((WBC N1 scan*) or WBCS) OR AB ((WBC N1 scan*) or WBCS) [1459]
S39 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR
S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR
S35 OR S36 OR S37 OR S38 [405,211]
S40 S9 AND S39 [1590]
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Key
MH = indexing term (CINAHL heading).
* = truncation.
# = wildcard, stands for zero or one character.
? = wildcard, stands for one character.
TI = terms in the title.
AB = terms in the abstract.
N3 = terms within three words of each other (any order).
Database of Abstracts of Reviews of Effects via (www.crd.york.ac.uk/CRDWeb/)
Date range searched: inception to 31 March 2015.
Date searched: 9 August 2017.
Records retrieved: 14.
The strategy below was used to search DARE and the HTA database.
The search of the DARE database was not updated as it closed at the end of March 2015.
Search strategy
1 MeSH DESCRIPTOR Osteomyelitis IN DARE,HTA [22]
2 MeSH DESCRIPTOR Petrositis IN DARE,HTA [0]
3 (osteomyelitis or osteomyelitides) IN DARE, HTA [51]
4 ((bone* or osseous or osteo) NEAR3 infect*) OR (infect* NEAR3 (bone* or osseous or osteo)) IN DARE,
HTA [21]
5 ((spine or spines or spinal or vertebra* or skeleton* or skeletal or musculoskeletal) NEAR3 infect*) OR
(infect* NEAR3 (spine or spines or spinal or vertebra* or skeleton* or skeletal or musculoskeletal)) IN
DARE, HTA [22]
6 ((tibia or tibial or femur or humerus or humeral) NEAR3 infect*) OR (infect* NEAR3 (tibia or tibial or
femur or humerus or humeral)) IN DARE, HTA [2]
7 (majeed syndrome*) IN DARE, HTA [0]
8 (petrositis or petrositides or Gradenigo* or petrous apiciti*) IN DARE, HTA [0]
9 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 [88]
10 MeSH DESCRIPTOR Diagnostic imaging EXPLODE ALL TREES IN DARE,HTA [2969]
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11 (imag* NEAR3 (diagnos* or test* or tool* or procedure* or method* or technique* or technolog* or
modalit*)) OR ((diagnos* or test* or tool* or procedure* or method* or technique* or technolog* or
modalit*) NEAR3 imag*) IN DARE, HTA [1173]
12 (radiograph*) IN DARE, HTA [1092]
13 (x-ray* or xray* or roentgen*) IN DARE, HTA [873]
14 (bone* NEAR2 (scan* or imag*)) OR ((scan* or imag*) NEAR2 bone*) IN DARE, HTA [48]
15 (radionuclide NEAR2 (imag* or scan* or diagnos*)) OR ((imag* or scan* or diagnos*) NEAR2
radionuclide) IN DARE, HTA [313]
16 (radioisotope* scan*) IN DARE, HTA [1]
17 (nuclear NEAR2 (medicine or imag* or scan*)) OR ((medicine or imag* or scan*) NEAR2 nuclear) IN
DARE, HTA [102]
18 (MRI or MRT or NMR or NMRI or fMRI) IN DARE, HTA [506]
19 (chemical shift imag*) IN DARE, HTA [1]
20 (compute* NEAR2 tomograph*) IN DARE, HTA [942]
21 (tomograph* NEAR2 compute*) IN DARE, HTA [809]
22 (tomodensitometry or cine-CT) IN DARE, HTA [0]
23 (CT scan* or CAT scan*) OR (CT imag* or CT imag*) IN DARE, HTA [186]
24 ((emission or positron or proton) NEAR2 tomograph*) OR (tomograph* NEAR2 (emission or positron
or proton)) IN DARE, HTA [602]
25 (PET or PET-CT* or PET/CT* or PETCT* or CT-PET* or CT/PET* or CTPET*) IN DARE, HTA [437]
26 (SPECT or SPECT-CT* or SPECT/CT* or SPECTCT* or CT-SPECT* or CT/SPECT* or CTSPECT*) IN
DARE, HTA [73]
27 (SPET or SPET-CT* or SPET/CT* or SPETCT* or CT-SPET* or CT/SPET* or CTSPET*) IN DARE, HTA [2]
28 (PET-MRI* or PET/MRI* or PETMRI*) IN DARE, HTA [8]
29 MeSH DESCRIPTOR Fluorodeoxyglucose F18 IN DARE,HTA [223]
30 ((FDG or fluorodeoxyglucose) NEAR4 (imag* or scan*)) OR ((imag* or scan*) NEAR4 (FDG or
fluorodeoxyglucose)) IN DARE, HTA [133]
31 (FDG-PET* or FDG/PET* or FDGPET*) IN DARE, HTA [200]
32 (ultrasound* or ultrasonograph* or echograph* or ultrasonic or sonograph* or echotomograph* or
echogram* or echoscop* or echosound*) IN DARE, HTA [1722]
33 (scintigraph* or scintiphotograph* or scintigram*) IN DARE, HTA [105]
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34 (scintiscan* or immunoscintigra* or leucoscintigra* or leukoscintigra*) IN DARE, HTA [1]
35 ((leucocyte* or leukocyte*) NEAR2 (scan* or imag*)) OR ((scan* or imag*) NEAR2 (leucocyte* or
leukocyte*)) IN DARE, HTA [2]
36 (leukoscan* or leucoscan*) IN DARE, HTA [1]
37 (white blood cell* NEAR2 (scan* or imag*)) OR ((scan* or imag*) NEAR2 white blood cell*) IN DARE,
HTA [1]
38 (WBC scan* or WBCS) IN DARE, HTA [4]
39 (magnetic resonance imag* or magnetic resonance scan* or magnetic resonance tomograph*) IN
DARE, HTA [852]
40 (MR imag* or MR scan* or MR tomograph*) IN DARE, HTA [31]
41 #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR
#22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR
#35 OR #36 OR #37 OR #38 OR #39 OR #40 [5045]
42 #9 AND #41 (16) (14 DARE, 2 HTA)
Key
MeSH DESCRIPTOR = indexing term (MeSH heading).
* = truncation.
NEAR3 = terms within three words of each other (order specified).
EMBASE via Ovid (http://ovidsp.ovid.com/)
Date range searched: 1974 to 8 August 2017.
Date searched: 9 August 2017.
Records retrieved: 14,494.
The search was updated on 20 June 2018 and identified 15,225 records.
Search strategy
1 osteomyelitis/or chronic osteomyelitis/or hematogenous osteomyelitis/or majeed syndrome/or petrositis/
[29,324]
2 (osteomyelitis or osteomyelitides).ti,ab. [22,929]
3 ((bone$ or osseous or osteo) adj3 infect$).ti,ab. [7658]
4 ((spine or spines or spinal or vertebra$ or skeleton$ or skeletal or musculoskeletal) adj3 infect$).ti,ab.
[5024]
5 ((tibia or tibial or femur or humerus or humeral) adj3 infect$).ti,ab. [476]
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6 majeed syndrome$.ti,ab. [46]
7 (petrositis or petrositides or Gradenigo$ or petrous apiciti$).ti,ab. [263]
8 or/1-7 [44,156]
9 exp diagnostic imaging/ [143,551]
10 (imag$ adj3 (diagnos$ or test$ or tool$ or procedure$ or method$ or technique$ or technolog$ or
modalit$)).ti,ab. [232,999]
11 radiography/ [253,398]
12 exp bone radiography/ [62,582]
13 X ray/ [59,947]
14 radiograph$.ti,ab. [227,261]
15 (x-ray$ or xray$ or roentgen$).ti,ab. [365,257]
16 (bone$ adj2 (scan$ or imag$)).ti,ab. [17,134]
17 (radionuclide adj2 (imag$ or scan$ or diagnos$)).ti,ab. [5946]
18 radioisotope$ scan$.ti,ab. [758]
19 (nuclear adj2 (medicine or imag$ or scan$)).ti,ab. [26,429]
20 exp nuclear magnetic resonance imaging/ [759,296]
21 ((magnetic resonance adj (imag$ or scan$ or tomograph$)) or MRI or MR imag$ or MR scan$ or MR
tomograph$ or MRT or NMR or NMRI or fMRI or chemical shift imag$).ti,ab. [681,481]
22 exp computer assisted tomography/ [846,193]
23 ((compute$ adj2 tomograph$) or tomodensitometry or cine-CT).ti,ab. [302,150]
24 ((CT or CAT) adj (scan$ or imag$)).ti,ab. [164,664]
25 exp x-ray tomography/ [11,890]
26 exp emission tomography/ [146,279]
27 ((emission or positron or proton) adj2 tomograph$).ti,ab. [79,931]
28 (PET or PET-CT$ or PET?CT$ or CT-PET$ or CT?PET$).ti,ab. [128,903]
29 (SPECT or SPECT-CT$ or SPECT?CT$ or CT-SPECT$ or CT?SPECT$).ti,ab. [39,774]
30 (SPET or SPET-CT$ or SPET?CT$ or CT-SPET$ or CT?SPET$).ti,ab. [1533]
31 (PET-MRI$ or PET?MRI$).ti,ab. [2339]
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32 fluorodeoxyglucose f 18/ [48,488]
33 ((FDG or fluorodeoxyglucose) adj4 (imag$ or scan$)).ti,ab. [17,045]
34 (FDG-PET$ or FDG?PET$).ti,ab. [34,822]
35 exp echography/ [640,877]
36 (ultrasound$ or ultrasonograph$ or echograph$ or ultrasonic or sonograph$ or echotomograph$ or
echogram$ or echoscop$ or echosound$).ti,ab. [479,205]
37 exp scintiscanning/ [172,675]
38 (scintigraph$ or scintiphotograph$ or scintigram$).ti,ab. [62,147]
39 (scintiscan$ or immunoscintigra$ or leu#oscintigra$).ti,ab. [3034]
40 ((leu#ocyte$ adj2 (scan$ or imag$)) or leu#oscan$).ti,ab. [857]
41 (white blood cell$ adj2 (scan$ or imag$)).ti,ab. [228]
42 (WBC scan$ or WBCS).ti,ab. [3270]
43 or/9-42 [3,184,438]
44 8 and 43 [15,191]
45 (animal/or animal experiment/or animal model/or animal tissue/or nonhuman/) not exp human/
[5,733,000]
46 44 not 45 [14,494]
Key
/ = indexing term (MeSH heading).
exp = exploded indexing term (MeSH heading).
$ = truncation.
? = optional wildcard, stands for zero or one character.
# = mandated wildcard, stands for one character within a word.
ti,ab = terms in either title or abstract fields.
adj3 = terms within three words of each other (any order).
Health Technology Assessment database via (http://www.crd.york.ac.uk/CRDWeb/)
Date range searched: inception to 8 August 2017.
Date searched: 9 August 2017.
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Records retrieved: 2.
See above under DARE for search strategy used.
The search of the HTA database was updated on 21 June 2018 and identified two records.
PubMed (http://www.ncbi.nlm.nih.gov/pubmed/)
Date range searched: inception to 9 August 2017.
Date searched: 9 August 2017.
Records retrieved: 1534.
The search was updated on 20 June 2018 and identified 1908 records.
Search strategy
Search (((((((((((((“Osteomyelitis”[Mesh:noexp]) OR “Petrositis”[Mesh:noexp]) OR ((osteomyelitis[Title/Abstract]
OR osteomyelitides[Title/Abstract]))) OR (((bone*[Title/Abstract] OR osseous[Title/Abstract] OR osteo[Title/
Abstract])) AND infect*[Title/Abstract])) OR (((spine[Title/Abstract] OR spines[Title/Abstract] OR spinal[Title/
Abstract] OR vertebra*[Title/Abstract] OR skeleton*[Title/Abstract] OR skeletal[Title/Abstract] OR musculoskeletal
[Title/Abstract])) AND infect*[Title/Abstract])) OR (((tibia[Title/Abstract] OR tibial[Title/Abstract] OR femur[Title/
Abstract] OR humerus[Title/Abstract] OR humeral[Title/Abstract])) AND infect*[Title/Abstract])) OR ((majeed
syndrome[Title/Abstract]) OR majeed syndromes[Title/Abstract])) OR ((petrositis[Title/Abstract] OR petrositides
[Title/Abstract] OR Gradenigo$[Title/Abstract] OR “petrous apicitis”[Title/Abstract] OR “petrous apicitides”[Title/
Abstract])))) AND ((((((((((((((((((((((((((“Diagnostic Imaging”[Mesh]) OR ((((diagnos*[Title/Abstract] OR test*[Title/
Abstract] OR tool*[Title/Abstract] OR procedure*[Title/Abstract] OR method*[Title/Abstract] OR technique*
[Title/Abstract] OR technolog*[Title/Abstract] OR modalit*[Title/Abstract])) AND imag*[Title/Abstract])) OR
radiograph*[Title/Abstract]) OR ((x-ray*[Title/Abstract] OR xray*[Title/Abstract] OR roentgen*[Title/Abstract]))) OR
((bone*[Title/Abstract]) AND (scan*[Title/Abstract] OR imag*[Title/Abstract]))) OR ((radionuclide[Title/Abstract])
AND (imag*[Title/Abstract] OR scan*[Title/Abstract] OR diagnos*[Title/Abstract]))) OR radioisotope scan*[Title/
Abstract]) OR ((nuclear[Title/Abstract]) AND (medicine[Title/Abstract] OR imag*[Title/Abstract] OR scan*[Title/
Abstract]))) OR ((((((((magnetic resonance imag*[Title/Abstract]) OR magnetic resonance scan*[Title/Abstract]) OR
magnetic resonance tomograph*[Title/Abstract]) OR MR imag*[Title/Abstract]) OR MR scan*[Title/Abstract]) OR
MR tomograph*[Title/Abstract]) OR (MRI[Title/Abstract] OR MRT[Title/Abstract] OR NMR[Title/Abstract] OR NMRI
[Title/Abstract] OR fMRI[Title/Abstract])) OR chemical shift imag*[Title/Abstract])) OR ((compute*[Title/Abstract])
AND tomograph*[Title/Abstract])) OR ((tomodensitometry[Title/Abstract] OR cine-CT[Title/Abstract]))) OR (((CT
scan*[Title/Abstract] OR CT imag*[Title/Abstract])) OR (CAT scan*[Title/Abstract] OR CAT imag*[Title/Abstract])))
OR (((emission[Title/Abstract] OR positron[Title/Abstract] OR proton[Title/Abstract])) AND tomograph*[Title/
Abstract])) OR ((PET[Title/Abstract] OR PET-CT*[Title/Abstract] OR PET/CT*[Title/Abstract] OR PETCT*[Title/
Abstract] OR CT-PET*[Title/Abstract] OR CT/PET$[Title/Abstract] OR CTPET*[Title/Abstract]))) OR ((SPECT
[Title/Abstract] OR SPECT-CT*[Title/Abstract] OR SPECT/CT*[Title/Abstract] OR SPECTCT*[Title/Abstract] OR
CT-SPECT*[Title/Abstract] OR CT/SPECT*[Title/Abstract] OR CTSPECT*[Title/Abstract]))) OR ((SPET[Title/
Abstract] OR SPET-CT*[Title/Abstract] OR SPET/CT*[Title/Abstract] OR SPETCT*[Title/Abstract] OR CT-SPET*
[Title/Abstract] OR CT/SPET*[Title/Abstract] OR CTSPET*[Title/Abstract]))) OR ((PET-MRI*[Title/Abstract] OR PET/
MRI*[Title/Abstract] OR PETMRI*[Title/Abstract]))) OR “Fluorodeoxyglucose F18”[Mesh:noexp]) OR ((FDG-PET*
[Title/Abstract] OR FDG/PET*[Title/Abstract] OR FDGPET*[Title/Abstract]))) OR ((ultrasound*[Title/Abstract] OR
ultrasonograph*[Title/Abstract] OR echograph*[Title/Abstract] OR ultrasonic[Title/Abstract] OR sonograph*
[Title/Abstract] OR echotomograph*[Title/Abstract] OR echogram*[Title/Abstract] OR echoscop*[Title/Abstract]
OR echosound*[Title/Abstract]))) OR ((scintigraph*[Title/Abstract] OR scintiphotograph*[Title/Abstract] OR
scintigram*[Title/Abstract]))) OR ((scintiscan*[Title/Abstract] OR immunoscintigra*[Title/Abstract] OR
leucoscintigra*[Title/Abstract] OR leukoscintigra*[Title/Abstract]))) OR (((leucocyte*[Title/Abstract] OR
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leukocyte*[Title/Abstract])) AND (scan*[Title/Abstract] OR imag*[Title/Abstract]))) OR ((leukoscan*[Title/
Abstract] OR leucoscan*[Title/Abstract]))) OR ((white blood cell*[Title/Abstract]) AND (scan*[Title/Abstract] OR
imag*[Title/Abstract]))) OR ((WBC scan*[Title/Abstract] OR WBCS[Title/Abstract]))) OR ((((FDG[Title/Abstract]
OR fluorodeoxyglucose[Title/Abstract])) AND (imag*[Title/Abstract] OR scan*[Title/Abstract])))))) NOT ((animals
[mh] NOT humans[mh])))) AND ((pubstatusaheadofprint OR publisher[sb] OR pubmednotmedline[sb]))
The above search strategy incorporates the following search line to limit to studies found in PubMed but
not available in Ovid MEDLINE: (pubstatusaheadofprint OR publisher[sb] OR pubmednotmedline[sb]).172
Key
[Mesh] = exploded indexing term (MeSH heading).
[Mesh:noexp] = indexing term (MeSH heading) not exploded.
* = truncation.
[Title/Abstract]) = terms in either title or abstract fields.
“ “ = phrase search.
Ongoing studies search strategies
ClinicalTrials.gov (https://clinicaltrials.gov/)
Date range searched: inception to 9 August 2017.
Searched date: 9 August 2017.
Records retrieved: 66.
The search was updated on 20 June 2018 and identified 76 records.
Searched in the condition field: osteomyelitis OR “bone infection”.
PROSPERO (www.crd.york.ac.uk/PROSPERO/)
Date range searched: inception to 9 August 2017.
Searched date: 9 August 2017.
Records retrieved: 20.
The search was updated on 21 June 2018 and identified 29 records.
Search strategy
#1 MeSH DESCRIPTOR osteomyelitis [6]
#2 MeSH DESCRIPTOR Petrositis [0]
#3 osteomyelitis OR osteomyelitides [38]
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#4 (bone* or osseous or osteo) adj3 infect* [18]
#5 (spine or spines or spinal or vertebra* or skeleton* or skeletal or musculoskeletal) adj3 infect* [29]
#6 (tibia or tibial or femur or humerus or humeral) adj3 infect* [2]
#7 majeed syndrome* [0]
#8 petrositis or petrositides or Gradenigo* or petrous apiciti* [0]
#9 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 [81]
#10 MeSH DESCRIPTOR Diagnostic Imaging EXPLODE ALL TREES [637]
#11 imag* adj3 (diagnos* or test* or tool* or procedure* or method* or technique* or technolog* or
modalit*) [460]
#12 imag* ADJ3 (diagnos* or test* or tool* or procedure* or method* or technique* or technolog* or
modalit*) [460]
#13 radiograph* [556]
#14 x-ray* or xray* or roentgen* [313]
#15 bone* adj2 (scan* or imag*) [16]
#16 radionuclide adj2 (imag* or scan* or diagnos*) [6]
#17 radioisotope* scan* [0]
#18 nuclear adj2 (medicine or imag* or scan*) [31]
#19 “magnetic resonance” adj (imag* or scan* or tomograph*) [373]
#20 “magnetic resonance” adj1 (imag* or scan* or tomograph*) [358]
#21 “MR” adj (imag* or scan* or tomograph*) [45}
#22 MRI or MRT or NMR or NMRI or fMRI or chemical shift imag* [678]
#23 compute* adj2 tomograph* [383]
#24 tomodensitometry or cine-CT [0]
#25 (CT or CAT) adj (scan* or imag*) [260]
#26 (emission or positron or proton) adj2 tomograph* [76]
#27 PET or PET-CT* or PET*CT* or CT-PET* or CT*PET* [142]
#28 SPECT or SPECT-CT* or SPECT*CT* or CT-SPECT* or CT*SPECT* [44]
#29 SPET or SPET-CT* or SPET*CT* or CT-SPET* or CT*SPET* [0]
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#30 PET-MRI* or PET*MRI* [5]
#31 MeSH DESCRIPTOR Fluorodeoxyglucose F18 [15]
#32 (FDG or fluorodeoxyglucose) adj4 (imag* or scan*) [13]
#33 FDG-PET* or FDG*PET* [24]
#34 ultrasound* or ultrasonograph* or echograph* or ultrasonic or sonograph* or echotomograph* or
echogram* or echoscop* or echosound* [838]
#35 scintigraph* or scintiphotograph* or scintigram* [28]
#36 scintiscan* or immunoscintigra* or leucoscintigra* or leukoscintigra* [0]
#37 (leucocyte* or leukocyte*) adj2 (scan* or imag*) [0]
#38 white blood cell* adj2 (scan* or imag*) [0]
#39 WBC scan* or WBCS [4]
#40 #39 OR #38 OR #37 OR #36 OR #35 OR #34 OR #33 OR #32 OR #31 OR #30 OR #29 OR #28 OR
#27 OR #26 OR #25 OR #24 OR #23 OR #22 OR #21 OR #20 OR #19 OR #18 OR #17 OR #16 OR #15 OR
#14 OR #13 OR #12 OR #11 OR #10 [2500]
#41 #40 AND #9 [20]
#42 leukoscan* or leucoscan* [0]
#43 #40 OR #42 [2500]
#44 #9 AND #43 [20]
Key
MeSH DESCRIPTOR = indexing term (MeSH heading).
* = truncation.
ADJ3 = terms within three words of each other.
Guideline searches
National Guideline Clearinghouse (www.guideline.gov/)
Date searched: 31 August 2017.
Searched for osteomyelitis – 38 results.
The search was updated on 21 June 2018 and identified 33 results.
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NHS Evidence (www.evidence.nhs.uk/)
Date searched: 31 August 2017.
Searched for osteomyelitis, filtered results to limit to guidance – 161 results.
The search was updated on 21 June 2018 and identified 141 results.
National Institute for Health and Care Excellence (www.nice.org.uk/guidance)
Date searched: 31 August 2017.
Browsed the diagnostics guidance page (www.nice.org.uk/guidance/published?type=dg) – zero relevant
records found.
Searched for the term osteomyelitis in the general website search box – 21 results browsed – two relevant
records found.
The search was updated on 21 June 2018 but did not identify any further relevant records.
Trip (www.tripdatabase.com)
Date searched: 31 August 2017.
Searched for osteomyelitis – 95 results – browsed for relevance and checked against previous search
results in EndNote for duplicates. One relevant record identified.
The search was updated on 21 June 2018 but did not identify any further relevant records.
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Appendix 2 Results of critical appraisal of
diagnostic accuracy studies (QUADAS-2)
TABLE 15 The QUADAS-2 signalling questions for risk-of-bias assessment
Domain
Domain 1: patient
selection Domain 2: index test
Domain 3: reference
standard
Domain 4: flow and
timing
SQ 1: was a consecutive
or random sample of
patients enrolled?
SQ 1: were the index test results
interpreted without knowledge
of the results of the reference
standard?
SQ 1: is the reference
standard likely to correctly
classify the target condition?
SQ 1: was there an
appropriate interval
between the index test(s)
and reference standard?
SQ 2: was a
case–control design
avoided?
SQ 2: if a threshold was used,
was it prespecified?
SQ 2: were the reference
standard results interpreted
without knowledge of the
results of the index test?
SQ 2: did all patients
receive the same
reference standard?
SQ 3: did the study
avoid inappropriate
exclusions?
SQ 3: (optional: multiple tests)
were the index test results
interpreted without knowledge of
the results of other index tests?
SQ3: not applicable SQ 3: were all patients
included in the analysis?
SQ, signalling question.
Risk of bias: could the
selection of patients have
introduced bias?
38% 56% 6%
Risk of bias: could the
conduct or interpretation
of the index test have
introduced bias?
62% 26% 12%
Risk of bias: could the
reference standard,
its conduct or its
interpretation have
introduced bias?
91% 8%1%
Risk of bias: could the
patient flow have
introduced bias?
87% 8% 5%
Applicability concerns:
are there concerns that
the included patients
and setting do not match
the review question?
92% 8%
Applicability concerns:
are there concerns that the
index test, its conduct or
interpretation differ from
the review question? 
97% 3%
Applicability concerns:
are there concerns that
the target condition as
defined by the reference
standard does not match
the review question?
100%
Low
Unclear
High
Risk of bias
FIGURE 20 Summary of risk of bias and applicability assessment.
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TABLE 16 The QUADAS-2 risk-of-bias decisions
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Abdel Razek
(2017)37
Unclear. Not stated if
enrolment was
consecutive
Low Low Low
Al-Khawari
(2005)38
Unclear. Unclear if
participants were
included consecutively
and limited reporting
of selection criteria
Low Low Low
Al-Sheikh
(1985)39
Low High. Index test results
interpreted with
knowledge of the results
of the reference
standard
Low Low
Aragón-Sánchez
(2011)40
Low Low. Although lack
of blinding to initial
probe-to-bone test for
radiography cannot be
excluded
Low Low. Although 91
patients with negative
radiography and probe-
to-bone test did not
undergo histopathology
tests (25.5%)
Aslangul (2013)41 Low Low. ‘There were
findings compatible with
OM on plain radiography
in 26 of 42 (60%) of the
patients who underwent
bone puncture. Thus the
enrolled patients were all
at high risk for underlying
OM.’ Plain radiography
was not an index test in
this study
Low Low. Although ≥ 1 year
follow-up and no biopsy/
culture for all 13 patients
with negative index test
(13/53 or 25% of total
patients). All positive
index test patients
received microbiology
Blume (1997)42 Unclear. Unclear if
patients were recruited
consecutively and
limited reporting of
selection criteria
Low. Although
antibiotics were used in
12/27 patients
Low Low
Bohchelian
(2002)43
Unclear. Unclear if
consecutively enrolled
and exclusion criteria
NR
Low Low. Although it is
unclear what methods
were used to prevent soft
tissue contamination
when collecting bone
sample for culture
Low
Bolouri (2013)44 Unclear. A total of
4/42 patients had a
known OM with
suspected exacerbation
Unclear. Owing to
uncertainty regarding
blinding of staff to
different index tests
Low. Although 12/35
had clinical follow-up
without histology, some
of which were positive
Low. 30 patients had
biopsy. 12 only had
clinical/imaging follow-up,
some of whom were
confirmed positive
Brunel (2016)45 Unclear. Unclear if
consecutively enrolled
Low Low Low
Chacko (2003)46 Unclear. Insufficient
information,
retrospective study
Low Low Low. Although the
number of patients who
received only 6≥months
of clinical follow-up in
the patients confirmed
negative (23/46) is
unclear
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Croll (1996)47 Unclear. Unclear if
recruited consecutively
High. Not blinded to
results of other tests
Low. Although 6 out of
27 diagnosed by clinical
follow-up
Low. Although 6/27 only
had clinical follow-up
Demirev (2014)48 Low High. MRI and PET-CT
results not blinded
(in 19/27, MRI was
performed before
PET-CT, and after in
8/27 cases)
Low. Although 15/27
patients had histology/
microbiology confirmed
from bone sample (most
confirmed positive).
Other methods of
sample collection
included blood sampling
(seven), pus aspiration
(five), soft tissue
debridement (one
negative). Clinical
follow-up in four
patients
Low. Although 15/27
patients had histology/
microbiology confirmed
from bone sample (most
confirmed positive).
Other methods of sample
collection included blood
sampling (seven), pus
aspiration (five),
soft tissue debridement
(one negative). Clinical
follow-up in four
patients
Enderle (1999)49 Low Low Low Low
Erdman (1991)50 Low Low Low. A total of 29/110
patients diagnosed by
clinical follow-up
Low. Although 29/56
of index test negative
patients were confirmed
negative by clinical
follow-up only
Ertugrul (2006)51 Unclear. Unclear if
patients were enrolled
consecutively and why
not all patients
received both index
tests (MRI: 28/31,
scintigraphy: 26/31)
Unclear. No reporting on
blinding to index test
results
Low Low
Ezzat (2011)52 High. Excluded patients
with ‘presence of any
chronic disease with
signs and symptoms
similar to acute OM’
Low Unclear. Most (23/27)
patients had surgery,
only two had cytology
(pus aspiration) and two
had 1-week clinical
follow-up. It is unclear
how many had
histology/microbiology
Low
Familiari (2011)53 Unclear. Unclear if this
was a consecutive or
random sample, detail
on exclusions lacking
Low. Several cut-off
values were considered,
but it does not appear
that optimal cut-off
values were derived a
posteriori based on ROC
curves
Low Low
Filippi (2006)54 Low Low Low Low
Filippi (2009)55 Low Low Low Low. Although 5/17
patients only had clinical
follow-up, the duration
of follow-up (24 months)
and results suggest a low
risk of verification bias
continued
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Franceschi (2013)56 Unclear. Conference
abstract, insufficient
information on
selection
Low Low High. Only participants
who received surgery
were analysed (17 out
of 39 who received
PET/CT)
Gemmel (2004)57 High. Only patients
with final diagnosis
confirmed by
microbiology and/or
pus visible during
surgery were included
Low Low Low
Guhlmann
(1998)58
Unclear. Not stated
if the sample was
consecutive and
exclusion criteria not
reported
Low Low Low for 18F-FDG-PET.
High for scintigraphy,
owing to exclusion of
significant number of
inconclusive results
(14, of which nine were
confirmed positive and
five were confirmed
negative)
Guhlmann
(1998)59
Unclear. Unclear if
consecutive and no
reporting of exclusion
criteria
Low Low Low
Hakim (2006)60 Unclear. Unclear if
patients were enrolled
consecutively and
limited information on
selection criteria
Unclear. Unclear if PET
and SPECT results were
interpreted independently
and blinded
Low Low. Only 4/34 (11.8%)
did not have a biopsy
Hartmann
(2007)61
Unclear. Unclear if
consecutively enrolled
Low Low Low
Hazenberg
(2011)62
Unclear (conference
abstract, insufficient
detail). Unclear
because of question 1
Unclear (conference
abstract, insufficient
detail)
Low Low (based on limited
data from the
conference abstract)
Heiba (2017)63 Unclear. Not sure why
the diagnosis was not
included in some
patients’ records
Low Low Low. A total of 12/33
had clinical follow-up
only but most were
confirmed negative
Horger (2003)64 Unclear. Unclear if
consecutive with no
inappropriate
exclusions
High. It appears that
interpretation of
scintigraphy + SPECT
and SPECT/CT were not
done blinded
Low Low. Although 9/29
sites had 6 months’
follow-up and no biopsy
Horger (2007)65 Low High. No blinding to
results of various index
tests
Low. Although 15/31
had surgery/biopsy and
16/31 had clinical,
microbiology and/or
radiography follow-up
Low. Although 15/31
had surgery/biopsy and
16/31 had clinical,
microbiology and/or
radiography follow-up,
and it is unclear if all
confirmed positive (nine)
had a biopsy
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Huang (1998)66 Low Low Low Low. A total of 10/42
(23.8%, five confirmed
positive and five
confirmed negative)
patients had clinical
follow-up only (6 months
to 3 years)
Johnson (2009)67 Unclear. ‘Repeated
examinations of the
same patient were
excluded from the
study, as were
examinations of patients
who had insufficient
clinical follow-up to
establish the presence
or absence of OM.’
Unclear how many
patients were excluded.
Patients with repeated
examinations may have
been harder to diagnose
Low Low Low. Although negative
cases confirmed by
clinical follow-up
(duration unknown) in
85% of cases. Positive
cases confirmed by
histopathology in 90%
of cases
Kaim (2000)68 Unclear. Unclear if
consecutive
Low Low. Although 5/18 only
had clinical follow-up
(> 16 months)
Low. Although 5/18 only
had clinical follow-up
(> 16 months)
Kim (2017)69 Low. Although limited
to those who had both
scans within 1 week
Low Low. Nine cases of
surgery/histopathology,
12 cases of clinical
follow-up, but all
positive cases confirmed
by bone biopsy
Low. Nine cases of
surgery/histopathology,
12 cases of clinical
follow-up, but all
positive cases confirmed
by bone biopsy
La Fontaine
(2016)70
Unclear. Retrospective
chart review, unclear if
all eligible patients
were included
Low Low Low
Larcos (1991)71 Unclear. Unclear if
consecutive recruitment
Unclear. Unclear if index
test results were
interpreted blinded to
each of the other index
tests
Low. It appears that
all positives and a
significant proportion of
negatives were confirmed
by histopathology
Low. It appears that all
positives and a significant
proportion of negatives
were confirmed by
histopathology
Larson (2011)72 Unclear Unclear. Unclear if index
tests were interpreted
blinded to one another
Low Low. Sensitivity and
specificity were reported,
although the final
number of confirmed
positive/negative cases
were not provided,
therefore the 2 × 2 results
could not be calculated
continued
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Ledermann
(2000)73
Low. Although high
rate of patients with
metal artefacts (11/15)
and only included those
with a possible relapse
of infection in chronic
post-traumatic OM
Unclear. Owing to lack
of information on
blinding to CT results
Low. Final diagnosis was
established in 11 patients
by intraoperative
microbiological and
histological examination,
although potentially less
accurate for clinical
follow-up in 4/15 patients
Low. Most (11/15)
confirmed by
microbiology/
histopathology
Levine (1994)74 Unclear. Unclear if
patients were enrolled
consecutively and why
there were significant
discrepancies in the
number of patients
receiving each of the
four index tests
Unclear. Owing to lack
of information on
blinding to reference
standard and other
index test results
Low. Although most
confirmed negative
patients did not have
histopathology (11/16)
Low. Although 9/36
patients were excluded
owing to ‘no surgical or
histological confirmation
within 2 weeks of MRI
or failure to resolve
with nonoperative
management’
Lewis (1988)75 Unclear. Unclear if
the sample was
consecutively recruited;
selection criteria were
not reported
Unclear. Owing to
insufficient details on
blinding of staff
performing index tests
Low Low. Although nine
(14.8%) excluded owing
to ‘failure to separately
examine the bony
portion of a pressure
sore specimen or
misrouting of specimens
to microbiology or
gematology laboratories’
Lipman (1998)76 Low Low Low Unclear. Unclear how
many received
radiography and
scintigraphy
Mahendra
(2017)77
Low Low Low Low
Malcius (2009)78 Unclear. Unclear if
consecutively selected.
Exclusions or reasons
for exclusions were NR
High. Not all patients
had the same tests
and all results were
considered together:
scintigraphy performed
if unclear diagnosis
based on early
radiography and/or
ultrasound, and MRI/CT
performed if unclear
diagnosis based on
scintigraphy
Unclear. Number
receiving histology/
microbiology vs. clinical
follow-up unknown.
Uncertainty about
blinding of reference
standard assessors to
index test results
Unclear. Number
receiving histology/
microbiology vs. clinical
follow-up unknown
Mason (1989)79 Low. Authors
suggested that there
was a selection bias
because only patients
considered likely to
need surgery were
studied. Such patients
are probably more
likely to have infection,
although they may not
be easier to diagnose
Unclear. Owing to
uncertainty about
blinding between index
tests
Low Low
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
McCarthy
(2017)80
High. ‘Patients were
excluded if they did not
have a preoperative
MRI, if they did not
have intraoperative
bone culture data, or if
they underwent
debridement only
without reconstruction’
Low Low Low. Only a small
proportion of participants
(indeterminate results,
8.5%) were excluded
from analyses
Meller (2002)81 Low Low Low. 9/11 positive
locations were confirmed
by histology or culture.
10/25 negative locations
were confirmed negative
by histology or culture.
Other locations were
diagnosed by MRI
(n = 15) or clinical
follow-up (n = 2)
Low. 9/11 positive
locations were confirmed
by histology or culture.
10/25 negative locations
were confirmed negative
by histology or culture.
Other locations were
diagnosed by MRI
(n = 15) or clinical
follow-up (n = 2)
Miki (2015)82 Unclear. Retrospective
study, only patients
with surgery. Unclear
if all eligible patients
were recruited
Unclear. No information
on blinding to reference
standard results
Low Low
Modic (1985)83 Unclear. Unclear if
consecutively recruited
and limited reporting
of selection criteria
High. Owing to lack of
blinding to other index
tests
Low. Although 14/37
appeared to have not
undergone biopsy.
Clinical follow-up
ranged from 6 weeks to
15 months and included
antibiotics use
Low. Although 14/37
appeared to have not
undergone biopsy.
Clinical follow-up
ranged from 6 weeks to
15 months and included
antibiotics use
Morales Lozano
(2010)84
Unclear. Unclear if
selection was
consecutive
Unclear. No evidence
that interpretation of
results of index tests
were blinded to each
other
Low Low
Morrison (1993)85 Unclear. Unclear if
consecutively recruited,
limited reporting of
selection criteria
Unclear. Owing to lack
of information on
blinding between index
test assessments
Low Low. Although small
risk of verification bias
(16.3% of patients
did not receive
histopathology), and it
was not clear when
histopathology was
performed
Morrison (1998)86 Unclear. Unclear if
significant number
of participants were
excluded because of
lack of participants
with no confirmed
diagnosis
Low Low. 34 were confirmed
positive by biopsy,
although nine confirmed
positive with clinical
follow-up including
blood cultures, and
30 confirmed negative
by clinical follow-up
(rapid improvement
after conservative
management)
Low. 34 were confirmed
positive by biopsy,
although nine confirmed
positive with clinical
follow-up including
blood cultures, and 30
confirmed negative by
clinical follow-up (rapid
improvement after
conservative management)
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Nath (1992)87 Unclear. Unclear
whether or not the
patients were recruited
consecutively and
because of limited
reporting of selection
criteria
Unclear. Unclear
blinding to reference
standard and between
index tests
Low. Although unclear if
all samples were taken
from fluid from the
bone itself
Low. Only three had
clinical follow-up only
Nawaz (2010)88 Low Unclear. Unclear if staff
were blinded to the
results of each of the
three index tests
performed
Low Low. Although 33.6%
of all patients received
histopathology. Most
patients with final
negative diagnosis
(94.5%) were confirmed
by clinical examination
only. Most (85.2%) with
final positive diagnoses
were confirmed by
histopathology
Newman (1991)89 Low Unclear. Radiography
and scintigraphy were
interpreted in a blinded
fashion, but it is unclear
if interpretation of each
of the two scintigraphy
methods was performed
blinded. Bone scans
were performed after
WBC scans
Low Low. Although between
35 and 39 out of 41
eligible ulcers were
included in the analyses
across the different
index tests. Reasons for
exclusion were not
reported
Newman (1992)90 Unclear. Unclear why
only 12 of 23 patients
were included. The
scintigraphy data are a
subset of Newman
199189
Low Low Low
Nigro (1992)91 Low. Unclear if
selection was
consecutive, although
it appears that all
eligible patients were
included
High. Readers were not
blinded to the results of
the other index tests
Unclear. Duration of
clinical follow-up for
13/47 examinations
(of which 11 were
confirmed negative)
was not reported
Low. Although 13/47 had
only clinical follow-up of
unknown duration,
including around 50%
(11/21 for MRI) of
confirmed negative cases
Park (1982)92 High. Only diabetic
patients who had
radiographs,
three-phase bone
scans, and histological
confirmation of the
diagnosis, and surgery
< 4 weeks after scan
Low Low Low. Although three
patients with absent
flow were excluded
from the analysis for
scintigraphy
Rastogi (2016)93 Low Unclear. It is unclear if
the results of each of
the two index tests were
interpreted blinded and
independently
Low. Although some
concerns about the
accuracy of Jamshidi
needle biopsy
Low. Reasons for
exclusion appeared
appropriate
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Remedios
(1998)94
Unclear. Unclear if
consecutively recruited
Low. The comparison of
the two scintigraphy
tests may have biased
the scintigraphy
assessment, although
the actual comparison
between MRI and
scintigraphy was blinded
Low. All four positive
cases were confirmed by
biopsy, although four
patients were confirmed
negative by clinical
follow-up only, and one
confirmed negative by
biopsy
Low. All four positive
cases were confirmed by
biopsy, although four
patients were confirmed
negative by clinical
follow-up only, and one
confirmed negative by
biopsy
Rozzanigo
(2009)95
Unclear. Retrospective
study, unlikely to be
consecutive. Limited
reporting of selection
criteria
High. Radiography
performed before MRI to
inform conduct of MRI
(although the study was
primarily designed to
evaluate MRI, not to
compare radiography
with MRI)
Unclear. Diagnostic
method and duration of
follow-up unknown for
confirmation of 5/16
Unclear. Diagnostic
method and duration of
follow-up unknown for
confirmation of 5/16
S¸anlı (2011)96 Low Low Unclear. Unclear
how many received
histopathology
or microbiology:
histopathology, or
microbiology or
observation at surgery,
or ≥ 1 year follow-up.
Unclear if reference
standard interpretation
was blinded to index
test results
Unclear. Unclear how
many received
histopathology or
microbiology;
histopathology, or
microbiology or
observation at surgery,
or ≥ 1-year follow-up
Sarikaya (2003)97 Unclear. Unclear if
consecutively recruited
Low. For radiography:
interpreted blinded to
scintigraphy results.
High. Owing to lack of
blinding between MDP
and scintigraphy
Low. Culture with/
without histology
conducted in 36/55
lesions. Histology and
culture conducted in all
positive cases. Clinical
follow-up only
(minimum 4 months)
conducted in 19/55
Low. Although clinical
follow-up only
(minimum 4 months)
conducted in 19/55
lesions. 26/55 received
culture with/without
histology. All positive
cases were confirmed by
histology
Schlung (2016)98 Unclear. Retrospective
selection of subgroup
of patients with MRI
findings
Low Low Low
Schwegler
(2008)99
Low Low Low. Although all 13/20
negative cases were
confirmed by clinical
2-year follow-up only
Low. Although all
13/20 negative cases
were confirmed by clinical
2-year follow-up only
Seabold (1990)100 Unclear. Unclear if
consecutively recruited
patients and limited
details about selection
criteria
Low. Results of
scintigraphy and MRI
blinded, although MRI
was interpreted in
conjunction with
radiography
Low Unclear. Only 7/14
participants were
included for the analysis
of MRI accuracy, with
reasons NR
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Seabold (1995)101 Unclear. Retrospective
study, insufficient
detail on selection
Low Low High. Equivocal test
results were excluded
from analyses (two for
SPECT and six for CT in
the initial test phase)
and MRI was only
conducted and analysed
in 11 out of 25 patients
Segall (1989)102 High. Only those who
had histology result
within 3 weeks of
scan: 83 patients had
three-phase bone scan,
of whom 23 met the
final inclusion criteria.
Risk of systematic
differences between
included and excluded
participants
Low Low Low
Shemesh
(2015)103
Unclear. Retrospective
study, limited reporting
of selection process
Low Low Low
Unger (1988)104 Low Low Unclear. 14/35 (40%)
only had clinical
follow-up, and it is
not clear if any of the
patients with surgery
had histology/microbiology
Unclear. 14/35 (40%)
only had clinical
follow-up, and it is
not clear if any of the
patients with surgery
had histology/microbiology
van Vliet (2018)105 Low, although
retrospective
Unclear. Unclear if
multiple diagnostic
cut-off points were
prespecified
Low. Although 1-year
follow-up only was used
in some (7/30, including
three confirmed positive)
Low
Weber (1995)106 Unclear. Retrospective
and limited reporting
of selection criteria
Low Low Low. Despite some
limitations (exclusion
of three patients, two
patients with no culture/
histology)
Weinstein
(1993)107
Low Low Low High. 15 patients with
no histology and clinical
follow-up only were
excluded from the
analyses
Wenter (2016)108 Unclear Low for qualitative results
High for quantitative test
results, owing to post hoc
choice of optimal cut-off
point based on ROC
analysis from the study
population
Low Low
Weon (2000)109 Low Low Low. Although duration
of clinical follow-up was
not reported in patients
who did not have
histology/microbiology
(11/37)
Low. Although most
confirmed negative
patients (10/13) only
received clinical follow-up.
Duration and criteria for
clinical follow-up were
not reported
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TABLE 16 The QUADAS-2 risk-of-bias decisions (continued )
First author
and year of
publication
Could the selection
of patients have
introduced bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct
or its interpretation
have introduced bias?
Could the patient
flow have introduced
bias?
Williamson
(1989)110
Unclear. Only small
number of patients
with recent
radiography and
scintigraphy
Unclear. No evidence of
blinding between index
tests and with reference
standard. Plausible that
the CT results were not
interpreted blinded to
radiography and
scintigraphy
Low. Although only
clinical follow-up was
used for patients with
negative CT (3/7)
Low. Although only
clinical follow-up was
used for patients with
negative CT (3/7)
Yang (2016)111 Low Low High. Unlikely that clinical
follow-up (reference
standard for 22/48
patients) was done
blinded to PET test
results. Concerns about
the reliability of follow-up
as the reference
standard: patients were
considered OM positive if
resolution of symptoms
was observed after
systematic antibiotic
treatment
High. Clinical follow-up
was the reference
standard for 22/48
(45.8%). Patients were
considered OM positive if
resolution of symptoms
was observed after
systematic antibiotic
treatment
Yuh (1989)112 Low Low Low. Nearly all positive
cases were confirmed
by histopathology.
14/24 patients had
histopathology. However,
10 had clinical follow-up
only (unknown duration),
and it is unclear if
reference standard
(including follow-up)
was performed blinded
to index test results
Low. Nearly all positive
cases were confirmed
by histopathology.
14/24 patients had
histopathology. However,
10 had clinical follow-up
only (unknown duration)
Zaiton (2014)113 Low Low Low Low
NR, not reported; OM, osteomyelitis.
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TABLE 17 The QUADAS-2 applicability decisions
First author and year of
publication
Are there concerns that
the included patients and
setting do not match the
review question?
Are there concerns that
the index test, its conduct
or interpretation differ
from the review question?
Are there concerns that
the target condition as
defined by the reference
standard does not match
the review question?
Abdel Razek (2017)37 Low Low Low
Al-Khawari (2005)38 Low Low Low
Al-Sheikh (1985)39 Low Low Low
Aragón-Sánchez (2011)40 Low. Note: diabetic foot
referral centre, high
prevalence of OM
Low Low
Aslangul (2013)41 Low Low Low
Blume (1997)42 Low Low Low
Bohchelian (2002)43 Low Low Low
Bolouri (2013)44 Low Low Low
Brunel (2016)45 Low. Although extrapolation
to patients with no spinal
chord injury may be limited
Low Low
Chacko (2003)46 Low Low Low
Croll (1996)47 Low Low Low
Demirev (2014)48 Low Low Low
Enderle (1999)49 Low Low Low
Erdman (1991)50 Low Low Low
Ertugrul (2006)51 Low Low Low
Ezzat (2011)52 Low. Although excluded
patients with ‘presence of
any chronic disease with
signs and symptoms similar
to acute OM’
Low Low
Familiari (2011)53 Low Low Low
Filippi (2006)54 Low Low Low
Filippi (2009)55 Low Low Low
Franceschi (2013)56 Unclear. Conference
abstract, insufficient
information about
participants
Low Low
Gemmel (2004)57 Unclear Low Low
Guhlmann (1998)58 Low Low Low
Guhlmann (1998)59 Low Low Low
Hakim (2006)60 Low Low Low
Hartmann (2007)61 Low Low Low
Hazenberg (2011)62 Low Low Low
Heiba(2017)63 Low Low Low
Horger (2003)64 Low Low Low
Horger (2007)65 Low Low Low
Huang (1998)66 Low Low Low
Johnson (2009)67 Low Low Low
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TABLE 17 The QUADAS-2 applicability decisions (continued )
First author and year of
publication
Are there concerns that
the included patients and
setting do not match the
review question?
Are there concerns that
the index test, its conduct
or interpretation differ
from the review question?
Are there concerns that
the target condition as
defined by the reference
standard does not match
the review question?
Kaim (2000)68 Low. Although highly
selected patient population:
only long-standing,
post-traumatic OM with
suspected recurrent OM
Low Low
Kim (2017)69 Low Low Low
La Fontaine (2016)70 Low Low Low
Larcos (1991)71 Low Low Low
Larson (2011)72 Unclear. Only some may
have been referred for
suspected OM (numbers
unknown)
Low Low
Ledermann (2000)73 Low. No significant
concerns, although high
proportion of patients with
metal artefacts (11/15) and
highly selected patient
group. Only included those
with a possible relapse of
infection in chronic
post-traumatic OM
Unclear. MRIs performed in a
high proportion of patients
with metal artefacts (11/15).
Of these 11, four rated as
‘metal artefact renders film
interpretation considerably
more difficult; two rated as
‘metal artefact impairs
complete evaluation of film
because of major obscuring
artefacts’
Low
Levine (1994)74 Low. Although limited
reporting of patient
characteristics
Low Low
Lewis (1988)75 Unclear. Selection criteria
and participant
characteristics NR
Low Low
Lipman (1998)76 Low Low Low
Mahendra (2017)77 Low Unclear. No reporting on use
of antimicrobials before MRI
Low
Malcius (2009)78 Low Low Low
Mason (1989)79 Low Low Low
McCarthy (2017)80 Low Low Low
Meller (2002)81 Low Low Low
Miki (2015)82 Low Low Low
Modic (1985)83 Unclear Low Low
Morales Lozano (2010)84 Low. Although high
prevalence of OM (79.5%)
Low Low
Morrison (1993)85 Low. All suspected OM Low Low
Morrison (1998)86 Low Low Low
Nath (1992)87 Low Low Low
Nawaz (2010)88 Low Low Low
Newman (1991)89 Low Low Low
Newman (1992)90 Low Low Low
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TABLE 17 The QUADAS-2 applicability decisions (continued )
First author and year of
publication
Are there concerns that
the included patients and
setting do not match the
review question?
Are there concerns that
the index test, its conduct
or interpretation differ
from the review question?
Are there concerns that
the target condition as
defined by the reference
standard does not match
the review question?
Nigro (1992)91 Low Low Low
Park (1982)92 Low Low Low
Rastogi (2016)93 Low Low Low
Remedios (1998)94 Low Low Low
Rozzanigo (2009)95 Low Low Low
S¸anlı (2011)96 Low Low Low
Sarikaya (2003)97 Low. Patients with initial
normal bone scan were
excluded
Low Low
Schlung (2016)98 Low Low Low
Schwegler (2008)99 Low Low Low
Seabold (1990)100 Low Low Low
Seabold (1995)101 Unclear. Retrospective
study, insufficient detail on
selection
Low Low
Segall (1989)102 Low Low Low
Shemesh (2015)103 Low Low Low
Unger (1988)104 Low Low Low
van Vliet (2018)105 Low. Although only for
differentiation between
aseptic and septic delayed
union in lower extremity
Low Low
Weber (1995)106 Low. Although combines
preoperative and follow-up
scans
Low Low
Weinstein (1993)107 Low Low Low
Wenter (2016)108 Low Low Low
Weon (2000)109 Low Low Low
Williamson (1989)110 Low Low Low
Yang (2016)111 Low Low Low
Yuh (1989)112 Low Low Low
Zaiton (2014)113 Low. Plain radiography
(no radiological changes
suggesting OM), patients
scheduled for surgical
management
Low Low
NR, not reported; OM, osteomyelitis.
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Appendix 3 Participant selection criteria in
diagnostic accuracy studies
TABLE 18 Participant selection criteria in diagnostic accuracy studies
First author and year of
publication
Criteria
Inclusion Exclusion
Abdel Razek (2017)37 Suspected acute diabetic foot OM Previous foot surgical intervention
Al-Khawari (2005)38 Suspected ankle and/or foot infection NR
Al-Sheikh (1985)39 Suspected bone infection NR
Aragón-Sánchez (2011)40 Diabetic foot infection Toe necrosis caused by critical ischaemia
Aslangul (2013)41 Chronic foot ulcer with over bony
prominence, relapsing infection, or slow
healing despite adequate blood flow and
care
Received systemic antibiotic in past 14 days
or requiring surgery
Blume (1997)42 Pre-existing pedal abnormalities and clinical
suspicion of OM
NR
Bohchelian (2002)43 Diabetic foot ulcer NR
Bolouri (2013)44 High suspicion of OM of the jaw NR
Brunel (2016)45 Pressure ulcer (stage III/IV) with
unfavourable evolution despite optimal
management, referred for surgical
debridement
Antibiotics within 2 weeks before biopsies,
or no biopsy
Chacko (2003)46 Soft tissue infection overlying bone,
including decubitus ulcers, cellulitis or foot
ulcer (87.5%), and recent surgery (41.1%)
NR
Croll (1996)47 Admitted with diabetic foot infection Obvious gangrene or a fetid foot requiring
immediate surgery
Demirev (2014)48 All consecutive patients who underwent
18F-FDG-PET/CT as well as MRI scanning for
diagnosis of OM. Referred because of
inconclusive previous evaluations test
(including radiography), or inconclusive
standard radiography and CT, or to identify
location and expansion of infection before
surgery
NR
Enderle (1999)49 Patients with type 2 diabetes only,
suspected of chronic OM with a foot lesion
≥ grade 2 in accordance with the
classification of Wagner (Wagner173).
Impaired wound healing, despite
pathogenesis-adapted therapy for
> 4 weeks
Patients with acute infection
Erdman (1991)50 Suspected acute or chronic OM, with
clinical follow-up or histopathologic data
Motion artefact or metallic artefact
Ertugrul (2006)51 Suspected diabetic foot lesion with Wagner
grade of ≥ 3 ulcer
NR
Ezzat (2011)52 Children with clinical suspicion of AOM,
negative or equivocal conventional plain
radiography and presenting within 2 weeks
of symptoms onset
COM, ‘presence of any chronic disease with
signs and symptoms similar to acute OM’
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TABLE 18 Participant selection criteria in diagnostic accuracy studies (continued )
First author and year of
publication
Criteria
Inclusion Exclusion
Familiari (2011)53 High clinical suspicion of foot OM based on
the presence of signs and symptoms of
infection (exposed bone, n = 7)
NR
Filippi (2006)54 Suspected OM NR
Filippi (2009)55 Diabetes, foot lesions, abnormal laboratory
tests and clinical signs of infection
NR
Franceschi (2013)56 Chronic diabetic foot infection NR
Gemmel (2004)57 Suspected spinal infection after previous
spinal surgery with a final diagnosis based
on microbiology and/or intraoperative
findings of macroscopic pus
Recently undergone surgery (no patients
with interval of < 2 months were included)
Guhlmann (1998)58 Recurrent OM or symptoms of OM for
> 6 weeks. Trauma or surgery dating back
at least 2 years
NR
Guhlmann (1998)59 Suspected COMwith symptoms of infection
lasting > 6 weeks or presence of recurrent OM
NR
Hakim (2006)60 Provisional chronic suppurative OM
diagnosis referred for scintigraphy, with no
previous COM diagnosis
NR
Hartmann (2007)61 Suspected COMwith symptoms of infection
lasting > 6 weeks or presence of recurrent OM,
with histopathology or microbiology results
Trauma or surgical intervention on affected
bone during the 6 months prior to the
PET/CT examination
Hazenberg (2011)62 Persistent OM despite antibiotics therapy Peripheral arterial disease
Heiba (2017)63 Clinically suspected OM No SPEC/CT data or definitive diagnosis
Horger (2003)64 Suspected reactivated post-traumatic COM NR
Horger (2007)65 Clinical suspicion of acute or chronic OM NR
Huang (1998)66 Paralysed with clinically suspected acute
OM of the pelvis/hip, equivocal radiography
NR
Johnson (2009)67 MRI of the foot for evaluation of suspected
OM
Repeated examinations of the same patient,
insufficient clinical follow-up for OM
diagnosis
Kaim (2000)68 Suspected relapse of bone infection in leg,
recurrent OM
Patients with orthopaedic devices (although
three with metal artefacts were included)
Kim (2017)69 Suspected OM and patients for whom time
interval between the two index tests was
< 1 week
NR
La Fontaine (2016)70 Received either MRI or SPECT-CT and a
biopsy within 8 weeks for suspected
diabetic foot OM
NR
Larcos (1991)71 Suspected pedal OM, with final diagnosis
proved by surgery or clinical follow-up
Patients with multisystem disorders and
inadequate documentation for the foot
Larson (2011)72 Stage IV pressure ulcers undergoing surgical
debridement with intraoperative bone
culture and prior radiography. Only some
may have been referred for suspected OM
Those without surgical debridgement, or
treated but lacking bone culture and/or
radiography were excluded
Ledermann (2000)73 Suspected relapse of infection in chronic
(at least 1.5 years) post-traumatic OM
of lower extremities with complete MRI
examination on admission
NR
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TABLE 18 Participant selection criteria in diagnostic accuracy studies (continued )
First author and year of
publication
Criteria
Inclusion Exclusion
Levine (1994)74 Suspected OM because of diabetic foot ulcer ‘No surgical or histological confirmation
within 2 weeks of MRI or failure to resolve
with non-operative management’
Lewis (1988)75 Spinal cord injury patients with pressure
sores
NR
Lipman (1998)76 Peripheral neuropathy, high clinical
suspicion of OM
NR
Mahendra (2017)77 Diabetic foot ulcer ‘Previously operated cases with persistent
ulcer’
Malcius (2009)78 Pain in bone area, fever, functional disorder,
and/or signs of infection. Scintigraphy
performed if unclear diagnosis based on
early radiography and/or ultrasound, and
MRI/CT performed if unclear diagnosis based
on scintigraphy
NR
Mason (1989)79 Clinical history of suspected bone infection,
soft tissue infection, or both; a completed MR
imaging study; prior trauma, surgery, or both;
and documented operative, pathologic,
microbiologic and clinical follow-up
Incomplete MRI examination, MRI after
resection, lack of follow-up data
McCarthy (2017)80 Surgical reconstruction of pressure ulcer
with preoperative MRI and intraoperative
bone cultures
No MRI, no intraoperative culture data,
debridement only without reconstruction
Meller (2002)81 Non-diabetic, suspected COM based on
positive scintigraphy
NR
Miki (2015)82 Diabetic foot ulcer, undergone surgery and
histopathology, type 2 diabetes
NR
Modic (1985)83 Strong suspicion of vertebral OM based on
symptoms, laboratory abnormalities,
abnormal or suspicious radiographic
assessment and predisposing factors
NR
Morales Lozano (2010)84 Diabetic patients with infected foot ulcer
attending a diabetic foot clinic with
suspicion of OM based on ulcer specimen
culture, radiography and probe-to-bone test.
Single ulcer (neuropathic or neuroischemic),
previous surgery for OM or unresolved ulcer
following local or antibiotic treatment
Critical ischaemia or due for an operation
unrelated to OM
Morrison (1993)85 Suspected OM NR
Morrison (1998)86 Suspected foot OM with minimum 6 weeks’
follow-up
NR
Nath (1992)87 Pain and swelling of the affected limb,
suspected OM
NR
Nawaz (2010)88 Diabetic foot disease and/or diabetes with
suspected deep-seated infection(s) of the
lower extremity(or extremities). Serum
glucose levels of < 200 mg/dl
NR
Newman (1991)89 Diabetic foot ulcer, inpatients and
outpatients
Myocardial infarction, severe peripheral
vascular disease, ongoing antibiotic
treatment of > 7 days or patient declined to
participate
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TABLE 18 Participant selection criteria in diagnostic accuracy studies (continued )
First author and year of
publication
Criteria
Inclusion Exclusion
Newman (1992)90 Clinical suspicion of OM by referring
physician
Myocardial infarction, severe peripheral
vascular disease, ongoing antibiotic treatment
for > 7 days or patient declined to participate
Nigro (1992)91 Patients with foot inflammation and
possible OM referred for MRI
NR
Park (1982)92 Diabetic patients who had radiographs,
three-phase bone scans, and histological
confirmation of the diagnosis
Surgical procedure performed more than
4 weeks after the bone scan
Rastogi (2016)93 Diabetic Charcot neuroarthropathy,
suspected diabetic foot OM, foot ulcer or
discharging sinus
Unfit for PET/CT or MRI, previous antibiotic
treatment for foot infections for > 72 hours,
peripheral vascular disease
Remedios (1998)94 Peripheral neuropathy chronic foot ulcers
and clinical signs of OM
NR
Rozzanigo (2009)95 Infected ulcer affecting the forefoot/
midfoot/hindfoot
NR
S¸anlı (2011)96 Suspected bone or orthopaedic implant
infection based on clinical signs
NR
Sarikaya (2003)97 Clinically suspected OM, diabetes,
non-healing ulcers or gangrene
Normal scintigraphy, antibiotics within
1 week of imaging and culture
Schlung (2016)98 Septic hip (presumed likely or confirmed)
with joint aspirate or culture data following
treatment with irrigation and debridement
and antibiotics who underwent preoperative
MRI
No septic hip (presumed or confirmed) with
joint aspirate or culture data, no preoperative
MRI
Schwegler (2008)99 Diabetes, non-healing chronic foot ulcer for
at least 8 weeks; absence of antibiotic
pretreatment and of clinical signs or
symptoms of local or systemic infection
Clinical signs of local infection, antibiotic
treatment at time of PET or within 1 month
Seabold (1990)100 High clinical suspicion of OM in or around
neuropathic joint(s)
NR
Seabold (1995)101 Suspected cranial OM undergoing
diagnostic imaging
NR
Segall (1989)102 Histological test for OM within 3 weeks of
bone scan
NR
Shemesh (2015)103 Cases suspected of deep infection following
osteosynthesis for fractures of the tibia,
treated surgically and had preoperative
PET/CT scan
NR
Unger (1988)104 Clinical suspicion of acute OM NR
van Vliet (2018)105 Underwent 18F-FDG-PET/CT at level 1 trauma
centre between March 2010 to October 2014
Surgery within 3 months of PET/CT
Weber (1995)106 Clinically suspicious postoperative initial
persistent or recurrent OM
NR
Weinstein (1993)107 Clinical suspicion of OM, non-healing foot
ulcer or soft tissue infection of the foot
NR
Wenter (2016)108 Suspected chronic OM treated in major
trauma centre. Pain, absence of clear
clinical or laboratory markers for acute local
infection, non-conclusive radiography
and MRI
NR
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TABLE 18 Participant selection criteria in diagnostic accuracy studies (continued )
First author and year of
publication
Criteria
Inclusion Exclusion
Weon (2000)109 Suspected OM NR
Williamson (1989)110 Suspected OM based on radiography NR
Yang (2016)111 Suspected diabetic foot OM, consecutively
included
NR
Yuh (1989)112 Diabetes with clinical suspicion of OM
and/or non-healing foot ulcers
NR
Zaiton (2014)113 Foot ulcers with sign of infection, normal
radiography with no sign of OM, scheduled
for surgical management
Recurrent or long-standing OM with evident
radiographic changes, ischaemic foot ulcers,
minor abrasion or laceration, presence
of contraindication to surgery or MRI
examination
NR, not reported; OM, osteomyelitis.
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Appendix 4 Results of diagnostic meta-analyses
TABLE 19 Summary of diagnostic accuracy studies
First author and year of
publication Population Cause Diagnostic tests used
Al-Khawari (2005)38 Adults Diabetic foot ulcers MRI
Al-Sheikh (1985)39 Adults NR Scintigraphy and radiography
Aragón-Sánchez (2011)40 Adults Diabetic foot ulcers Radiography
Aslangul (2013)41 Adults Diabetic foot ulcers SPECT/CT
Blume (1997)42 Adults Diabetic foot ulcers Scintigraphy and radiography
Bolouri (2013)44 Mixed Multiple CT, scintigraphy, SPECT/CT and
radiography
Brunel (2016)45 Adults Pressure ulcers MRI
Chacko (2003)46 NR Multiple PET
Croll (1996)47 Adults Diabetic foot ulcers MRI, scintigraphy and radiography
Demirev (2014)48 Adults Multiple MRI and PET-CT
Enderle (1999)49 Adults Diabetic foot ulcers MRI, scintigraphy, ultrasound and
radiography
Erdman (1991)50 Mixed Multiple MRI
Ertugrul (2006)51 NR Diabetic foot ulcers MRI and scintigraphy
Familiari (2011)53 Adults Diabetic foot ulcers PET-CT and scintigraphy
Filippi (2006)54 Adults Multiple SPECT/CT
Filippi (2009)55 Adults Diabetic foot ulcers SPECT/CT
Franceschi (2013)56 Adults Diabetic foot ulcers PET-CT
Gemmel (2004)57 Mixed Surgical Scintigraphy and SPECT
Guhlmann (1998)58 Adults Trauma or surgery PET and scintigraphy
Guhlmann (1998)59 Adults Trauma or surgery PET
Hakim (2006)60 Adults Dental infection, trauma, others PET and SPECT
Hartmann (2007)61 Adults Trauma PET-CT
Hazenberg (2011)62 NR Diabetic foot ulcers MRI
Heiba (2017)63 Adults NR Scintigraphy and SPECT/CT
Horger (2003)64 Adults Trauma SPECT/CT
Horger (2007)65 Adults Multiple SPECT/CT (n = 15), MRI (n = 6) and
radiography (n = 20)
Huang (1998)66 Adults Skin ulceration MRI
Johnson (2009)67 Adults Diabetes, other MRI
Kaim (2000)68 Adults Trauma MRI and scintigraphy
La Fontaine (2016)70 Adults Diabetic foot ulcers MRI and SPECT/CT
Larcos (1991)71 Adults Diabetic foot ulcers Scintigraphy and radiography
Ledermann (2000)73 Adults Trauma MRI
Levine (1994)74 Adults Diabetic foot ulcers MRI, scintigraphy and radiography
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TABLE 19 Summary of diagnostic accuracy studies (continued )
First author and year of
publication Population Cause Diagnostic tests used
Lewis (1988)75 Adults Skin ulceration CT, scintigraphy and radiography
Lipman (1998)76 Adults Diabetes (85%), peripheral
neuropathy (100%)
MRI
Mahendra (2017)77 Adults Diabetic foot ulcers MRI
Mason (1989)79 NR Trauma (93%), other (7%) MRI and scintigraphy
McCarthy (2017)80 Adults Skin ulceration MRI
Meller (2002)81 Adults Multiple PET and scintigraphy
Miki (2015)82 Adults Diabetic foot ulcers MRI
Modic (1985)83 Adults Multiple MRI, scintigraphy (and SPECT n = 5)
and radiography
Morales Lozano (2010)84 NR Diabetic foot ulcers Radiography
Morrison (1993)85 Mixed Multiple MRI
Morrison (1998)86 Adults Diabetes (85%), others (15%) MRI
Nath (1992)87 Mixed NR Ultrasound and radiography
Nawaz (2010)88 Adults Diabetic foot ulcers MRI, PET and radiography
Newman (1992)90 NR Diabetic foot ulcers Scintigraphy and radiography
Newman (1991)89 NR Diabetic foot ulcers MRI and scintigraphy
Nigro (1992)91 Adults Diabetic foot ulcers, foot ulcers or
inflammation
MRI, scintigraphy and radiography
Park (1982)92 NR Diabetic foot ulcers Scintigraphy and radiography
Rastogi (2016)93 Adults Diabetic foot ulcers MRI and PET-CT
Remedios (1998)94 Adults Diabetic foot ulcers MRI and scintigraphy
Rozzanigo (2009)95 Adults Diabetic foot ulcers MRI and radiography
Sarikaya (2003)97 Adults Diabetic foot ulcers Scintigraphy and radiography
Schwegler (2008)99 Adults Diabetic foot ulcers MRI, PET and scintigraphy
Seabold (1990)100 Adults Neuropathic osteoarthropathy MRI and scintigraphy
Seabold (1995)101 Mixed Multiple CT, MRI and SPECT
Segall (1989)102 Adults Diabetic foot ulcers Scintigraphy and radiography
Shemesh (2015)103 Adults Trauma or surgery PET-CT
Unger (1988)104 Mixed NR MRI and scintigraphy
van Vliet (2018)105 Adults Trauma and septic delayed union PET-CT
Weber (1995)106 Mixed Multiple CT and SPECT
Weinstein (1993)107 Adults Diabetic foot infections MRI, scintigraphy and radiography
Wenter (2016)108 Adults Trauma PET-CT
Weon (2000)109 Mixed Mixed Scintigraphy and SPECT
Williamson (1989)110 Adults Mixed CT and scintigraphy
Yang (2016)111 Adults Diabetic foot ulcers PET
Yuh (1989)112 Adults Diabetic foot ulcers MRI, scintigraphy and radiography
Zaiton (2014)113 Adults Diabetic foot ulcers MRI
NR, not reported.
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TABLE 20 Results from logistic regression model to compare tests
Test
Difference in log-odds of specificity Difference in log-DOR
Estimate Standard error p-value Estimate Standard error p-value
Comparison with radiography
MRI –0.149 0.228 0.512 2.392 0.339 0
Scintigraphy 0.83 0.198 0 0.554 0.272 0.041
CT –0.399 0.465 0.391 1.139 0.565 0.044
SPECT 0.261 0.362 0.471 2.493 0.53 0
PET –1.085 0.377 0.004 2.516 0.493 0
Comparison with MRI
Scintigraphy 0.977 0.224 0 –1.838 0.336 0
Radiography 0.149 0.228 0.515 –2.2392 0.339 0
CT –0.247 0.482 0.608 –1.258 0.609 0.039
SPECT 0.412 0.352 0.242 0.1 0.526 0.85
PET –0.936 0.371 0.012 0.126 0.498 0.801
TABLE 21 Summary of studies of scintigraphy
First author and year
of publication
Number of
participants Type or cause of osteomyelitis Isotope and scintigraphy type
Included in main meta-analysis
Al-Sheikh (1985)39 22 Multiple 67Ga
99mTc-MDP
99mTc-MDP/67Ga
111In WBC
Blume (1997)42 27 Diabetic foot ulcers 99mTc-HMPAO WBC
99mTc-MDP
Bolouri (2013)44 42 Jaw/head 99mTc-DPD
Croll (1996)47 22 Diabetic foot ulcers 99mTc-MDP
111In WBC
Enderle (1999)49 16 Diabetic foot ulcers 99mTc-MDP
Ertugrul (2006)51 26 Diabetic foot ulcers 99mTc-WBC and 99mTc-MDP
Familiari (2011)53 13 Diabetic foot ulcers 99mTc-HMPAO WBC
Gemmel (2004)57 22 Surgical in spine 99mTc-ciprofloxacin (Infection;
Bayer plc, Newbury, UK)
Guhlmann (1998)59 37 Contiguous (multiple locations) 99mTc-AGAb/99mTc-MDP
Heiba (2017)63 33 Pelvis/hip Not reported
Kaim (2000)68 19 Long bone trauma 99mTc-DPD/99mTc-Mab
Larcos (1991)71 49 Diabetic foot ulcers 99mTc-MDP
Larcos (1991)71 51 Diabetic foot ulcers 111In WBC
Levine (1994)74 11 Not reported 99mTc-HMDP
111In WBC
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TABLE 21 Summary of studies of scintigraphy (continued )
First author and year
of publication
Number of
participants Type or cause of osteomyelitis Isotope and scintigraphy type
Lewis (1988)75 52 Skin ulceration 99mTc-WBC
Mason (1989)79 11 Long bone trauma 111In WBC
Meller (2002)81 34 Multiple 111In WBC
Modic (1985)83 20 Multiple 67Ga
99mTc-HMDP
Newman (1991)89 39 Diabetic foot ulcers 99mTc-MDP
111In WBC
Newman (1992)90 16 Diabetic foot ulcers 111In WBC
Nigro (1992)91 39 Diabetic foot ulcers 99mTc-HMDP
Park (1982)92 36 Diabetic foot ulcers 99mTc-MDP
Remedios (1998)94 9 Diabetic foot ulcers 99mTc-NA
Sarikaya (2003)97 55 Diabetic foot ulcers 99mTc-MDP
99mTc-dextran
Schwegler (2008)99 20 Diabetic foot ulcers 99mTc-Mab
Seabold (1990)100 16 Neuropathic osteoarthropathy 111In WBC/99mTc-MDP
Segall (1989)102 24 Diabetic foot ulcers 99mTc-MDP
Unger (1988)104 31 Multiple 99mTc-MDP
Weinstein (1993)107 22 Diabetic foot infections 99mTc-MDP/67Ga
Weon (2000)109 12 Hip/knee 99mTc-HMPAO WBC
Williamson (1989)110 7 Foot (mixed causes) 99mTc-MDP
Yuh (1989)112 29 Diabetic foot ulcers 99mTc-MDP
Additional studies reporting only scintigraphy
Glaudemans (2013)132 61 Multiple 99mTc-HMPAO WBC
Harwood (1999)136 47 Diabetic foot ulcers 99mTc-MDP
99mTc-Mab
99mTc-WBC
Kolindou (1996)142 107 Multiple 111In WBC/99mTc-MDP
Mora (2010)148 94 Not reported 99mTc ciprofloxacin
Nepola (1993)149 44 Trauma or surgery 99mTc-MDP and 111In WBC scan
Nijhof (1997)150 26 Multiple 99mTc-MDP
111In IgG
Noriega-Alvarez (2017)151 27 Multiple 99mTc-HMPAO WBC
Oyen (1992)152 52 Multiple 99mTc-MDP and 111In IgG
Sorsdahl (1993)165 126 Multiple 99mTc-MDP(3 phase) + 67Ga
DPD, diphosphono-1,2-propanodicarboxylic acid.
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TABLE 22 Results from logistic regression model to compare tests
Test
Difference in log-odds of specificity Difference in log-DOR
Estimate Standard error p-value Estimate Standard error p-value
Comparison with radiography
MRI –0.149 0.228 0.512 2.392 0.339 0
Scintigraphy 0.83 0.198 0 0.554 0.272 0.041
CT –0.399 0.465 0.391 1.139 0.565 0.044
SPECT 0.261 0.362 0.471 2.493 0.53 0
PET –1.085 0.377 0.004 2.516 0.493 0
Comparison with MRI
Scintigraphy 0.977 0.224 0 –1.838 0.336 0
Radiography 0.149 0.228 0.515 –2.2392 0.339 0
CT –0.247 0.482 0.608 –1.258 0.609 0.039
SPECT 0.412 0.352 0.242 0.1 0.526 0.85
PET –0.936 0.371 0.012 0.126 0.498 0.801
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FIGURE 31 The HSROC curves in studies of people with diabetic foot ulcers.
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FIGURE 32 Summary PPV and NPV in studies of people with diabetic foot ulcers.
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TABLE 23 Univariate meta-analyses of studies of people with diabetic foot ulcers
Test Outcome Estimate (%) 95% CI (%) I2
MRI Sensitivity 95.76 91.83 to 97.85 0
Specificity 81.79 69.35 to 89.91 0
DOR 51.08 21.3 to 122.53 60
PR 70.43 64.03 to 77.47 1
PET Sensitivity 84.34 52.77 to 96.29 0
Specificity 92.8 75.67 to 98.16 0
DOR 33.91 11.75 to 97.92 12
PR 45.88 27.81 to 75.69 36
Scintigraphy Sensitivity 84.69 65.86 to 94.07 0
Specificity 73.99 54.96 to 86.89 0
DOR 8.66 4.74 to 15.83 16
PR 73.57 64.29 to 84.2 9
SPECT Sensitivity 95.53 75.95 to 99.31 0
Specificity 55.09 19.26 to 86.32 36
DOR 22.91 1.91 to 274.73 62
PR 76.7 62.79 to 93.69 0
Ultrasound Sensitivity 78.57 2.39 to 99.82 –
Specificity 80 1.61 to 99.9 –
DOR 14.67 1.16 to 185.23 –
PR 63.16 30.87 to 129.23 –
Radiography Sensitivity 68.91 57.55 to 78.38 11
Specificity 77.99 63.67 to 87.76 0
DOR 5.97 3.09 to 11.51 62
PR 51.95 41.08 to 65.68 62
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FIGURE 33 Meta-analysis of scintigraphy studies in people with diabetic foot ulcers.
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FIGURE 34 Difference in DOR between studies – patients with diabetic foot ulcers.
TABLE 24 Results of logistic regression to compare tests – diabetic foot ulcers
Test
Difference in log-odds of specificity Difference in log-DOR
Estimate Standard error p-value Estimate Standard error p-value
Comparison with radiography
MRI –0.175 0.255 0.493 2.188 0.366 0
Scintigraphy 0.727 0.244 0.003 0.731 0.344 0.034
SPECT 0.792 0.728 0.277 0.43 1.043 0.68
PET –1.121 0.424 0.008 1.991 0.541 0
Comparison with MRI
Scintigraphy 0.902 0.281 0.001 –1.458 0.389 0
Radiography 0.175 0.255 0.493 –2.188 0.366 0
SPECT 0.968 0.682 0.156 –1.758 0.992 0.076
PET –0.946 0.429 0.028 –0.197 0.588 0.738
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FIGURE 35 The PPV and NPV by test location.
PP
V
 (
%
)
PP
V
 (
%
)
60
70
80
90
100
Trauma or surgery related
50
40
30
NPV (%)NPV (%)
NPV (%) NPV (%)NPV (%)
100 8090 6070 4050 2030
Unstated/other
100 8090 6070 4050 2030
60
70
80
90
100
Contiguous
50
40
30
PP
V
 (
%
)
PP
V
 (
%
)
60
70
80
90
100
50
40
30
60
70
80
90
100
50
40
30
PP
V
 (
%
)
60
70
80
90
100
50
40
30
Infection or ulcer Multiple
100 8090 6070 4050 2030100 8090 6070 4050 2030100 8090 6070 4050 2030
CT
MRI
PET
Scintigraphy
SPECT
Ultrasound
Radiography
Test used
FIGURE 36 The PPV and NPV by cause of osteomyelitis.
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FIGURE 37 Summary sensitivity and specificity by test location.
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FIGURE 38 Summary sensitivity and specificity by cause of osteomyelitis.
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TABLE 25 Univariate meta-analysis – patients without diabetes
Test Outcome Estimate (%) 95% CI (%) I2
CT Sensitivity 67.86 37.14 to 88.3 0
Specificity 90.78 55.85 to 98.71 0
DOR 9.74 3.33 to 28.48 10
PR 51.72 32.82 to 81.51 20
MRI Sensitivity 95.26 87.48 to 98.3 0
Specificity 76.27 55.69 to 89.15 0
DOR 30.28 10.64 to 86.19 43
PR 80.69 71.97 to 90.47 22
PET Sensitivity 80.75 59.87 to 92.18 0
Specificity 90.25 67.8 to 97.6 0
DOR 34.2 12.5 to 93.55 36
PR 53.5 42.2 to 67.81 0
Scintigraphy Sensitivity 83.01 65.12 to 92.74 0
Specificity 69.32 48.95 to 84.19 0
DOR 9.34 4.15 to 21.05 36
PR 70.12 59.79 to 82.22 0
SPECT Sensitivity 94.88 85.51 to 98.31 0
Specificity 90.06 74.84 to 96.5 0
DOR 95.82 21.89 to 419.35 52
PR 72.32 61.11 to 85.58 0
Ultrasound Sensitivity 96.77 52.46 to 99.88 –
Specificity 30 0.49 to 97.37 –
DOR 12.86 0.56 to 292.75 –
PR 86.27 63.14 to 117.88 –
Radiography Sensitivity 60.26 34.57 to 81.31 0
Specificity 89.79 59.53 to 98.13 44
DOR 7.07 2.71 to 18.41 0
PR 56.29 40.33 to 78.57 0
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FIGURE 39 Comparisons of DORs across tests – patients without diabetes.
TABLE 26 Results of logistic regression to compare tests – patients without diabetes
Test
Difference in log-odds of specificity Difference in log-DOR
Estimate Standard error p-value Estimate Standard error p-value
Comparison with radiography
MRI 0.472 0.598 0.43 2.062 0.898 0.022
Scintigraphy 0.989 0.412 0.016 0.325 0.567 0.566
CT –0.144 0.545 0.792 0.813 0.687 0.236
SPECT 0.408 0.538 0.447 3.108 0.841 0
PET –1.003 0.829 0.226 3.607 1.092 0.001
Comparison with MRI
Scintigraphy 0.507 0.519 0.329 –1.722 0.797 0.031
Radiography –0.484 0.598 0.418 –2.045 0.897 0.023
CT –0.625 0.667 0.348 –1.236 0.946 0.191
SPECT –0.074 0.581 0.899 1.061 0.942 0.26
PET –1.488 0.811 0.066 1.562 1.076 0.147
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